Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 3
1 [ . . . . : . . . . 1 . ] 120
batch____ bits E-value N 100.0% 1:120 METRLNLLCEAGVIDKDICKGMMQVVNVLETECHLPVRSEQGTMAMTHMASALMRSRRGEEIEPLDNELLAELAQSSHWQAVVQLHQVLLKEFALEVNPCEEGYLLANLYGLWMAANEEV
1 UniRef50_C9RTD1 PTS modulated transcription... 99 3e-20 1 19.1% 9:118 197:305 --------KLLGLVDRKKLSIIEQQIERVKEKLPFTMADSSYIAFVVHLALAIERIKQGEAIH-FDPRDLQALQATKEYEIARVLAESLERAFGIDIPNEEVGYMTMHLMGAKWRSRQ--
2 UniRef50_Q67SK7 BglG family transcription a... 98 9e-20 1 17.6% 2:120 55:171 -RNRKRFLRLTETLSGDVIGVAEEILNLAAARFG-PLGEEAHLTLAEHLAATVDRVRKGMPIPNPFLAQI-QLLYPEEYALAGQAVEMIASRLGVTLPEEEQGILALHLLGAWRRESPKV
3 UniRef50_C6DCM5 Transcriptional antitermina... 95 8e-19 1 14.2% 7:119 59:170 ------LSQLLADIPPDCLAVTQQIITLAQKTLRLNVQDTLFLALSDHINFAIQRHKKGQTIKNLMLWDIRQF-YHSEFAVGLEALALIRTRLGIDLPEDEAGFIALHLANATNNSDMQ-
4 UniRef50_B0PCB1 Putative uncharacterized pr... 95 8e-19 1 6.2% 6:117 85:195 -----RLKQLFSSMPLEHIEVTNRIIAYARKILGKRLNHSIYITLTDHISFSVLRFRQNMMFHNALLAEMRRF-YPQEYSIGQYALDLIAKELGVRFPDDEAASIAMHIVNAEYDIS---
5 UniRef50_C2HCM5 Transcriptional antitermina... 94 1e-18 1 8.8% 6:119 81:193 -----QFQELAQAIPLEYLEISCEIIEYTKEALQVQLNDSVYIALTDHLYTAIERHKMGIFVPNVLLYDIKQLFH-KEYAIGKKTVKKISDKYHIKLSEDEAGFIALHLVNAQGIQSQQ-
6 UniRef50_A4ILQ1 Transcription antiterminato... 94 1e-18 1 9.5% 2:117 71:185 -REQEQYKKLLPELSEEFIALMNEVIQHIKQRVGVPLNEHIHVALTDHIAFTLKRLEQGLDVKNPFLVETKSL-YPLEYEIAAEVAELIGDKLGVALPEGEVGFITLHIHSAISKQS---
7 UniRef50_C6CTN7 Transcriptional antitermina... 94 1e-18 1 14.8% 5:112 66:172 ----LHYHSLLEELDPEVVQISEQIIDEIRERLGTPVDPKVYFALPSHIQFVVYRLRNGMEIVNPFLYETK-MCYPQEFKIAAKAAKMISEKFDITIPEDEVGFLTYHVYSA--------
8 UniRef50_C9B3C8 Transcriptional antitermina... 94 2e-18 1 11.2% 3:118 55:169 --AKNQFQQLMADIPAEEIEWVKQVVEQAEDKLKVEFSPNIYLTLTDHLHYAITRAKENIQLPNPLLFETKKF-YPKEYQAAKEALLFVKQKTGVELSEDEAGFIAFHFVNSQQGNED--
9 UniRef50_B0K352 Transcriptional antitermina... 93 2e-18 1 12.4% 3:115 56:167 --NKIKFSELMEKIRGDVIGIAEEIIAMAEKIKGKKLNEHIHIALADHIAFAIERINMGIEIKNPFDIEIKAL-YKDDYNIALKALELINQRLNISLPEDEAGFIALHLHAALEN-----
10 UniRef50_P15401 Levansucrase and sucrase sy... 93 2e-18 1 10.8% 5:115 56:165 ----KQFEEILETLPEDHIQISEQIISHAEKELNIKINERIHVAFSDHLSFAIERLSNGMVIKNPLLNEIK-VLYPKEFQIGLWARALIKDKLGIHIPDDEIGNIAMHIHTARNN-----
11 UniRef50_UPI000178876C transcriptional antitermina... 93 3e-18 1 16.8% 6:112 67:172 -----QAHHLLEEFDPQVMEITDQILNLIGQEFPGTLNDKVYLALPSHIQFTIYRIRKGMDIINPFLEETR-ISFPKEYDIAAKAAELIGKTFDIEVPEDEIGFLTYHVYSA--------
12 UniRef50_C9KJT4 Transcriptional antitermina... 93 3e-18 1 21.8% 9:118 196:304 --------YLLKLVDKQMIHDLEQLVHEVESGLPHHLSDTAFIGLVVHLSLAIQRMRKKEDIH-IDTATLAALRKRREYRMAKELARRITAQFQTEVPEDEIGYITMHLMGARSFYRK--
13 UniRef50_A8F9J0 Transcriptional antitermina... 92 3e-18 1 11.8% 1:119 55:170 VHERMKMLLL--EVPYDVVKVTEEMIQYAHTKLNRRLNESLHVSLADHIHYAIERLKKNHLIENSLIWEIKRL-YKDEFLVAKDCLEMIEERLHIELPEDEAGFIAMHIINAELNEDMN-
14 UniRef50_Q8EN85 Transcriptional antitermina... 92 3e-18 1 17.1% 9:119 196:305 --------RLLGLVDAEKLDKIEEQIQRMRNQLPYDLADSAYIGLVVHIALAMERLQKG-DIIHFDDEYKEQIKDEQEYKIAAEVIGHLEEAFSLFIPEDEIGYITMHLMGAKLRENQN-
15 UniRef50_O31691 PtsGHI operon antiterminato... 92 5e-18 1 10.5% 2:115 58:170 -KEQKQFKKLLDYVDEKLVDISNDVIYHISNRTNHSLNEHIHIALTDHIAFAIKRQQQGFDMKNPFLMETQSL-YPEEYQIAKEVIDMINEKAGLCLPEGEIGFIALHIHSALTN-----
16 UniRef50_B0K3R4 Transcriptional antitermina... 91 7e-18 1 20.5% 3:119 188:303 --EKNIDLRLLNLIDYDTVLKIEKAILKLKSQIDYEIVESSYLGLVVHLALAIKRLQNGETIE-MGEDNLQELKKTNEYKFAKKLAKYLQEELDIPIPEDEIGYVTIHLIGAKYRSTTQ-
17 UniRef50_Q18DC6 Beta-glucoside bgl operon t... 91 8e-18 1 11.9% 5:113 59:166 ----KQFLELMDDIPVDILKITQEIIVEAEKLLNSSFNKNLYLILADHFNFAIERMRKGIKITNRVFWEIKNY-YPNEFKVGMVAIYMVEERLGIQLPEEEAANIAFHFANAM-------
18 UniRef50_A4EAF5 Putative uncharacterized pr... 91 8e-18 1 14.0% 6:119 51:163 -----RLAHLLESIPTVNLVISEDIVQMLRRELNVDINDKILIALADHISLALERERKGISCENPLLLEIQQF-YRKEYALAGRALQIIKEYMGIQMSEEEQGFITLHIVNATMPQRSD-
19 UniRef50_B7GIF9 Transcriptional antitermina... 91 8e-18 1 9.5% 2:117 58:172 -REQEQYKKLLPHVDEEFIGLMNDIIHHIQKRTNSSLNEHIHVALTDHILFAIKRLEQGMDIKNPFLVETKSL-YPLEYDVATEVVNMLNERLRIQLPEGEIGFIALHIHSALTNHQ---
20 UniRef50_B7GJR6 Transcriptional antitermina... 91 9e-18 1 18.7% 9:115 197:302 --------KLLGLVDKKKLFMIERQIEAMKDDLPFTIADSSYIALVIHLALAIERIMQGEAIH-FDAQHLQTISMTKEYETAEKIAKRLEEVFHLVIPKEEIGYITMHLMGAKLR-----
21 UniRef50_C0Z8I8 Transcriptional regulator n... 91 1e-17 1 23.4% 9:119 197:306 --------RLLGLIDREKLIKVENALSHLDEELPYPLADSAYLGLVTHLALAMERIEKGEGIH-FDEHTLSELNGTPEYEIASNIMERLKQIFQMEIPADEIGYITMHLRGAKLRHSPD-
22 UniRef50_C6PDR4 PTS system transcriptional ... 91 1e-17 1 11.8% 1:119 424:541 ITEEKNKQNLIHILGEDIINITDRIAELVSELLGKELSQNSYTALALHLNTLIERVNKNKPIVNPQLSKIKQL-YPREFEVAVEAKKIIEKYLNVSIPEDEAGFITIFLISDKEYINRQ-
23 UniRef50_A8SBZ8 Putative uncharacterized pr... 90 2e-17 1 12.7% 2:111 122:229 -ELQTKFLKMLDNVTPQVMQAAERISLAAEEQ-GILLSSKSTISLVDHISFALERVEKGTFLPNLMLSETR-MLYPKEYAVGQRALELVRQFCGVQLPEDEAGYIALHLVA---------
24 UniRef50_C5D9V5 PTS modulated transcription... 90 2e-17 1 18.4% 5:118 180:292 ----KQLKLIEDVLKPYELTLIEKEIRKMDEWLEFPLTDQSVISLTIHIAIAIKRIKKGHRIH-IDTNQLQELQKKPEYKLAEQLAKQIEQWVAVKIPKAEIGYITLHLLGARLRYDQ--
25 UniRef50_Q67S02 Putative transcriptional an... 90 3e-17 1 32.1% 1:112 6:119 LEMRLRLLQESGQISPEVAELTRWILKRVEERYDMTVTEENGAMFTTHLAVALERLRSGQAIDEMVSEGLAEVkyPEEWAFVNEVVaeAGRRLGARVPEAEVGYLTAHLITL--------
26 UniRef50_A6TVY0 Transcriptional antitermina... 89 3e-17 1 25.6% 1:117 199:311 IKTRNRLL---NLIDKETIRTLEGLIYIAEEEMGYKLADSAYVGLIVHLALAIKRIKNNEIII-MDKEFLNELNQNPEFIIARKLALNLSDFFNIDIHEDEIGYITMHLMGSKNRGN---
27 UniRef50_A4J1C8 Transcriptional antitermina... 89 3e-17 1 13.0% 6:113 65:171 -----KALALMEQVDPAVINVTQNIIELAKAQLGEGLHPRVHVALADHINFTLIRLAQGMEIKNPFLAEIEAM-YPKEFSIAKQGAVLILEKMNIFIPPEEIGFIALHLHSAR-------
28 UniRef50_C5WHP5 Putative uncharacterized pr... 89 4e-17 1 13.6% 6:115 62:170 -----DLSDLYEQLPDEELNLFISLIDQAEQSLGLTFDENLHLSLTDHLHFMVVRVRQGVSISNPLAWEVRKF-YAQEYQVAKEMLVHLRKKLALDIPDDEAASIALHLINAQTE-----
29 UniRef50_C3RIA8 Transcription antiterminato... 89 5e-17 1 8.5% 2:119 54:170 -KQNNRFLELIKDIPVDVLNVTDEIIDFARNGLDKELNDGIYITLTDHINYAIERYLQGINVQNPLLWEIRQF-YQEEYKIAAEALKIINQKLMVNLSEDEVGFIALHFVNAELNSEME-
30 UniRef50_A8FJ69 BglG family transcriptional... 89 5e-17 1 9.6% 5:118 58:170 ----KEFLQLLDSMPQEFIDLTQRIVQYAEKRLNSSLNSGVYFTLMDHLNFAVERHKKNINITNRVYWEIKNY-YTEEFEVGKYALELVNDTLSIQLPKEEAANIAFHLINALGEESD--
31 UniRef50_A4IML7 Regulatory protein n=10 Tax... 89 5e-17 1 11.8% 1:110 481:586 IRNRRDLEK---MVTPDVLALTEAMVVYVEKKLGRRLAKKVTYALALHIQTAINRLRAGTIVSHPKLNEVRAA-YKHEFAVALDCLHLMEEKMHIDLPIDEAGFLTMFFA----------
32 UniRef50_D1PSC1 Transcription antiterminato... 89 5e-17 1 12.5% 4:115 56:166 ---QRRLRELVEQIPIEHLDLTEAMIAEIKAAIHQPLNESLLITLADHISFAIQRKAQGIEFKNPLAGSIL-CYYPTEYQLGQRCLAMVKERFGVELSPDEAAFIALHIVNAELN-----
33 UniRef50_P96574 Putative phosphotransferase... 89 6e-17 1 18.9% 9:119 191:300 --------KMFGVVSKGELLKMERILFQLKEKIAFSLSDSSYIALVVHLTYAIERIKLGETIT-MEQNELEELMNAKEYSSALEIAGELERAFGVTIPEAEVGYITIHLRSANRKYKTE-
34 UniRef50_P26211 Beta-glucoside operon antit... 89 6e-17 1 10.7% 6:117 58:168 -----RLSDVLERIPLEVVTTADRIIALAKEKLGGNLQNSLYISLTDHCHFAIERHRQGVDIRNGLQWEVKRL-YQKEFAIGLDALDIIHRRLGVRLPEDEAGFIALHLVNAQLDSH---
35 UniRef50_B1MZ35 Transcriptional antitermina... 88 7e-17 1 13.0% 5:119 57:170 ----KEYVQLLEAIPITILDATRRIVSEAEKRLNTKLNPMLYIMLSDHLNFAIERAMTGINITNRAFWEMKNY-YPEEFDLGLFALQVIEQQMNIVLPEEEAANIAFHLINAQTAEGIK-
36 UniRef50_C4FAP7 Putative uncharacterized pr... 88 8e-17 1 12.3% 6:119 57:169 -----RLERLIKGIPSEYLLIAEDIVAMLRRESDSVIDDSVLIALTDHISMALEREQAGIICDNPLLFEIKRF-YGREFELALKAREIIRGHLGIEISEAEVGFIALHIVNATMKQRTD-
37 UniRef50_P39805 Transcription antiterminato... 88 9e-17 1 8.0% 6:117 58:168 -----KFKTLLYDIPIECMEVSEEIISYAKLQLGKKLNDSIYVSLTDHINFAIQRNQKGLDIKNALLWETKRL-YKDEFAIGKEALVMVKNKTGVSLPEDEAGFIALHIVNAELNEE---
38 UniRef50_D1ALQ6 Transcriptional antitermina... 88 9e-17 1 10.6% 5:117 59:170 ----KKLEDTIERIPAEYIDITEKIVKLAEEKLQMKLSDTIYITLSDHIYFAVKRFGDGQSLKNILFWEIKS-SYKDEYLIGQEALKIIKDTVDLSLPDDEAGFIALHIVNAELNEN---
39 UniRef50_A8W0Y8 Transcriptional antitermina... 87 1e-16 1 16.5% 13:115 1:102 ------------YVDEQFVGVMNEFIDKLETRFGANLNEHIHIGLTDHLHFAVKRIENGQGIHNPFLQET-ELAYPQEFAVATELTEWFGNQVGIRIPPGEIGFITLHIHSALTN-----
40 UniRef50_C2Q5B4 Putative uncharacterized pr... 87 1e-16 1 11.6% 5:116 57:167 ----NKLLQLINEIPTEHFELTTQIVEYIKKQISNSISDNIYLTLTDHINFAINRFQQGQIIRNPLFWEIKKF-YPEEYNVSLTALTIIKEHTGFELPEEEAGSIALHVINAQQDN----
41 UniRef50_A0ALC5 LicT protein n=38 Tax=Firmi... 87 1e-16 1 9.7% 6:118 58:169 -----KLSELLSEIPLKHLRVADDVVQYAQETLETDLSDNIYLTLTDHINFAVSRYNQGINLKNALLWEIKRF-YHAEYLVGMKALDFIEQEVGIRLDEDEAGFIALHIVNARQDGQQ--
42 UniRef50_B9Y8L7 Putative uncharacterized pr... 87 1e-16 1 7.8% 2:117 56:170 -QQQEDFVKLMKEIPINHLELTKKIVEMAQKELNVQFDDVIYIGLTDHIHFVIKRAKQNEQLKNALLWEIKKF-YPREFAASMKALELIEYSEGLQLTEDEASFIAMHFVNGQQSGE---
43 UniRef50_A5KQG9 Putative uncharacterized pr... 87 1e-16 1 11.1% 10:117 1:107 ---------MIGAIPPEYFELVEEIFEKAKEEYGFLPKEKETLALLDHIHFAIKRMKENLVLDNPFETEIRQF-YPKEWEIGLYAKKCIKRRFGIEIPDAEVGYIAMHIIASEFQKS---
44 UniRef50_A6TMP5 Transcriptional antitermina... 87 1e-16 1 13.6% 9:118 52:160 --------EELNIKGDEIVGVSEEIIVMAEKQLGESLGDKVHTGLIDHIHFAINRIQEGINISNPFLNETKAL-YPVEFSIASQAVALLCVRLGIDVPQDEIGFIALHIRANRKNLKK--
45 UniRef50_C5EIH6 Transcription antiterminato... 87 2e-16 1 12.6% 5:115 57:166 ----KDYSRMIEEIPQETLEAVQEAVDAAGSSLSCPLDSQAFFTLLDHLIYAMERCQKGIVLQNRLLWEVKKF-YPREYRAGKDAVDYLNQRLGLKLPEEEAGNIAFHLVNAQTE-----
46 UniRef50_P26212 SacPA operon antiterminator... 87 2e-16 1 11.2% 3:118 52:166 --ENEKFKQILQTLPEEHIEIAEDIISYAEGELAAPLSDHIHIALSDHLSFAIERIQNGLLVQNKLLHEIKAL-YKKEYEIGLWAIGHVKETLGVSLPEDEAGYIALHIHTAKMDAES--
47 UniRef50_C9A770 Transcriptional antitermina... 87 2e-16 1 13.2% 6:119 58:170 -----QFADLVDEIPLYYFEMTKEIVQLAQKMLPYPLNSTIYLTLSDHLHFAVERQQKGLSVTNRLYWEIKNY-YTDEFRAAEQALRLLKEKYQIELPEEEASNIAFHLINAQSNTEEN-
48 UniRef50_Q5WKS9 Transcriptional antitermina... 87 2e-16 1 20.7% 9:119 304:415 --------NLKKVFDDEYYKLAKAIVEKVERELDLNidQELLVSLMLHLKPAINRYRYGMNIRNPMLADIKQ-HYTLAFEAAVIGQAVIKDKLGISIDENEIGYLALHIGAALERRNQQ-
49 UniRef50_C9XN38 Putative transcription anti... 87 2e-16 1 11.4% 6:119 72:184 -----KISKLASQVDEKFFEISTEIIAYAEENLNTKLYEYIYVALTDHIAFAIKRYHENITIKNDLLHEIKRI-HKKEYEIGKWAVDYINKEFDVKFPVDEAGFIAMHIVNSNYKGSSK-
50 UniRef50_C0ZH78 Probable transcriptional an... 87 2e-16 1 12.6% 4:114 67:176 ---QKQYQNILSQVDPAVVGIAEEIIALIASEITPELNEHVHVALPDHIQFAIYRLNNGMEIVNPFLFEIQTL-YTKEYALANRAADMIKNAFDLDIPDSEIGFLALHIHSAIS------
51 UniRef50_C6CKX7 Transcriptional antitermina... 87 2e-16 1 12.5% 6:117 58:168 -----RFKHLAQEVPLEILQLTADIVEMVKTQLPQKLSEGIYVTLADHLAFALQCQRNGTVIQNPLQWEVRHF-YKQEFAVAEQALALIREALGVALPNDEACSIALHIVNAELGDN---
52 UniRef50_O07655 Antiterminator homolog n=16... 87 2e-16 1 12.2% 2:116 71:184 -EQKNKLYKLIEHVDIEYVSVAEKIVQYAEKNLEKNLNPSLLLILADHISNAISRVVSGIQINNVFLDEIKAL-YKAEYAISRDALTIINEQFSVQLPDDEIGFIALHILNNYENS----
53 UniRef50_B0N7R7 Putative uncharacterized pr... 87 2e-16 1 7.6% 2:119 61:177 -KQNNRFLELIKDIPVNVLNVTDEIIDFARKGLDKELNDGIYITLTDHINYAIERYLQGINVQNPLLWEIRQF-YQEEYKIAAEALKIINQKLMVNLSEDEVGFIALHFVNAELNSEME-
54 UniRef50_C7VAG3 Predicted protein n=2 Tax=E... 87 2e-16 1 8.8% 4:116 61:172 ---KKDYIKLFEAAPDDLIICVKRIIDYANAKFDFKLNKSLFFTLVDHLKHAIERSQKGIVFQNRLLIEIQKY-YPKEFEIGCYAIQLINKKMNVQLPEEEAGNIAFHIVNAQSEQ----
55 UniRef50_Q9K679 Transcriptional antitermina... 87 2e-16 1 18.9% 9:119 194:303 --------RLLHLINLELVRNIQEVLADFRKQMVEPMADRAYIGLIVHLTLAIERIRQGEKIE-IDPSYLSKLKMDKEFELAADLARRLEQKLGMNIPEAEVGYMTMHIRGAKAHIETE-
56 UniRef50_D1B6P9 Transcriptional antitermina... 87 2e-16 1 16.1% 2:113 55:165 -KERLRYAKVLAEIDGSFAALVAQGIAIMEDHLGVPLGERIHASLTDHLFFAVKRLREGIAVRNPFAREVAAM-YPKEHAASQAMLRWLSEEVHLDMPDDEAAFVALHVHSAM-------
57 UniRef50_C0D1K5 Putative uncharacterized pr... 86 3e-16 1 19.1% 8:117 60:167 -------LQAVNGIDPVYIEVTARIIEAAEGLLG-PIRHDILIAMADHIALAVSRAKEGCELPNPFSQDIRAL-FSQEYEAALKGRELIRQELGVEISEDEVSYITLHIHGGLSDEN---
58 UniRef50_B1YFN4 Transcriptional antitermina... 86 3e-16 1 15.7% 2:116 29:142 -ENAEQFKEILTTTPLDIIDLSEQIISYAEGELKTPFHDYIHVSLTDHLAHAVRLAREQLVVHNRLAEEIR-LLYTAEYQIGEWAVAHIEQKLAVSLPKEEAANIALHLYNARQRH----
59 UniRef50_Q03XR5 Beta-glucoside operon antit... 86 3e-16 1 10.6% 7:110 58:160 ------FNEMADTISSDYVEIASHIISTAEKSLGLSFDGYLLIGLADHIQFAVERLQKNLPIKNELLWETKHF-YPDEYRIGALAVAFINEQMGVQLPEDEVGFIALKFV----------
60 UniRef50_A0Q2H7 SACPA operon antiterminator... 86 3e-16 1 13.4% 8:119 63:173 -------LQFTNNLDPKIAELTKDILKIISEEFSRPLNPNVHVNLIDHIQFTVKRLKSGMILENPFLTETK-LLYPKEYAVAEKAVEILSKGLNMHFPDAEIGFITLHICGGLNEKSKK-
61 UniRef50_B0NY82 Putative uncharacterized pr... 86 3e-16 1 7.9% 5:118 57:169 ----MKFQEILLDIPSKYLEVSNCIIERAKKYLDAEIDDNIYISLTDHIHMAVKRYLDGMQVPNPLLLDIKRF-YNKEYEIGCQALEIIKDQLKVELPEDEAGFIAFHFVNAQQNLES--
62 UniRef50_B0A809 Putative uncharacterized pr... 86 3e-16 1 22.5% 9:119 205:314 --------RLLNLIDKSIIKKVENSLSETIKDINLKISDSAFIGLVVHISLAVQRLRNGETI-SMEQDVLNELKSIEQFKTATKIAQQIEEEFDIKVPIDEIGYITMHLRGSKLRLETK-
63 UniRef50_B8CZR0 Transcriptional antitermina... 86 4e-16 1 17.1% 7:117 199:308 ------FKEFDKLVSGIDLTKIESVISFAEKQLGFQFADEAYASLLVHLALAISRLLEGKDIQ-LPEERLKVIKKSDEYKIAKKIGKIMEQIFDISIPDSEIGYVTLHLMGAKLWQK---
64 UniRef50_A7ZA83 LicR n=3 Tax=Bacillus RepID... 86 4e-16 1 16.9% 2:119 287:405 -QSQLEGKELTRLIDGETSRLTEAMIEAIERELKLGITDdlKAGLALHIKPAINRNRYGMNLRNPMLSAIKE-NYPLAFEAGVIAGIVIKEQTGIDIHENEIGYLALHFGAAIERRKTE-
65 UniRef50_A6VMZ3 Transcriptional antitermina... 86 4e-16 1 11.5% 6:118 59:170 -----RLTEILSEIPQEYFQLTNCVVDFANQQLGTTLSNSIFVSLPDHIFHAVERAKQNQTVPNGLLFEIQRL-YKQEFAIGLYTLQLIEKRFGVQMTEDEAGFIALHIFNARTDGST--
66 UniRef50_C0CT65 Putative uncharacterized pr... 86 4e-16 1 10.3% 2:117 58:172 -KNQNNFKQIFRGDGPEFVDFCEELILLIARSFHEELHETIHISLIDHISCTLRRLKLGEQIVNPFLSEIEAL-YDQEFQIAGEVCRRIEERYDVSMPEGEVGFIALHIHSARYNGE---
67 UniRef50_D2EH42 Transcription antiterminato... 85 5e-16 1 8.4% 6:112 58:163 -----KFSRILNEVTSEELLVTSKIISMARQELKVKLSESIYISLTDHIHYVIERYHQGKLMTNTFLWDIKRY-YPKEFEVALKAVHLINKKFNIKLKDDEAGYIAFHFINA--------
68 UniRef50_B1YKV9 Transcriptional antitermina... 85 6e-16 1 14.5% 3:112 61:169 --EQAQYKALVGHLDENFIALMNEIVSMIETRFGKRVDEHIHIGLTDHLTFTFKRLEQGMEVTNPFLAETEAL-YPEEYALAEEIVEFISAEMNFYLPPAETGFIALHIHSA--------
69 UniRef50_P46321 Putative phosphotransferase... 85 6e-16 1 14.2% 7:119 178:289 ------LNEKADILPKEEIEIIRSAILKKMKNDRIPLSNMGLNNLIIHIAIACKRIRTENYVSLFPKD-MDHILHQKEYQAAEAIVKELESKLSVTFPKDETAYITMHLLGTKRMTQSQ-
70 UniRef50_C1I943 BglG family transcriptional... 85 7e-16 1 25.5% 9:118 213:321 --------RLLNFIDKSIIKAIEEIVSGLEKENDIRLVDSAYIGLVVHLSLAIQRIKNKENIK-IDPDVLEELAKLPEFEIGKMLVRNIESKFNIEIPVDEIGYITMHLKGAKLRLNS--
71 UniRef50_A7B640 Putative uncharacterized pr... 85 7e-16 1 12.0% 6:113 58:164 -----QFKDLLADMPLEHVKVSSDIITYAKENLKLKLNQSIYVTLTDHINFAITRYQQGIK---PQNALLWEIkySREYELGMYAVKTIEEKLRIRLPEDEAGFIALHFLNAE-------
72 UniRef50_A8FIW8 Transcriptional regulator n... 85 8e-16 1 17.1% 9:119 291:402 --------TLFHLLEEDHFRFIHQLLAYVEEhlNIQFDKELIVGLSLHLRSAIHRFRYGMNIRNPYLTDIKR-HYPIAFEAGVYMGRWLKEKEGIEIHEDEIGYLALHIGAAIERTKSQ-
73 UniRef50_C8P2Y2 Transcription antiterminato... 85 8e-16 1 14.7% 4:112 54:161 ---QDDFEQLLNKIPVDYFEATRAIVEYAHSVLDTSLSDTINVALTDHIYYAVLRSKDDVELPGLFTEEIK-MYYPDEFKVGAWALNYINKRFEVTLPQDEIGYLVIHIVNA--------
74 UniRef50_Q9L8G7 ScrT n=3 Tax=Clostridium Re... 85 8e-16 1 9.3% 2:119 55:171 -NENLKFQSLISEIPIEHIKVSENIISYAKRKLDVKFDEHIYISLTDHLSFAFRRYSKGIKIKNNMLWDIKRI-YKKEYNIGMWAVEYIKGELGIKMDEDEAGFIALHIIDASLNESMD-
75 UniRef50_B1IKY9 Transcriptional antitermina... 85 8e-16 1 13.9% 10:117 70:176 ---------LMSNVDSDIIGLCEEVISMISDELNEPLNEKIHVSLTDHISYTIKRLMENNSIENPFLVETETL-YKREFAIAKKAVRMLEDRLNLVIPDEEAGFITLHIHSARNEGK---
76 UniRef50_C4L0D3 Transcriptional antitermina... 85 8e-16 1 7.0% 1:115 50:163 MPENDKFQQLLSRIPVEHFTVSEDIISYAEKRLETSFNEHIHIVLTDHISFAIEREMDGISLRNKLLNEIK-ILYRNEYEIGLWAIEHIAEKLNVQMPKDEAAFIALHIHTMKVK-----
77 UniRef50_C2HQQ4 Beta-glucoside transcriptio... 84 9e-16 1 11.8% 5:114 65:173 ----NSISETLSQIDPKYIELSDRIISEAITSSGKKLSDDIYVSLPDHLQFAVERVKNGILIQNKLTVETMQT-YPDEFQLGKRVLKYLSEKTGLDFPDDEATNIAMHLITAEE------
78 UniRef50_B0K247 Transcriptional antitermina... 84 9e-16 1 16.5% 9:117 203:310 --------QITKLFEDIDIPYIEECIQIAERELETVFSDAAFSGLVIHIAIAIKRIQLGKDII-MPKEELKALEITKEFAVASNIAKMLEDHFKVSIPLDEIGYITVHLLGSNVSKT---
79 UniRef50_C5EMV1 Transcriptional antitermina... 84 9e-16 1 15.4% 1:117 53:167 VTGKTSALQQVNSIEPVYIEAAGRIIEEAEGTMGV-LSHDILIPMADHIALAVSRAREGRELPNPFRHDIKAL-FSSEYQSAMKGVAIIRELTGVTISEDEVGYITLHIHAGLSEEN---
80 UniRef50_C3RIJ4 Transcription antiterminato... 84 1e-15 1 9.4% 3:119 59:174 --QQKRFEQSIETVPAIYFEITNKIVNQANKELDTDFSGEIFLAISDHISFAVKRKKEEIYLPNVVLSETK-VLYKKEYKVGLWALDYIEEKTGIRLDDDEAGYIALHLVNFSLDNKAN-
81 UniRef50_C0D786 Putative uncharacterized pr... 84 1e-15 1 18.2% 16:114 209:306 ---------------QENMTRVARCVAEVIDTENFTVNSVAYQNLIVHICIAVQRIQENCYV-PLDEERQERIRRSKEYRIAQKITERLNQSFAIRFPDQEIAYIAIHLAGKQS------
82 UniRef50_B6GAF6 Putative uncharacterized pr... 84 1e-15 1 10.7% 15:117 77:178 --------------PVEFFNISKSIMDEAEKRLHIVLKDQVLIALTDHIVFAVERARNGEGFSNLMFSEVRGL-YRREYEIGLWGIHLVEEALGIRLPEDEASFIALHILNGQSDLS---
83 UniRef50_A6M2G4 Sigma-54 factor, interactio... 84 1e-15 1 13.0% 2:109 424:530 -SAKVDMTNIKNIVDKDVMDIIEEIILFCEEELGIKLDKKISYGLAVHISNSIDRIRRNKKIVNPKLSSIRE-ENKKEFSVALDALKMIERSIDISMPIDEAGFIAMFL-----------
84 UniRef50_A8RDI0 Putative uncharacterized pr... 84 1e-15 1 13.3% 15:119 94:197 --------------PEEYFKLSQSIMEKAMEELNISFQDQTIIALTDHICFAVERYETGTELPNLVLDEIKTL-YKEEFKIGLWSVKYINQELKIDLPIDEAGYIAMHIINGANNTNSN-
85 UniRef50_A0JW54 Transcriptional antitermina... 84 1e-15 1 12.8% 6:114 59:165 -----NLVELLSQVPVEFVELTRQIVSDAESE-GLELDPHIYLVLTDHLHFAVERKKRGLVVVNRLAWEMRTV-YPKQYAVGSRAVELMNTHKGFALPDDEAANIAFHLANAER------
86 UniRef50_B0MFG1 Putative uncharacterized pr... 84 1e-15 1 11.4% 5:118 62:174 ----NRLSELLKQIPIDYFYLADQIKQHAEQKLSKELNQNIYVTLCDHMYYAVERFKQGLLFQNQLMWEIKRF-YPKEYQIALEAIKLMNSTLNVKLPEDEASFVALHIINAELNGHE--
87 UniRef50_B0KCX3 PTS system transcriptional ... 84 1e-15 1 21.3% 3:110 433:539 --DKNNLEELYKVVDKKIVDIVNDFLNYASKKLKRPFSEKTLYGLSMHVASSVERILSGKDIVNHQLENIKKV-YEKEFEVANVLRERVQKEFNIKVPDDEVGFVTMFLC----------
88 UniRef50_A7GGX3 Transcriptional antitermina... 84 1e-15 1 15.2% 6:117 60:170 -----NYNKVLDNIDNKIVGISEEIINFSEKALNTKLNEGVHISLPDHINFALRRIEKGINIENPFLEELGII-YPKEYEIAMKALNMINERLKVNLPKDEAGFICLHIRAGITKQQ---
89 UniRef50_B0KCF7 Transcriptional antitermina... 84 1e-15 1 18.8% 7:118 191:300 ------LMQLRELFDIDYKQL-EKIVSNAESKLKFRFSDEAFISLVIHVAISIERLKHKKDVK-LSKAVLNNLKQKDEYVIAQQMAKEIEAKFNVVLPESEIGYIVLHIIGTKMQQNK--
90 UniRef50_C9XQT4 Transcription antiterminato... 84 1e-15 1 8.9% 5:116 64:174 ----NKLQELLNNIPIEHMKLSSEIIEYAQIKLNKKLNESIYISLSDHTYSAIQRMKEGINVKNAILWEIKRF-YKEEFEIGMKALDIIENKTGIKLPEDEAGFIAFHIVNAQLSE----
91 UniRef50_A6LXA2 Transcriptional antitermina... 84 1e-15 1 8.8% 5:118 57:169 ----NKLIELLSDIPLEVIQTTNEIVSYARYSLGKKLNDNIYILLTDHISFAMERVNKGLQFKNALLWEIKRF-YNHEFLIGKEALQIIEKRLHVDLPEDEAANIALHIVNAQLNSSN--
92 UniRef50_D2C0F0 Transcriptional antitermina... 84 1e-15 1 13.7% 2:118 54:169 -EKRSGYIEGLSAIPDEVIEMAAMIISRANLQLSSKVREQIFFTLADHLTFAIERSRKGIVIQNRLLPEVRRF-YPQQFRVASEAVAIIRQQYGIELPEEESGNIAFHLVNGQSEGDD--
93 UniRef50_P24401 Transcription antiterminato... 84 1e-15 1 15.3% 2:112 55:163 -TSRQNLYFLLKNIPIDVVTTTYEIIDVAQKQYRLKVLDYIYITLSDHIYEAYKRYQAGTYQETMVPDF--HIQYPAEYAVAKQALQIIATNLGVQFPQSEIKNLALHFINA--------
94 UniRef50_Q03E27 Transcriptional regulator w... 84 1e-15 1 18.8% 3:119 478:595 --TRQAESKLAEIVDKGIIDFAKQVQPKIENQLDYHFKENFIYAMSLHISSFIKRIQSGKPMRLMGNDLVAMVkyPEELAVAKSIKEMLEQRYGMPIPESESYYLAVLLISLRTVPTSN-
95 UniRef50_A9QSQ6 Transcription antiterminato... 84 1e-15 1 11.2% 2:117 54:168 -SSRDSLLEIYEQLPSEEIDLVAALIKEAEEQFHQTYFLSLYVSLADHIHYAISRTRDGISIKNPLVWEVKKF-YAKEYALSKKYLIKINKDMGISLDEDEAAAIALHFVNARQEDS---
96 UniRef50_UPI0001C4223B transcription antiterminato... 84 1e-15 1 13.9% 2:116 58:171 -EEQKQYRELLSDLDEALIVHINEIIRMIQRELPKPLYERIHLALTDHIQFAIRRLEQGIEISNPFLTET-EMMFPNEFHLARKAVDYLNAHLTVELPEAEIGFVALHIYSASSNQ----
97 UniRef50_C8XAD4 Transcriptional antitermina... 84 2e-15 1 10.6% 6:118 58:170 -----RIAALVNEIPPEDIDLTGRIVELARGRLGPHITDHILLPLADHLSFALRRAAEGAGEIEYPLRWEVQYLYPAEVQVARAALDLVAQERGVRLPEVEAVPLALHLVNAQFDTSD--
98 UniRef50_B6GBJ5 Putative uncharacterized pr... 84 2e-15 1 17.8% 17:117 157:256 ----------------ESLEVIAASVEDALTDGPININAISYQNLLVHIAIALVRINAGCYV-PLASEDMSDIERRSEYAAARRVAGGIKSRLGMELPEEEVAYIAIHLAGKRTLND---
99 UniRef50_Q0TV06 Transcription antiterminato... 84 2e-15 1 12.0% 6:113 66:172 -----NFRRVVGSNDEKFIAFCEELILEISRDFSEELNEIIHIGLIDHISFAIERMKKGEILRNPFLVEIETL-YPKEFEAATKMVKKLEDFTGVSIVDDEIGFIAMHIHSAR-------
100 UniRef50_C5RLN3 Transcriptional antitermina... 84 2e-15 1 10.3% 2:118 59:174 -ENKAKLNSLYRNVDSSLIGATEEAISYISKVTESDLGKIIHITLLDHLAFTIERIKNGIKIGNPFLYETK-VLYEKEFSIAEDVLEIINDRMNLELPKAEVGFIAMHIHAALNNQKS--
101 UniRef50_C4V0J7 MtlR transcriptional regula... 83 2e-15 1 19.2% 10:113 216:316 ---------LLGLVDPAQIRRIDDAV--AAETQDRNIPDSARVGLVVHLALAVRRLQQGDTI-AMDAGTLEELRQTEEFSVAETIAARMGEVFSISIPAAEIGYITMHLLGAR-------
102 UniRef50_B1C5P5 Putative uncharacterized pr... 83 2e-15 1 18.7% 8:114 202:307 -------LYKEALFDEEDLYKIIDSISYLEDLLETKFDDSSYVSLLIHLAIAMKRLKKGNKI-LMSDEQLEQLKNEDEYSVSKSFAKYLNTIFDIDIPDEEIGYITIHLMGARR------
103 UniRef50_C7UQ76 Predicted protein n=3 Tax=F... 83 2e-15 1 13.0% 7:114 58:164 ------FSYLLANTEESLFEIVRSIILRAEELFQKKATDYLYLTLLDHIDYALKRGKKGQYISNPLLWEVRRY-YPKSYQLGVEVVERLNKEYNVSFPEDEAASIALHLVNIQE------
104 UniRef50_C4L0E0 Transcriptional antitermina... 83 2e-15 1 12.7% 6:115 57:165 -----RFVHFLNEMPTDEMETVKQIVRLAEGRLTQPIHDSLYVTLADHLHFALSRYQDGIQIRNPLVWEVKRF-YAPEFAIGKEAVKLINERHEVKLDEDEAVAIALHLVNATMS-----
105 UniRef50_C7TGE9 Transcriptional antitermina... 83 2e-15 1 11.7% 7:117 59:168 ------FSSLINEVPYAILSVSEKFIDEAASQLKQKLNASLHVSLVDHIYHALKRYEKGQLISNSLIFEIENL-YPEEFELSEHFLQMIAEQEGVQLPVDEAGFIAMHLINAEMNEE---
106 UniRef50_Q67LZ9 Putative PTS system, IIA co... 83 3e-15 1 17.9% 12:117 266:372 -----------DIVHPADLELAEQMAVLVETRLGIGldREFLMGLALHLRPIAERLRRGEAVENPLLDEVQA-KYPAACLAAQDVGRALSAIWGLTVPEPEIGYLAIHIAAALEREK---
107 UniRef50_C7GD80 Transcription antiterminato... 83 3e-15 1 7.9% 6:119 58:170 -----QFQELLENIPLEHMQLTSDIISYAIKNLNVQLNQNIYITLTDHINFAIQRQSQGIQLKNALLWETKKF-YHQEYLMGKYAVDLLNEKLGTEFTEDEAGFIALHFVNAEYNTTIN-
108 UniRef50_UPI0001C368A3 beta-glucoside operon antit... 83 3e-15 1 9.1% 10:119 58:166 ---------LVNEIPEEVFEVAAKIVDMAVNYIDCELSSNLVFTLADHINFAIERNQRNMNLRNPFLYDIR-YFYEKEMDIGNLAVKMIRRYLKVSLPEEEAGNIALHFINAEALSEKE-
109 UniRef50_Q184L9 Transcription antiterminato... 83 3e-15 1 11.1% 3:119 54:169 --QRDKYNQILNKTSIEYFKISEEIIEKANEVLNTQVNDSIILALTSHIEFAVQREKQGIKLPNLILNETKQL-YREEFEFGLWAIDEIEKRIGIKLPEDEAGYIAIHIINGLENSQKD-
110 UniRef50_A4VWG8 Transcriptional antitermina... 82 4e-15 1 8.0% 5:116 80:190 ----NRFTELFIDVPIELVYVCEKIINLGKITLGNHFDEIIYINLTDHINSSIERHKEGVVVTNPLRWEIAKY-YKEEFELGKKALSIIKKDLHVELPVDEAAFIALHFVNANLEN----
111 UniRef50_C6Q8D8 PTS system transcriptional ... 82 4e-15 1 12.3% 5:110 427:531 ----IDVSDIENVVGAEIVRAVEEIIKFSEKRLNKVLSKEMYYAMAVHIYTAIERIKRNRKIVNPQLNKIRT-EYSEEFNIALDCLKIIERVLDVSMPIDEAGFLAMFFA----------
112 UniRef50_Q71VY8 Transcription antiterminato... 82 4e-15 1 7.9% 6:119 60:172 -----KFKMIVNEIPIQFLEVTDDIVKLFKMKTTKDISDVIYISLSDHLYFATQRLQENVVIENPLSWEVKRF-YQEEYAVAKEAAKMVESKLEIELPDAEISNIALHFVNAEVDSDMN-
113 UniRef50_C6CA98 Transcriptional antitermina... 82 4e-15 1 8.0% 6:117 58:168 -----RFKDLVHEVPLAVLQLTDDIVELARRTLQQRLSEGIYVTLADHLTFALNCQRDGTVIRNPLHWEVRRF-YRQEYAVAAQALALIAEKLHVSLPEDEACSIALHIVNAELNDD---
114 UniRef50_D2NVK8 Transcription antiterminato... 82 4e-15 1 9.1% 6:115 59:167 -----RFVQLIKEVPINHLDLTNKIIKDAESELNVTFDELTYLGLADHINYAISRYKSGHQIKNALLLEIKKF-YPKEFNAAKNSVKTISYYENVKLLEDEAGFIALHFVNGQQE-----
115 UniRef50_A6M213 Transcriptional antitermina... 82 5e-15 1 13.9% 3:117 62:175 --NLRNFKQVIENVDEEFFVLCEKMISYVANELKENLDERIHVALVDHLNFAVKRLSDKEEIENPFLMEIRAL-YPQEYSLAEKVAEVLQNEKKVKIPEGEIGFIALHIHSARNSGK---
116 UniRef50_A4WFZ1 Transcriptional antitermina... 82 5e-15 1 15.1% 7:112 59:163 ------FLSLTDTIPAAFFEISHEILTLARTLCGDKLNSVLLFTLAEHLHFAVERSRSGQVILNKLSWEVKRY-YPQEYSVGMQARANVNAQFGVDLPEDEAVNIAFHLINA--------
117 UniRef50_A1JND6 Beta-glucoside operon antit... 82 5e-15 1 10.0% 14:113 66:164 -------------LPEELFDIVLDIVKQATTKLDRKIHKSVYASLLDHISFAIERAKQGVHVRNMLLWDIKRL-YRNEFIIGISALENIKQKLNVDLAEDEAGFIALHLLNSQ-------
118 UniRef50_B6FYA9 Putative uncharacterized pr... 82 5e-15 1 6.1% 6:119 71:183 -----KFKRLIEELPIEHFKVSNDIINYAKRTLGKRLNQNIYITLTDHINFSVYRFKNGMKFSNPLLWEVKHF-YNPEYIIGEYAVNLIKEKLGVEMGEDEAANIALHIVNAEYNTEMN-
119 UniRef50_B0MAI9 Putative uncharacterized pr... 82 5e-15 1 20.8% 11:116 205:309 ----------MDLLNEEILDKVIKILKKCEDEFLSRITRHSYIGLVIHLVIAIERLLSGKTIT-MEEELLRALKEDPYYKKAKELTAYFEEEFHIEVPESESAYVFMHLKGARMKY----
120 UniRef50_B9EBW1 Putative uncharacterized pr... 82 5e-15 1 9.5% 2:117 58:172 -SEQERYKSLLTLTNDEVIQTVIEVIEFIDHKTNGEMNDNILLSLTDHIIFALKRYQEGIIVANPFLKETESL-YRQEFLIAEQVVAMLNDRLQVQFPKTEVGFIALHIHSSVNNHS---
121 UniRef50_C9AZS3 Beta-glucoside operon antit... 82 6e-15 1 14.3% 6:117 61:171 -----DLEQLLKRIEYRDLQLASDILKLFEEAFQCESNPALLVALADHIGFALTRAREGMKIQTPLEWELKQV-YPKEYEIGLQAVELMQKRTHLNIPKDEAAFITLHFVNFLGDNN---
122 UniRef50_C2BFD9 BglG family transcriptional... 82 6e-15 1 9.6% 5:119 56:169 ----IKFKELMANIPMDCMLIADDIIIHAKKILKRKFSDLLYINLADHIDAAINRVEEGITIKNLLIIDVKRF-YPEEFELGKYGLNIINNKFGVSLPEDEAGFIALHIVNAEEKYEDK-
123 UniRef50_C6DD15 Transcriptional antitermina... 82 6e-15 1 13.2% 7:112 59:163 ------FLSLTDTIPAAFFDITHEIVTLAQSQYAEKLNSVLFFTLAEHLYFAVERSKTGNHFVNKLSWEVKRY-YQKEYAIGVQAKDRVSARFNVMLPDDEAVNIAFHLINA--------
124 UniRef50_Q5WDU8 BglG family transcriptional... 82 7e-15 1 17.3% 9:118 189:297 --------RLLHFVDLETIRLVQSTIQRVKEKHFDDMADQSFIALVVHATLAIERIKQGEQIR-MDAGQLEALHKEDSLPVAQELAEALAQTFQITIPEAEIGYLVMHLRGARIGHIQ--
125 UniRef50_B9WWD1 Transcriptional antitermina... 82 7e-15 1 13.3% 3:115 55:166 --QQSDLSSLYLQMESGEVEVVNAIINRAEETLEVQFDLSLYLALADHLHFVFQRCREGIFIENPLSWEVRKF-YPKEYQIGLEALQLVQERLGLELGKGEASSIALHLVNAQKN-----
126 UniRef50_D0KIH3 Transcriptional antitermina... 81 8e-15 1 10.6% 6:118 93:204 -----EFARLIEHVREEYVHIVNKIIDDANRQLHGRLSEQVFFTLIDHISFAIERYRKGISIQNRLLYEVKRF-YPQEFAIASRALNDINQQMTLELPEEEAGNIAFHLVNAQTDIQN--
127 UniRef50_A6LWC3 Sigma-54 factor, interactio... 81 8e-15 1 12.9% 9:109 511:609 --------ELKNIIDEKILNVVEK-VTDIAKQYIENIQENFYYCVAMHLNSTYERLKQGRIVRNPESDYIKKEYY-NEYRIAKILTKEINNSLDIELPEDEIGFIAMYL-----------
128 UniRef50_Q184X6 Transcription antiterminato... 81 9e-15 1 8.8% 6:118 58:169 -----ELHSLLDRIPLKDVELVSEIIQMGREELGDNLNDSILITLSEHISYMLKRMDEGLVFQSPLQWEIRQI-YPNEYNFSKKAVEYLRKKLDKNIPDSEIAFITIHFANAQLETKD--
129 UniRef50_B6FR13 Putative uncharacterized pr... 81 1e-14 1 19.0% 2:117 72:185 -TERGSAKELAKSIAPEYLEIANAILVEAEEKFG-RIDRRILFPLADHISFAVERIRHGEQISNPLTEDIRALFGS-EYQVASKLKEILKERLSVEIDSHEIGYVALHIHSAIEDEN---
130 UniRef50_C8WQV6 Transcriptional antitermina... 81 1e-14 1 18.8% 4:115 298:412 ---RVRLDDDFRLLPSNvlDLAHRFVRAVEDITRLPfsDHLLVslAQHLAPALDRVRAGLPIRNPLLETVKA-RYPELFAAAESASREVFAPHGLRLPDEEIGFLAMHLGASRER-----
131 UniRef50_D1PP25 Putative SacPA operon antit... 81 1e-14 1 9.1% 6:115 50:158 -----KYFDLLRDVPQEVFLAADDIAENARDELNCPLNPNLTYVLADHLNFAIQRCREGVALQTPLAYDIRHL-YPQEYELAHTALKALREQLQVDLPENEAISIALHIITAEAE-----
132 UniRef50_A6BJ08 Putative uncharacterized pr... 81 1e-14 1 15.5% 2:117 57:170 -KERGGAKEIVKSIAPEFLEVTNAVLDEAEKIFG-KIDRMVLFPLADHIAFAVKRIQNHEQISNPLTEDIR-VLFHMEFKAAESIRPLLQKQFGIDIEDDEVGYVALHIHSAIEDEK---
133 UniRef50_C2GFH3 Transcriptional antitermina... 81 1e-14 1 12.6% 3:113 108:217 --ERAQFLKGVLSLDPAVMETISAAVDLAVDLLG-ELHPSVYVVLAEHISFAVQRAGSGEQIRNSLVDEIRAA-FPLEFQAAQLMVSYINSHtnATLPVDEAAFIALHLNAAR-------
134 UniRef50_C1PAW0 PTS modulated transcription... 81 1e-14 1 17.6% 2:120 175:293 -RNQEAFLKelQLIDPELFKKIKEVIVQKVNKYKIEISDISLENLATHIAIACRRIQEGFVIEELADVLVDD--HPFEKIVANEIIKEVEDFTSLTFPETEIDYIIVHLLGTKLLHKKEL
135 UniRef50_C9XM49 Putative transcription anti... 81 2e-14 1 14.2% 4:116 56:167 ---KKSIIQLATEIDAEYFGIAQMIIAYGIEKYNLKLMNHIYLALTDHIAFAVRRFKEGIMIENHYLFEIKEF-NPKEYDIGKYAITVFKEVLGLDLPEEEIGNIAGHFINAQQDN----
136 UniRef50_B6GAR4 Putative uncharacterized pr... 81 2e-14 1 16.7% 6:119 65:177 -----RLLEGIKEIPQDVLLFAARAAEHVRAELSYALSPNMAFLLADHIAFAIKRAREHLQVRMPLAYDV-EHNYPEEYRVGLRLVRQIRKEFLVDLGDDEAAGIAMNLVNSRLESVSE-
137 UniRef50_B0K7D9 PTS system transcriptional ... 80 2e-14 1 12.0% 10:109 490:587 ---------LKGIVGEKIVEAAEKAYEIAKKSFS-RLEENLFYSLAIHLSATYERILSGKPIINPQLENIIR-EYPAEYSTAKIMAKQIERELGIELPEEEIGFIAMYL-----------
138 UniRef50_A9VR47 PTS system transcriptional ... 80 2e-14 1 13.6% 1:110 421:529 ISKKTSHENVFKIVDRNIVSVCEKIAELAEKYLSKTFDEKVFLALSLHVQTTLQRLQGGKQIHHPQLNQIRT-KYKEAFSVAMQCIQLLEEELQITIPIDEAGFLTMFFV----------
139 UniRef50_A4QHA6 Putative uncharacterized pr... 80 2e-14 1 10.6% 6:118 63:174 -----QLARLIAELNPEIISLARELAETAEFMCDVTILDSTVVAMADHIRFAIDRAAQGISLPNPLRWEVSQF-YPREFAFGRKALAHIKSTTRVSLPEEEAVSLALHVVNAQFAQNT--
140 UniRef50_C9XLB5 Putative transcription anti... 80 2e-14 1 17.4% 5:119 205:318 ----LSENRLLNLMDRCIIRKVEATLTKKLSDLDVNLADSAYIGLVVHISLALQRIKNGENIT-MDKEFLKELSITEEFKLAKEIVKGMETDFNMDIPVDEVGYITMHIRGAKQRSSSN-
141 UniRef50_C5RMW0 Transcriptional antitermina... 80 2e-14 1 7.0% 6:119 84:196 -----KFKLLLEDVPSEYVSLCYDIIQYAKNMLSTKLNDYIYVTLTDHIYNAIKLYDEGLKNLNPLIWEIKKF-YAKEFQVGLKALEFIEEELGKKLPEDEAGNITLHLINAQLNSSYN-
142 UniRef50_C2FLI7 Transcription antiterminato... 80 2e-14 1 11.1% 6:113 59:165 -----QLLATIASSSPQLIEITQTIVSEATEQLQSKLSDTLYVALLDHLKFTLERAAKGIVITNRVYWEIKTY-YSHEFEIGQLAVRLVNRAFKTDFSEQEAANIAAHIINAE-------
143 UniRef50_C7V767 Transcriptional antitermina... 80 2e-14 1 11.1% 6:113 58:164 -----EYLRLFDSIPAVYFDITQQIIKKAEKLLNTKLNTSLFFTLSDHLNFSIERHKNGLNILNRVFWEIKNY-YPIEFSVGEYALKLLKKELGQILPQEEAANVAFHIINAQ-------
144 UniRef50_C7XXG9 Transcription antiterminato... 80 2e-14 1 10.4% 15:110 67:161 --------------PMDEVLIAERIINYAKIKLGRKLNEIIYVNLTDHLHGAIERYRSGIKLTNPLKWDIARL-YPDEYDVGMKAVELVKRKLGIDFLDDEAAFIALSFL----------
145 UniRef50_B4F212 Transcriptional antitermina... 80 2e-14 1 11.4% 6:119 58:170 -----RVLDLLSNITLDYVEIADNIIQYAKEKMTLDTQDSIYIALIDHIQASIERYKEGTFIRNKILWEIKNF-YSEEFDIGLYGLKLINDRFNISMPEDEAGFIALHIASIRTNDNIQ-
146 UniRef50_B0MGY1 Putative uncharacterized pr... 80 2e-14 1 10.7% 7:118 55:165 ------YLELLSEIPEDIFNVSSKIVDYARSKVGCELNPSLAFMLADHINFGVIRLKKSIDITNPLTNDIKYL-YKTEMEIGYKALDMIEEDLQIRFPKGEAASIALHIINAEGMQND--
147 UniRef50_C9A6G2 Regulatory protein n=2 Tax=... 80 3e-14 1 8.3% 6:114 61:168 -----RFLSLLSSIPTNYVSLADDIISLAKAEIKQELSETLYVSLTDHLYNLFKLHEQGITVTNRLSWEIKKF-YPQEFEVGKKALEMIGQETGIVFEEEEAGNIAMHLINAQV------
148 UniRef50_UPI000196B732 hypothetical protein CATMIT... 80 3e-14 1 11.7% 14:116 73:173 -------------VDPIFLEIANEIIRYAEKEFG-DIDTKILLPLADHIAFSIDRIKNDMVISNPLTSDIR-LLFADEYEVATKARKIIKRRLGYEITDDEIGYISLHIHAALSSQ----
149 UniRef50_C6JD93 Transcription antiterminato... 79 3e-14 1 11.3% 14:119 66:170 -------------IPEKYLDFVEAFVNDVKEKEGMKLNDSIYFSLSDHIMGAISRLENGIRLQNMLLLDIKQL-YHKEYEIGLELLKKVNEMFEVDLSADEAGFFALHFVNAEDGGKTD-
150 UniRef50_C7TNE9 PTS system, fructose-specif... 79 3e-14 1 19.2% 13:116 195:296 ------------NIDSSVVNILARVVQNASEKLGLSLSEYAIQSLVIHLAIAINRIKAGNPIGQNDDLIRNIGNERK--SEAVQLAAMVEKEVNVRLPDEEIAYIQIHLIAASANQ----
151 UniRef50_B0MGF2 Putative uncharacterized pr... 79 3e-14 1 5.4% 6:117 65:175 -----RFKELITDLPMELLNTCSNIIMYAKGILDTKLNENIYITLTDHINFALQRMEQDMMYPNPLSREVKTF-YDLEYKIGEYALGIVEKDLGVRLPKDEAVSIALHVVSAEYDTK---
152 UniRef50_B6GCR8 Putative uncharacterized pr... 79 4e-14 1 10.3% 1:116 80:197 VEQQSQLYQLVESIPQRYFDLAREIVDYAQSTLSVRLADSIYIALTDHIAYVHERAQKGLLPKNSLTWEISQY-YRREFEVGKKVVELLEDELDGtlGDAEAASIALHLINAEQEE----
153 UniRef50_C2HEQ1 BglG family transcriptional... 79 4e-14 1 16.1% 2:119 72:188 -EGQIKLQNLLNQIDERFLFAAETIIDHAETVLMEKLNEHVLIALTDHIAFSAENINNGIVIRNKLLREI-EVLYSDEFSIAQWAVEYLTKELGIPYTYDEAGYIAIHIHSGRSGRNNN-
154 UniRef50_C9BK18 Transcriptional antitermina... 79 4e-14 1 10.7% 5:116 74:184 ----KRFSEIVSQIPIEFMDFAEEVIELITARISSPLDSNIYITLTDHIYFAIQRKREDRDVTAIMLPEMR-FLYPNEYDIAVEVVERINHRYQTELGSNEVGFITMHIINAELGE----
155 UniRef50_A8VWD6 Transcriptional antitermina... 79 4e-14 1 14.5% 3:119 60:175 --EQDRYKALVTEDNEERLLAVHEAIARIESEMAIRLPDSALFALTQHLALALQRTTDGTDIQNPFLLETK-WLYRDSYRLAEQAVHFLMKETGLSLPEAEIGFVTLHIQSALRDSGPE-
156 UniRef50_Q723N6 PRD/PTS system IIA 2 domain... 79 5e-14 1 18.2% 11:120 200:308 ----------TGIFPEEGLKEIIAIVQAFSERHDFAFTDYAFQSIVIHLAIAVERIRAGEYIENVESDPMKDVFDSQR-NNTEILVSMLEDRLDIKIPAFEVGYIQLHLTAAYNQQHDEL
157 UniRef50_B9Y4R0 Putative uncharacterized pr... 79 5e-14 1 8.8% 6:119 57:169 -----KFKTLVQDVPYKTILVSEEIIDYIKTQSTKRINDSIYVTLTDHIANMIERIKMGIVFDPTLLLNVKSL-YKEEYRLGLKVTELLRQKLKIDIDDGEASFIALHIINAELDSNMQ-
158 UniRef50_Q040S8 Beta-glucoside operon antit... 79 5e-14 1 13.8% 2:117 54:168 -SQRKLLLETIHETDPIFFQISQKIVDRLKHEENIELADSVYITLTDHLATSVERAKKGLYLSNKFIWEVKNY-YPKEYRYGLWALKLLDAQFDLNFPEDEAGFIAVHIISGELGND---
159 UniRef50_A6NQL9 Putative uncharacterized pr... 79 5e-14 1 15.0% 15:114 213:311 --------------PKADVGEMAKIIHDAEKKYDFYLMDSYYTSLLVHLSIAVERLSGGQSVVDSDAYPESILEY-REGEIAKYIAWRMEEAFHICIPNSERSYICIHLMGAEL------
160 UniRef50_C9XMN6 Transcriptional antitermina... 79 5e-14 1 11.2% 2:117 53:166 -HMQTKFLELLKNVSPEVMDASQQIISLIPGNEG-KFNNKGILSLVEHISFAIDRMKNNVFLPNLMLLDIK-MMYSKEFELGVKALEIIYRVCHIHLPEDEAGYIALHFVNLQSNDN---
161 UniRef50_B9Y2N3 Putative uncharacterized pr... 79 5e-14 1 12.7% 3:120 268:385 --QRKDDETLKTIVGPQIFKLTHEIIDEINRRYHLQLneTLLVPLSLHFKNLFYRSQQQTSLKNPLLETIQSSC-PLLYDCAICITDYLDEHFNIQISPDETAYLAMHIGADLERQQKDI
162 UniRef50_A6M218 Sigma-54 factor, interactio... 79 6e-14 1 11.7% 1:120 445:563 ITTNVKKDEIAKIVNIKVATVAEKMLSIASEKLNRDFDQKVYFGLALHLQGSIERINSGKKIYHPKLNIIR-VENREEFAVAMDIIKIAEKEFHIDIPLDEIGYITMFLAACNDENSEQL
163 UniRef50_C0Z8L8 Transcriptional regulatory ... 79 6e-14 1 14.5% 1:110 420:528 VHQRVNKGDMARIIDPFIIHLVEEIVRFAEAKLEKILSQKVIFGLALHIQTSKERLAQGKQIVNPQINHVR-IKYKKEFAVALECVRMIEEAILMDLPIGEAGYLTMFFV----------
164 UniRef50_B0MED2 Putative uncharacterized pr... 79 6e-14 1 15.9% 3:115 436:544 --EKKNLLK---IIDAKVYYAVEDILQFAEIKLGRKMPERIKVGIAMHVNAMTERISKGIMLKEKELNDI-VLNHPQEFQTAKVMLRLLEEELGIQVPKQEIGYFTMFLCAMDEE-----
165 UniRef50_C9LB93 Putative SacPA operon antit... 79 6e-14 1 10.3% 2:117 56:169 -EERNSTMNVVNTIDPVYIEAAGKIIEAAEQVFD-TIKRDILLPLADHIAFAAKREQEKIFLSNPFVPDIK-ILFGKEYAVALKSREIIEKMTGYRISDDEAGFIALHIHSGLSDEQ---
166 UniRef50_A4ED34 Putative uncharacterized pr... 79 6e-14 1 16.8% 14:114 85:184 -------------LPSDIVMFAAKVMDIVANELPYDLSTNATLFMADHLSFAVARAQKGVRIAMPLAYEVRET-YPKEYKAAQFIVMRLEKELGERLPKDEIASIAMNLVNARV------
167 UniRef50_A8SDU2 Putative uncharacterized pr... 78 7e-14 1 11.5% 6:118 54:165 -----RYFEMISTLPQEILLASADITEDAQVVLNTTLNSNLPLTLADHLNFAVERFRSGLNLTIPIAYDIRHL-YPNEFDLGVKALDILKEYTGVSLPDSEAVSIAMHLINAEIENSE--
168 UniRef50_C6PFM7 PTS system transcriptional ... 78 7e-14 1 15.8% 6:119 448:560 -----NVKEIEKLVDKEIIDFSAEVKDFAERKLNIKLNDNFLYAFSFHLEALIKRIKNGQPITNLRLNEIRN-KYINEFKISEEIVKMIRDKFKINVSTEESGFITLFLVSGMRDINEK-
169 UniRef50_C5EP68 Transcription antiterminato... 78 8e-14 1 13.3% 6:118 58:168 -----RLQQIVQSVSEQYLGIAGRVVDAARNE-GLKVNDVLYITLTDHINSAVERLRSGIALKNMMKMDMRRF-YEKEYAIGQMAVGRVLEETGIDLGDDEAAFIAMHIVTSELDNSK--
170 UniRef50_B6FZM9 Putative uncharacterized pr... 78 8e-14 1 20.2% 1:119 195:311 IENK-SSKNIYSLLDTDIMKRVISCLINLNNEQIANLTDSSYAGLVIHITIAINRIMHNEIIE-PDSRLDEDIEHDRDYSLAVIIASSLEKEFDIEIPEIEVTYICLHIRASKMQNTSN-
171 UniRef50_P45551 Uncharacterized protein yhf... 78 8e-14 1 100.0% 1:120 1:120 METRLNLLCEAGVIDKDICKGMMQVVNVLETECHLPVRSEQGTMAMTHMASALMRSRRGEEIEPLDNELLAELAQSSHWQAVVQLHQVLLKEFALEVNPCEEGYLLANLYGLWMAANEEV
172 UniRef50_A7GUY2 Sigma-54 factor interaction... 78 8e-14 1 16.2% 6:110 424:527 -----NHENVFKIVDHCIVSVCEKIASLVEKHLSKTFDEKVFLALNLHVQTTLQRIRSGKQIHHPQLNQIRT-KYKEAFSVAMKCLQVLEDELQITMPIDEAGFLTMFFV----------
173 UniRef50_C6PFK2 PTS modulated transcription... 78 9e-14 1 15.5% 10:119 181:289 ---------LKDLLKDVDLNAIQRIIQGSEEKFNYILSDVSFKGLLIHLAISIKRLWEGKKVTLDLKDLNLLKK-EKEWEIAKDLAKNIEKRFNVVVDDTEIGYITMHLMGAKLQNDIE-
174 UniRef50_C5ENS0 Transcription antiterminato... 78 9e-14 1 11.3% 6:120 58:171 -----DMIHLLSLISEEYIEVSKKIVDYGRTVLKTGVHDSIYVTLSDHIELAVSRKKKGIAFDNAMTWSIKKT-YREEYHIGEVALKIIQIECGVTLPEEEAGLIALHFVNAKIHNEPEV
175 UniRef50_C7TG18 Transcription antiterminato... 78 9e-14 1 10.9% 4:113 57:164 ---KNHFTSLLKDVPIDIVVATFGVIGMAKKKYHYPVLNYIYVTLTDHVFQMYKRLTAGKYQASPAPDIRD--RYPLPYQIAADARRQLNHDLGVQFPEAEIKNIALHFINAK-------
176 UniRef50_A0AFA4 Complete genome n=2 Tax=Lis... 78 9e-14 1 7.8% 12:113 64:164 -----------EEVPLEVIQMCAHLLKSGKKVLGPHITDNLLIPLADHINFAITRVKEGIQIEYPLKWEIRHM-YPEEVAFAESVIKWMKDKENIELPKEEVVPIAMHFVNAR-------
177 UniRef50_C6PVA3 PTS system transcriptional ... 78 1e-13 1 12.8% 2:110 440:547 -EQEVKKEELSKIVDKRIINIVEKFLDIASKKMKKVFPVKIFYGLCLHISSSIERIIHNKNLINHNLNEIVE-KDREEYKLALILVDKLEDEFNIKIPSEEIEFIAMFLC----------
178 UniRef50_A6LX09 Transcriptional antitermina... 78 1e-13 1 16.7% 12:119 184:290 -----------KLFKDMDIEFIGNVIKTAEDQLESTLSDYSFNNLLIHIAIAIKRIELAKDIV-MDDNELKNLSKTCEFSIASAMARMLENRYDIKIPKSEIGYMTIHLLGSNVMLKEE-
179 UniRef50_C9A723 BigG family transcription a... 77 1e-13 1 10.5% 15:119 66:169 --------------DEKQMAVIYEIVRLFRDSVGTDFNPNVYFTLMDHILFAISRQKQEIVLTNPMHWEIKKI-YAKEYAVSVQAVELIRKELYPDFSQEEAAFITLHFVNAQIEKSAN-
180 UniRef50_A5ZAD7 Putative uncharacterized pr... 77 1e-13 1 10.0% 6:115 58:166 -----KFSELIEMIPHNYLNLSVDIISYAQQVMPKRLSPSIYISLTDHINFLLERSTKGELFENPLFNEIKSF-YPSEYLVGKKALELIESEAGIKLPQDEAASIALHFVIAEYN-----
181 UniRef50_B9Y2L9 Putative uncharacterized pr... 77 1e-13 1 9.6% 2:115 80:192 -SARPQLLSLFEQVPFEIIELTQRIIDIAQEDLKMTFNVNLVVALADHIQFSVNQYKAGFDMPALVNEEVKRF-YKDEYEVGKKAVRLINETLHIQLKREESTSIAFHLITAAEK-----
182 UniRef50_B5CMP9 Putative uncharacterized pr... 77 1e-13 1 12.9% 2:117 56:169 -SNRGNAKELATSIQPIYLEIANEILDEAEKVFQ-NIDRAVLFPMADHLEYAVKRIQNHEQISNPLTDDIR-VLFHLEYKTAECVRPILKERLGITIDDNEVGYISLHIHSAIKDEN---
183 UniRef50_C1PBK9 PTS modulated transcription... 77 1e-13 1 16.5% 9:117 170:276 --------QQNTPFNQDLFQKVKQILIRIISKYRIRFSDIELQNLATHITLACKRIEDGFTIEPLPFHFKE--SYTFERKVAKEITGEVEKSVGIPFPPAEIDYILVHLLGTKLISK---
184 UniRef50_B1QS11 Transcription antiterminato... 77 1e-13 1 7.1% 7:119 59:170 ------FTKLLSEIDLVNFEFIENLINYVKSTLGKKLNNSIYITLTDHINTLLERAATNAYVKNTMLWDIKRI-YRDEFKIARDVVCRINERLGSNFDDNEAASITMHIVNAELETNMK-
185 UniRef50_A0AJH4 Complete genome n=52 Tax=Ba... 77 1e-13 1 17.3% 12:109 433:529 -----------EIIAPAVWELTGKVYAMAEEKLNRKYNEKMKFAFSLHLQSTIERVREQKHIIHPDLNNIRK-KYPKEFQVAIDLSALIEQELSIEIPFDEIGFLTMFL-----------
186 UniRef50_C7WZJ5 Predicted protein n=7 Tax=E... 77 1e-13 1 12.5% 15:118 295:399 --------------DEKYVDLVYRLISRMSKIEKIDldEHLFNSLLYHIPAMILRLKRGIHIENPLLENIRD-QYSELFSIVWYALVIVEQQYNVILNDDEISFILIHFQIALDRQSK--
187 UniRef50_C2LUU8 Transcription antiterminato... 77 1e-13 1 8.9% 13:113 65:164 ------------NLPDGEMQVFLNILTFAEAVLQTKFDPSFFIALADHLHYAIERSSEGVSLQNPLAWEVRKF-YPREYEIGKQALRLIAKDLEVQLADDEAASVALHFVNAQ-------
188 UniRef50_C8ZY62 Transcriptional antitermina... 77 2e-13 1 13.9% 4:118 478:592 ---FNSENKLSEFVDQKVITMTNRIYDLVRTRLNYEFQQNFVYAMSLHISSFLKKIHLGEERHTNDNIRQMVADYPKEFEVAKEIRTFIGDSFKVSIPESETYYLAVLLVSLRTDHSS--
189 UniRef50_B1IBZ3 Transcription antiterminato... 77 2e-13 1 11.8% 2:120 55:171 -ESRENFMALLKDVPLDFITVTYEIIDKLSKKYHYPIQEYLYVTLTDHIYCSYQALTQGRYKDSNLPDISA--KYPVAFQIANEAFEIYRQKLADHFPEDEIIRIAYHFINAEGENEVEL
190 UniRef50_B9Y734 Putative uncharacterized pr... 77 2e-13 1 13.0% 2:116 68:181 -KEKNFLMNLVEDIDPVYIDITTKIIALFESRLHCKVNVMMNISLSDHIHNAVRNKQEGFQVPLDILEEVKTM-YPREFLIAKEGLDLIEKETRTTLSEDEAGYIVLHYINAQGQH----
191 UniRef50_B3DQG5 Beta-glucoside operon antit... 77 2e-13 1 15.4% 9:112 61:163 --------QMLADIPPEIIRVVVESMQEaeRETG---STTLVMALSDHVANAVERVRRGIDITYPLLGEVSNL-YPQEYAQGRAMLASLNARLDVTLPDGEATALAMHLVNA--------
192 UniRef50_Q02YC0 Beta-glucoside operon antit... 77 2e-13 1 10.9% 2:111 58:166 -SEQQNFSELLSEIPSGIVELSILTLEKAKTKFDKTISDTVLVAFADHLNAAIIREKDNIAIKNFLLWDIKRF-FPEEFALCLETLQKVKEKLNISLPEDEAGFLAMHIVN---------
193 UniRef50_Q5WCP1 BglG family transcriptional... 77 2e-13 1 12.7% 7:116 58:166 ------FSELIDNIPVAVFEVAAMMIRKAETIIGVQLSDHLFLALADHLNYAIQRTLDGIDYPHSHPWELDRL-YPKEHKAAKEAVRIVFDELDVLLPKSEESFLTYHFVNAQGQQ----
194 UniRef50_C6IXJ3 Phosphoenolpyruvate-depende... 77 2e-13 1 18.6% 14:115 187:287 -------------FREEELDSVYRIIVSTEQQIGMEWTDETILHLTLRIWLSANRMKQGRTVQ-LEEEEKAALRETLQFKAATQIADELGERFDLRVPEDEIGYLAIYLLAAKVN-----
195 UniRef50_C9KQ73 Putative transcription anti... 77 2e-13 1 18.2% 8:117 63:170 -------LQRVNGLDPHAVELAARVLDEARKSFP-AMTDDILLPMADHIAMALERCRRGIRLPNPLQHDIM-VMFPDEYRIAEQGLHAIEREEGLSLPPEEAGYLSLHIHAGISEQN---
196 UniRef50_A8SDV4 Putative uncharacterized pr... 77 2e-13 1 9.2% 14:111 285:382 -------------IHPSTMRLVDSIVQAVKQVYDIDLTddFFIPFALHIDNMLVRIRQNVSVHNPLLHSIKAMS-PIIYDIAVYISNLINHQEHVQLCEDEIAYIALHIGA---------
197 UniRef50_D2EKZ6 Transcription antiterminato... 77 2e-13 1 14.8% 2:116 52:166 -KDRLEHLslLTHSDKKIITLVNKIVDYGENYLKVKVTDYLYLALLDHISFALKRGQKGQFIASPLVWEVKKF-YPQYYEIGIKAINWLNQTYEVNFPEDEAIPISLHFINVQDEQ----
198 UniRef50_B9CU63 Transcriptional antitermina... 76 3e-13 1 11.8% 10:119 193:301 ---------QQSLVDLDRIFKIERILMDYLGQLPYTLTESSYLTLTIHIVLSITRMQNGEYV-SLNKDIYETVKDTFEHEVATEIAKRLEEIHNVEFNQAEITFITIHLRGAKRKGTKD-
199 UniRef50_C4V3X4 Possible N(Pi)-phosphohisti... 76 3e-13 1 13.6% 15:117 297:400 --------------DEHVKELVEKVLVDVDKKFGLDfdEYLKDGLALHLRIAIARVNFHVNIRNELLSSVKQ-DYPLAFQIAVYAAKLVRDIDHIEFNENEIGYIALHFCAAMSRNS---
200 UniRef50_Q8NVE5 MW2083 protein n=56 Tax=Sta... 76 3e-13 1 11.4% 12:116 195:298 -----------DFVDLERIFNVERLLMDYLSALPYQLTESSYLTLTVHIVLSISRIKNGEYV-ALNDDIYDSVQNTFEHKVASELADKLGQIYDVTFNQAEIAFITIHLRGAKRKN----
201 UniRef50_B4U1G3 Transcription antiterminato... 76 3e-13 1 14.5% 2:118 62:176 -EARENLLLLLKDVPLDVITVTYDVIDWLVLTYHYPVQQYLYVTLTDHIYAAYHMLQKGTYSVNRLPDISKEFGQ--EYEMAQAALEMFRQRLRTTFPDDEVTKIALHFINAKGEESS--
202 UniRef50_A0FL05 Putative transcriptional an... 76 4e-13 1 10.5% 6:110 29:132 -----SFKELAREIPRSYFELTDSIISLAQKSINVEFDGHLLIPLTDHIYFAVQRIKSGLVVSNPMLFDIRRL-FPKEFQVGQEALALISSFSDVSFSDDEAGFIAMHLI----------
203 UniRef50_C9PC09 Beta-glucoside bgl operon a... 76 4e-13 1 12.6% 2:112 58:165 -SERLKVLMES--LPLEVVQMTEFICDEAEKALNRKFGNGLFVSLSDHLDFAIKRSKDGLSIPNPFEWEIRSF-YDKEFKFAEGIIQKILLNWGVLLEKSEACSIALHIINA--------
204 UniRef50_A6M341 Sigma-54 factor, interactio... 75 4e-13 1 15.5% 10:119 468:576 ---------LLKIVDKDIVDFAEEIKMLAENRLSRKLSDRFIYAISLHFSALFNRIKKN-TVSFSTNIELTLSSNSKEYGVAKEIHKLIEDRYNLIIPEVEIEYLALLLSSIQELSHQE-
205 UniRef50_C7TEP6 Beta-glucoside operon antit... 75 5e-13 1 9.3% 14:120 65:170 -------------LPDEYLTIAARIIQEAEVQLHTKFNSYLLIELADHIHFAVTRLHEQLILHNKLLWEI-QIAYEPAFRMGEWALTEIANQIGEQLPEDEAGFIALKFVSNDLSQQHPV
206 UniRef50_C5EW03 Phosphoenolpyruvate-depende... 75 5e-13 1 14.3% 20:117 313:411 -------------------SFVHEFLEMVSSVLGINIPQdlYENLKYHLSDMICRMKIGMTIRNPLLHEIKD-KYPSVFGASWAFSILFEKYFGLMVNDNEIAFIATYLLTAREQLN---
207 UniRef50_A8RFC1 Putative uncharacterized pr... 75 5e-13 1 13.7% 2:118 59:174 -ENRKYIETIIGQIPYTLFKVVDDVIKQAEDDLQTKFKDVLYLSLLDHIYFAYKTWEDKQKIENPLLNELK-MFNSKEFNAAKHSIQIINNTLKTDFDEHEAAFIAFHYINALSNLSS--
208 UniRef50_A6LYH3 Transcriptional antitermina... 75 5e-13 1 10.5% 6:119 58:170 -----KFKLLLEDIPTEHVSLCYDIIEYAKNMLSVELNDYIYITLTDHISYALKLFDEGL---NRPNALIWEIkyPKEFEIGLKALDLIQSETNKKLPEDEAGNIALHLINAQTNNSGN-
209 UniRef50_Q8XP92 Probable transcription anti... 75 5e-13 1 12.9% 6:106 66:165 -----NFRRVVGSNDEKFIAFCEELILEISRDFSDELNEIIHIGLIDHISFAIERMKKGEILRNPFLVEIETL-YPKEFEAATKMVKKLEDFTGVSIVDDEIGFIA--------------
210 UniRef50_A6M2B9 Sigma-54 factor, interactio... 75 5e-13 1 16.7% 9:110 427:527 --------NLLTIIDEDTLKCIDSIVSHITRKLPVIFDSNLYTAFALHINTLINRINSDKIIINTNLNRIKDL-YPSEFAVALEIKEIIENTINKSIPIDEAGYLTLFLI----------
211 UniRef50_D0R5U6 Transcription antiterminato... 75 6e-13 1 10.6% 6:118 55:167 -----DEVNQVKEINASTIDLTNKVIQMVEPLLNVKFNDFQHLALADHIDFALSRIEDNIDISAANIRWEVKNLFPKEYKISEKVIALINKEMKVNLPASESTFMTYHFVNAASDNDQ--
212 UniRef50_B6GB96 Putative uncharacterized pr... 75 6e-13 1 15.2% 9:113 57:160 --------RIMRDLPADVLIFTAKVMDIVSNELPYEVSPNAVLIMADHLAFAIARQKKGICFDMTLAYDVRQL-YPLEYKIGRYIVARLRQEMGVELPHEEIASIAMNLVNAK-------
213 UniRef50_A5CU91 Putative transcription anti... 75 7e-13 1 9.0% 16:115 313:412 ---------------ESDLDVVRAIVRRVKQEYLVDLEDEDfvRFSLHLGNLVARAADRSFSRNPLARSIKT-SYPMTYEIAVFIASEVQRRRGIAINDDEIAYIALHVGSHRER-----
214 UniRef50_C9B2H8 Beta-glucoside operon antit... 75 7e-13 1 9.4% 11:116 63:167 ----------MNNVPVKYIELAYEVIQEAEKYLDTELSANTLFSLTDHIYFTVERIRDNVIMTSSMYWEFKRF-YPEEFQAAQKGVAIIEKALGISLNEQEAANITFHIINGNSRS----
215 UniRef50_A5IPR4 Transcriptional antitermina... 75 8e-13 1 10.1% 10:118 176:283 ---------EADIFNSESIALVRRAIIKTLNSENYHLVQSAIDGLIYHILIAIQRLNENFSFDIPIN-EIDKWRHTNQYAIASKMIENLERSCNVTFPESEIIFITLHLLGSKMTEHT--
216 UniRef50_UPI0001788D94 transcriptional antitermina... 75 9e-13 1 13.7% 19:120 195:295 ------------------LEQVYRLISDSEITLGVDLTDEMLFHLTARFLLYVRRIQTAQWV-SIDDDERSVLRRTPEYEAAARIAEGLGQMFGVSVPDDEVCYFAMHLLGARVNRMEQM
217 UniRef50_B1SDR3 Putative uncharacterized pr... 75 9e-13 1 15.5% 2:117 55:168 -ESKENFLTLLKNILLDILTVTYNMIDDLVAKYHFPVQEYLYVSPTDHVYLVYQKLLKGAHQESHLPDISAA--YVTEFQMAQEAVAILSQKLSVTFPEDELGRIAIHFINAKREGE---
218 UniRef50_D1ANJ9 Transcriptional antitermina... 75 9e-13 1 14.2% 2:114 57:168 -EDKKYLSDIMSNTDSEILDIVEDALKIIDKELKEKLSIYFHLTMLSHLSFAIERSKYGTIIRNPFLEELR-VLYPQEYRIAEKFIAEVNKHLEYKLEIDEVGFITMHIHAALR------
219 UniRef50_C0CVJ7 Putative uncharacterized pr... 75 9e-13 1 12.6% 9:119 3:113 --------NLKQYVEQEYIEAARYIVEQVKEHYLVnfSDDFFVKFTLHLKNLFIRSSKNLTAKNPLKDKIK-WTYPLIHDISVFIADILDHRFGLHIDEDEIGYIAFHLCTCLYGMNQE-
220 UniRef50_C4FGL9 Putative uncharacterized pr... 74 1e-12 1 12.5% 9:112 79:181 --------ELLADIPPEIIRLVAEAMTRIGMGAQVERRPALVMALADHLTGAIRRINKGVNVEYPLQAEVQSL-YAREYEQAEKLVAILNTYLGGILPEGEVSAFAMHLVNA--------
221 UniRef50_A4W1H2 Transcriptional antitermina... 74 1e-12 1 16.8% 1:113 2:112 MKPKQNFLTLLKDIPLDFISATYTVINHLVETYHYPVQEYLYVTLTDHIYCAYQAVLKNTYQESRLPNISAE--YPLEYKMAREALAMFREKLLNDFPNDEIGKIALHLINAK-------
222 UniRef50_B9YD06 Putative uncharacterized pr... 74 1e-12 1 11.4% 4:117 52:164 ---KTDTLPVLDEIDEELFADTGYIVSQIRQRLKKEISDSLFFVLVDHLNFAIKRARAHIYFQFSIVSEVVQM-YQMEMQAGQWAVDYLNDKYGVKLPSDEAAIIAIHIVGSYDDES---
223 UniRef50_B6FWC4 Putative uncharacterized pr... 74 1e-12 1 16.5% 2:110 488:594 -ENRKKIHIMSENLNPETINIMNKVITVIKNQYRF-VNNGLYMVLATHIEEAIKRVRNEKNIINPSLDNIKE-NMSEEYDLARYVVTIIENIAKISLPEDEIGYIAYYIY----------
224 UniRef50_Q03GK2 Transcriptional antitermina... 74 1e-12 1 11.8% 10:119 276:385 ---------MKDNISKETLNLIKSILSYVRSIYRIDLtpEFLNQFAIHVSRLIQRLKSGKSIQNPMATQMKA-QSPTVYECAVLISHKIASQVGVEVPDNEIAYIAMHIGNAIAKQIED-
225 UniRef50_UPI000196B5EC hypothetical protein CATMIT... 74 1e-12 1 14.5% 5:114 120:231 ----LDFFSECDIIDQETESITLEAVQEINNRLGLNlnDDFYQGLSMHFYPAIQRLKNDEQLHDNVLTDKIKTENETEYQCAMILNDVVKEHYHKSFNEDELAYIALHFGTALR------
226 UniRef50_Q8EMS7 Transcriptional antitermina... 74 1e-12 1 13.9% 13:120 188:297 ------------TLPDQQMSMIKNIIIQQLDSHQMTLSDIAIHNLFIHIAIAVLRIRDGHPIdaAHREEMQDMKDTKAYFVAEKIVEDTEKQLHLSFPKTETTYVALHLLGTKMVGSTNI
227 UniRef50_C6P9Z8 PTS system transcriptional ... 74 1e-12 1 16.7% 6:119 505:617 -----NRSVLFKFVDPYILNAVEYAFNGIKDSFNGVITQKVIYLLSLHIKTLLERLKMGIVILHPDRESIAK-SYKVAYDAAKEVKTRLEEKLNVDIPEDEIAFLAMFLQALQYGKNNN-
228 UniRef50_A8RFW3 Putative uncharacterized pr... 74 1e-12 1 9.4% 2:118 61:176 -RQKNLNLTLFEEVPFEVIEVSQHIIDYAAKTLNQKYNVNLLVSLSDHIDFSVKQFREGNNTSKLFNEEIKRF-YEDEYQVGKCAIQYINETLHVDLPKDEATSIAFHLIVASQEKTN--
229 UniRef50_B3WDA1 BglG family transcriptional... 74 1e-12 1 10.1% 4:112 56:163 ---KSEMIQSLNNIPPVYISITSQIVTYAEQQLQLSLLPSIYYALTDHLAFSVQRYHSKQSLGNRIYWEMK-PYYPEMFAIGEYGLTVVEATLQLALPREEAANIAFHIINA--------
230 UniRef50_A0AGN0 Complete genome n=21 Tax=Fi... 74 1e-12 1 13.6% 1:118 462:575 IHNRENILK---IVNEEILNFAEGIEQRIEHQLGKKLNERFLLAFSLHLTSFIKRIESNKPLK-YTNIENVVNDQPEAYELSREIKDDIEATFHIRVPNMEVMYLTLLISSLLKEQEN--
231 UniRef50_C0CYQ2 Putative uncharacterized pr... 74 1e-12 1 12.3% 5:118 280:393 ----ITVSNLADFITPECLALVRELISDVNSYYYIDLTeeFLIRFALHIRNLLQRSKNNYFSRNPLTEEIKTSC-PLIYDVSVCLSSTIKERTGISINDDEIAYIAFHLGSTLEAQKN--
232 UniRef50_Q041B0 Transcriptional antitermina... 74 1e-12 1 10.6% 6:118 67:179 -----DEVNQVKEINASTIDLTNKVIQMVEPLLNVKFNDFQYLALADHIDFALSRTEDHIDMSAANTRWEVKNLFPKEYKISERVIALINKEMKVNLPPSESIFMTYHFVNAASDNDQ--
233 UniRef50_C5EEI0 Predicted protein n=1 Tax=C... 74 1e-12 1 8.2% 23:120 297:395 ----------------------HAILELCQEKYGYDFSQDiySSLSIHLNALFKRARNNNYSINPMIDEMKTYSL-LAYDIAFDLSLLINDRLGVCLPDDEISYLAIYLHLAIERKKRNI
234 UniRef50_B4U3Q3 BglG family transcription a... 74 2e-12 1 15.0% 10:109 187:284 ---------DNTFLDHIKFADITIIVLDECRDAKLKLSDFVMHNLVLHIALMVQRIRSGYPLAFFSIP--AAIRQSDEYQVALRILYRVEEVMGIRFPKEEANYIALHL-----------
235 UniRef50_C8ZX11 Predicted protein n=1 Tax=E... 74 2e-12 1 13.4% 9:120 295:407 --------NLKNQYDNDLLEFVHTIISSISEILQQPLTEDKILelTNHLRSAIFRMKYGHKNSSELTRDLKKL-YGRVFLSVWSTSQLFEDYYNVQLTEDEIAYIVLYIEAAILRNQSQV
236 UniRef50_A6CNR6 MtlR n=2 Tax=Bacillus RepID... 74 2e-12 1 14.5% 11:120 295:406 ----------ADSIDYDSiqLIKKVIEDVSTKLHVDLSDdlYQGLLAHMEPSIFRLKQKMELFNPLTDDIKK-KYPVLFMAVRDSLE--NEFKDIHFPEDEVAFVVLHFGSALLMHEEKV
237 UniRef50_C6VMT2 Transcription antiterminato... 74 2e-12 1 13.4% 14:110 4:99 -------------IEPEYFEVASQIIELAEQQLQTTFNVYLLISLTDHIHFAVYRHHHQMDIHNEILWETKRI-YHREFQVGMQALALIKKHFDVTLLEDEAGFIAMKFV----------
238 UniRef50_C3RR39 Predicted protein n=2 Tax=B... 74 2e-12 1 11.7% 1:120 167:282 IKEQLELQLGHSTIKKEWLATISDIVVDSLMKAKYRISDVVLQNLVLHICVSIQRMQHGIYIDNPQMAR----QYGHEHVIAKKILDELASIYHFIITENEISFLAIHLLGKRSYEENDL
239 UniRef50_Q7N5F7 Similar to unknown protein ... 74 2e-12 1 52.5% 1:118 1:118 MENRLNLLYQGNVIDQDIHDGMLQVVAQLENDWEIPVRNALGEIVITHMANALMRSRRGEQISSMDNELLMEVRQSRIFSHLQAINASLLAHFDVQLHPCEEGYLLANLFSLWAAKGQ--
240 UniRef50_UPI0001C42D0A transcriptional antitermina... 74 2e-12 1 20.0% 9:113 195:297 --------KLLYLIDLNVILKVLETLHELRRD-GEPIADVSYVGLAVHLSLAVDRIKRGEKIEKHSEGFEKVLK-TNEYEAAKRLVKKLEETFSIDIPQIEVAYVAMHLLGAK-------
241 UniRef50_C4G9M5 Putative uncharacterized pr... 73 2e-12 1 16.0% 16:115 319:419 ---------------EDLLEIIDRMIDQFDTEMANSldEEFIRGLIMHLQPAMFRMSEKMSIYNPVLPEIKR-EYPEIYAKSRRAAEVIRDETAFEVSDDEIGFLSMHFGAAVER-----
242 UniRef50_A0AMB6 Complete genome n=18 Tax=Li... 73 2e-12 1 14.7% 9:117 187:293 --------TERNFFSEVNLEMIEQVVISNIAKYNIHMTDISVKNLIIHIAIAVCRVKDNCYVHVTDLEDIEFSI--PEFRAAQDIIKEIDLSEGIHFPESEISYLLLHLSSKNRKSD---
243 UniRef50_Q63A16 Possible transcriptional an... 73 2e-12 1 15.3% 10:120 193:302 ---------ETDTLARETLYIIKKILANCEEFLGVQYTDEVLENLSVYMYLFHRRILKGKCVE-MEEAEKNVLKDSKQFEAAKYIAKQFERAFVVKFPIDEIYYITTHLLGAKVNYQENV
244 UniRef50_D2MNU4 PRD domain protein n=1 Tax=... 73 2e-12 1 10.6% 1:113 51:162 LKNLARYEKLISETEDQIVSLSEQIIRELEECFSQDFDRNIHVSLLDHLQFSVKRYRENMIVQNVFLDETA-YFYPKEFAFAKQALAMVNESLKINLPLSEAGFLCMHIHAAL-------
245 UniRef50_B1CAJ2 Putative uncharacterized pr... 73 2e-12 1 16.5% 9:111 451:552 --------NLLKIVDAKILDTCDDAINFAEMKLNRKLSSRIKIGMIMHINSLVSRISNGDSIENKKINDI-VLNNPKEFKIAKFIFTLLEENLNIKIPKYEIGFLTMFLCA---------
246 UniRef50_B6FTX2 Putative uncharacterized pr... 73 3e-12 1 8.3% 6:113 54:160 -----KYIELFKDIPEKVVHFTAKLVEIAKNELGYEMNPNLVVTMSDHIHFSIQRAQKNIDVQMPLIYEVEQT-FPAEARIGKYAVKQIERRFNVRLDPNEASGIAMNFVNAR-------
247 UniRef50_C6VLU3 Transcription regulator, ma... 73 3e-12 1 15.7% 10:117 289:395 ---------EDGYIDLDRSGLVERTIVDWLRSVLTDYDNQLLRNLTLHLRPALVRIKNGISITNPYCNQVKTY-FPVAFDQALALAMAIEKQYHLQLTEDEIAYLALHFESFIERRK---
248 UniRef50_UPI0001794F42 hypothetical protein CLOSPO... 73 3e-12 1 22.6% 1:115 3:117 LTLRLKLLKDGAQIDEDTYNNLLKIIKSFKKDFQIELSEENGGMFITHLAVALERIKKKELVEPIEELIFEEVRNDKNFKKANDILESLEKDINISVPEVERPFILMHIVTLLSK-----
249 UniRef50_A8RAU5 Putative uncharacterized pr... 73 3e-12 1 14.4% 5:115 53:162 ----KEYLNLFEYIDSEIFSIAADVIDLATTMLSVPLKHNAQYTLADHLNFAIERMDKGMIFSTPISNELRDL-YPVEVKIAKYTLGLMKKRRNIDLPEEEMYAIAMNIINSEEN-----
250 UniRef50_C6IY31 Transcriptional antitermina... 73 3e-12 1 14.0% 14:120 185:290 -------------FAPHELDIVTRELKQLELDAQLAFTDEAFDNLLIHTLLMIRRTKLKQPIT-FSEQEKVFVRGKPEFRWTGAFIRKLERFFAVRFPEDEVAYLTAHILGGKIRSRARI
251 UniRef50_C3RPC3 Transcription antiterminato... 73 4e-12 1 12.1% 5:120 53:167 ----NRYYGLLKEIPNNIFNLVTKMVDVAKKNIEDELSPNLVFILADHINFAIIREKNGMDISLPYSYEL-EYEYPLLTKISKWMVKKTNEELDTHLPKGEVTSITMHFINALEGTNTKM
252 UniRef50_Q67QV8 Transcription antiterminato... 72 4e-12 1 9.0% 9:119 281:391 --------NIREYIEEKYILLAKMALRRLEDTFYlpFDDDFVIQFTIHIRNLIQRALTGSHVKNPLVGKFKTT-YPLIYDMAVLVANQLREIEGIHVPDDEIVFIAFHIGAYLEQNKAD-
253 UniRef50_B7CDV3 Putative uncharacterized pr... 72 4e-12 1 11.2% 2:117 55:168 -QAKQKSNNIFDYIDPMYIEISSEIITLTKEKFG-KVEHDILLSLADHIYFAVKRIKEKDFPSNPFNMDI-QLMFPDEYSVALKAKDVIEKYTHEEINAEEIAFITLHIHSAISVNK---
254 UniRef50_UPI00017890F3 PTS modulated transcription... 72 4e-12 1 15.4% 15:118 308:410 --------------DVEMVEIAHRLIERVQGRTGIPFQEdlRAGLVEHIGAALKRIREGTRIRNPLLSPIRK-DYEELFGIVRRSVDEL--KLDLSIPDEEIGFLVMHFGASSERLNQ--
255 UniRef50_B9Y8Z0 Putative uncharacterized pr... 72 4e-12 1 15.1% 1:119 711:827 MENLLNYLTILN--PEIILGNVETIIRSIEAQLGLRITSNVKVGLYLHISCLIERLIINKTVAPYDKLDELQQKHQDFIAVIRKSFAEVERIYNVSIPLSEIGYLYEYIALGSVEKEEN-
256 UniRef50_B5MJF8 Transcriptional regulatory ... 72 4e-12 1 7.3% 1:110 351:459 IKSKDDIKTIQDYVTGTISELTDEIIQLSQKRLEKTFDINFQYALSIHLEKTLNRLKFDQLITHPRLNDIR-IKHNREFNVALDCLRIIEKKVDISMPIDEAAFLTMLFI----------
257 UniRef50_Q1JGE0 Transcription antiterminato... 72 4e-12 1 16.5% 19:109 195:283 ------------------FAEIMIIVLYECRDAKLKLSDFVMNNLVLHIALMVQRIRSGCPLELFSIPI--AIRQSDEYQVALRILYRVEEVMGIRFPKEEANYIALHL-----------
258 UniRef50_C5DAC1 PTS modulated transcription... 72 4e-12 1 15.9% 10:116 194:299 ---------EQNMVILAELKCILNILNECEKDLNIQFADDVLHHLALRFWLFGKRIVQGKKIE-FDPIEKEVIQQTREFEAAKKASKKLESIFQTSIPDDEVYYLATHLLSTKVQY----
259 UniRef50_B9Y4S7 Putative uncharacterized pr... 72 4e-12 1 8.5% 1:118 815:930 LDNLIDYLTILN--PEKIIVYVEEILEQIQKRLEFTLSNNILIGLYLHISCLIERLIIDKRFVYYLNLEKFEAEHGDFIAMIREVFGRVCRAYNVVIPTAEIGYLYNYIVQGKSVEKQ--
260 UniRef50_C8P1A7 SACPA operon antiterminator... 72 5e-12 1 11.6% 6:117 74:184 -----QYEKIVMNTDDQVLLVTEAAIAYAEKTLNYKFDESIHISLLDHINFAIYRYHNRVKMSNFFTEEY-YLMYSELYDISKHMVEMINDELDVELPHSEVGSVILHLHAAMHQGK---
261 UniRef50_C9XLZ0 Putative transcription anti... 72 5e-12 1 14.0% 14:120 300:407 -------------INDSVKEVVDEVTSFLLETSGIDFKEdlIENLEYHLYFALNRMRFNIRVKNPLLQEIKE-RYTFPYSVAKIAAMIIEEKFDLKICDHEIGYIALHFGSYFEKNSRKV
262 UniRef50_B6G9P7 Putative uncharacterized pr... 72 5e-12 1 21.8% 37:114 207:283 ------------------------------------INSVAYRNLITHIVIALLRIREGCYV-PMEGEQLTEIRKSPSFPIARRISDSIGARTGVVLPDEEVAYIAIHLTGKRL------
263 UniRef50_B0MGK7 Putative uncharacterized pr... 72 5e-12 1 16.5% 17:119 310:413 ----------------KQLDLVTQLIARVEERFGFPYSEdlAENLMLHINMALERIRSGMNVSNPLNDDIYQ-SHPKLYDIVKQSFIEVFNHTSVPVPDDEIGYIVIYFIASMEYLTKQ-
264 UniRef50_C5EFS9 Predicted protein n=1 Tax=C... 72 6e-12 1 15.7% 9:116 179:285 --------KLVPFFEETDLQEIHTILHDMEDDYGFTFADSSYAEMMISLAITVERVRNGN-VCCPTEGELNGYRQKNQWSMAGHMARKLEQEFHIVMDEGEQAYITMNLMGAKLQN----
265 UniRef50_C6IZU2 PRD domain-containing prote... 72 6e-12 1 15.4% 15:118 313:415 --------------DMELVDTVYRLTENVVKRTGIPFQEDRLlgLLEHMGPAFKRIREGSRIRNPLLGAIRK-DYDELFGIVREAMN--ESVAGLEIPDEEIGFLVMHFGASMERLNQ--
266 UniRef50_A8FDU8 BglG family transcriptional... 72 6e-12 1 13.4% 7:118 57:167 ------LESQLTAIPTDILLLTEKIIRVGEEMLNKKLGSSVLFSLSDHLTFAIQRHEEKIAYENPIVWEIPHL-YFQEYQIGKKALTIIQKMMGISFEDTEASLIALHFVNAQIDGQS--
267 UniRef50_A8U6I0 Sigma-54 interaction domain... 72 7e-12 1 15.0% 5:117 465:578 ----NNEHNLRDIVEQEVITLTKEVWKMAEEHLGYKFKQNFLYAMSLHLSSFIKRSKEGfqIKQNSELDKIILNYQKEYEVAIMIKDHMKENYQIIVPEVECWYLTMLLVSLKDPNN---
268 UniRef50_UPI0001C35E6F mannitol operon transcripti... 71 8e-12 1 14.0% 15:114 287:387 --------------NEFALEITKNLITEFEREACVLFeeDLIRNLYRHIAASLYRYRFGIQIGNPMAEDIRR-EYPYIFDTTRAVVKYLEQQIGVLISDSEVAYLALHFGAHLE------
269 UniRef50_Q5WK94 Putative uncharacterized pr... 71 8e-12 1 22.5% 1:111 3:109 LYTRLQILKEAGTITDKAYRVTTQVVD---EQVPDHLHEN-YAMLVTHLAMALTRIEQNEALTGPGDAVMEEVLASPHLPAAKEAVEKIESLVGEPLPKEEQQFLYMHFVS---------
270 UniRef50_C7REJ5 PTS modulated transcription... 71 8e-12 1 13.1% 15:113 182:279 --------------DEELFTRIQAIIADIDFPESFYMPYANFKNLVVHIYISILRIKEGKYIDLSDELSKRVISY-DEFNIANKVVKELSKKLDLTFPEDEILYLTMHLISKN-------
271 UniRef50_C4FUH4 Putative uncharacterized pr... 71 9e-12 1 11.1% 17:115 295:394 ----------------ELRQQVQALIQRVSDFLNVDLSQdlLAMLANHMSSMIFRLRHHMHVTNPALDEIRK-QYLTLFNIVWLVLRDFAEHYDMEVPDEELAFLVIHFQIALEK-----
272 UniRef50_C2C483 Possible MtlR transcription... 71 9e-12 1 16.2% 9:113 193:294 --------RLLHLIDRKLIQKVEKVLRNWRQQLEYQITDDAYISLVIHIVISIDRMLAGHFIYELRNENAKRY---PEFQTAKEIIAECLEMEADVVPDGEAGLVTMHIRGAK-------
273 UniRef50_D1AMX4 Transcriptional antitermina... 71 1e-11 1 10.0% 6:115 56:164 -----NYERLAMEIPEIYFEIAGEIVERANKEFTGIFNAQLFLSLTDHISYSVERVNKGIVLQNRLIWDIKAF-YSKEFTVGLWALTLIKEKIGIQLPEEEASNIAFYLVNAQSS-----
274 UniRef50_B6G824 Putative uncharacterized pr... 71 1e-11 1 11.2% 13:119 107:214 ------------VISDEVWQVVSDMLDRVWRVFRFDFRNDlrMNLARHIQPLSVRLRYNLKLKNPMLDDIKA-RYPLSFSIAVDASTVIAEAYGAPLSHDEIGYVALAFELALERSKTE-
275 UniRef50_D1AQP8 Transcriptional antitermina... 71 1e-11 1 10.7% 7:118 58:168 ------FSYLLSHSEPNHITLVNQIIKYGEDKLGKKSNDYLNLTLLDHIEFALKRAQKGQFIRSPLTWEVKRF-YPKHFQIGIYALDLIKEQIGSEFPVDEAVSIALHFVNMEEGKSN--
276 UniRef50_C7BJX4 Cryptic beta-glucoside bgl ... 71 1e-11 1 9.7% 6:118 56:167 -----KISQILSTIPVSVIELTEQIITIGKNFLAKPLNDSLLITLSEHLSFAFERVNKGYQIGNVLQWEIPHL-YPLEYEVGKQALIHINNQIKQPLSQIEASLIALHFVNAQYEGQT--
277 UniRef50_C9A1R6 Predicted protein n=4 Tax=E... 71 1e-11 1 11.9% 17:117 298:399 ----------------NVIETTEEMIEKMSRLLDTDLTQdlLQALLSHIVPMIHRLKNGMLVKNPLLRLIKK-QYSTMFTLTKYAIGGLEKNFALFLTEDEVSFLTIHFQLAFEKIK---
278 UniRef50_D1B7A6 PTS modulated transcription... 71 1e-11 1 15.3% 4:114 177:284 ---RGRVSMEDPIFHPGEMSFLEARVRRALEMAQVRLTGEAVLGLTVHLAVSIKRVRTGGALEICRDEGLE---GRREMEAARLMARWVEEGLGVTMPPGEVEYLAMHVMSSRR------
279 UniRef50_Q2BFG3 ManR n=1 Tax=Bacillus sp. N... 70 1e-11 1 10.1% 11:119 183:290 ----------LDLFQPYEIDIVRKALKEIQNNESIRFTDEALDSLVVHALIMIKRTRQRAPV-FVEPAEMEKIALRKEYEYASAFFTRLADSFQLSFPEAEIVYYTWHFISAKRSEEAE-
280 UniRef50_A4W4E8 Transcriptional antitermina... 70 1e-11 1 14.0% 10:109 186:283 ---------ETNLLPDIRFTDLMLIVLDECRDAKLRLSDFVMQNLVLHIALLLQRLKIGSGLDRFPIPE--RIQSSQEYLVAQRIIDRIEETFQVTIPSEEANYIALHL-----------
281 UniRef50_O31644 Putative phosphotransferase... 70 2e-11 1 17.2% 18:116 192:289 -----------------EVDFVTKEIKSLQKKHSLYFTDETFESLLLHTLLMVRRIKMKQPI-SLSPKEMAAVKKKKEYQWTFACLQRLEPVFAIRFPEEEAVYLTLHILGGKVRY----
282 UniRef50_UPI0001C346E1 Cryptic beta-glucoside bgl ... 70 2e-11 1 12.4% 6:118 56:165 -----DIHNFVDNIPIGIIKLTLEVINKCKPILNAKLSDSLVITLSEHITFAIERSKNREMSISLYEV---PYLYHLEFIAGKVAVDYINEKLGVNLPPGEASLIALHFVNAKLNNKS--
283 UniRef50_Q9KG92 BH0220 protein n=2 Tax=Baci... 70 2e-11 1 11.5% 13:116 196:298 ------------IFTIEELQKVYDVISESEKVLKIQYTDDVLHSLSLRFLLFMKRVAKGKFIKVHPL-EKQVLKGTKEYEAAKVMSFKLEQAFGVHYPDEEVLYLTTHILSSKINY----
284 UniRef50_C9A391 Transcriptional antitermina... 70 2e-11 1 15.5% 9:118 283:392 --------ELEKVTDKNCLDLVRKILAKVDELYFIDGNeeFFIRFALHIKNLLYRINNGYSCRNPMTETLKK-ECPLIYDCAVQVSHVIQKEIGYTISEDEIAYIAFHLGYALEIQKQ--
285 UniRef50_C6QUF4 PTS modulated transcription... 70 2e-11 1 16.2% 22:120 192:289 ---------------------VKNIIRQSETFSAIRYTNDVIHTLTVYLSIFLKRWIRGKYIQ-MDEQEKEVLQSTREYKTAHHIITQIENVFQVDVPQDEICYLTTYLLGSRVTDDKQI
286 UniRef50_C0D455 Putative uncharacterized pr... 70 2e-11 1 19.8% 14:109 191:285 -------------LNRQEVEGIRIILRLVCREFSIVLSDASLSNLVIHVFIALTRYRFYNFIEA-DEALQAEYRDAVEYAAAKRLTEALEEAYDFVIPDDEVIYYAMHL-----------
287 UniRef50_C2H7N3 BglG family transcriptional... 70 2e-11 1 17.4% 5:119 184:296 ----KEYLGQSRFFTDISFEELVIIILDETREAKLKVSDFIIQNLSLHLALGIKRLREGFEIKELGIE--QEVSDRVEYQVAQRIVQRIEVIADVSFPQEEIAYLTLHLMAKSNHRENK-
288 UniRef50_B0MGN0 Putative uncharacterized pr... 70 2e-11 1 15.0% 13:119 306:409 ------------VIPVLIGEVIYRIISRF--RINFYLDFALYDLLVDHMKSSVYRMSSGEVLENPFRGEIEK-GYPEVFCTVEECLKPLEDYLGVKVPRDEVSFLVMYFASMLERDKLE-
289 UniRef50_B0NYU6 Putative uncharacterized pr... 70 2e-11 1 15.1% 14:119 284:389 -------------ISEGVADLIIEILDRIKAELNVTvaNELFDDFVYHVFFMINRLKYGFHIYNPMVDDFKN-KYSVAYKMAEIAKGVLEERVGIEMTEDEMGFLAAYFGVFLLEQEPE-
290 UniRef50_B0K1N4 PRD domain protein n=3 Tax=... 70 2e-11 1 22.4% 3:118 7:123 --NRIDLLVQGNVIDFDTGKAIKKIDEELRVNYEICAEDEHYEMFITHLAMSIKRLKEEEKLEsiDDELFNEVKNCPNYYRALGILQNIEDRIEIKLPESEKRFVLLHLCNLLERGKS--
291 UniRef50_O33618 GlcA/glcB genes antitermina... 70 2e-11 1 12.9% 2:117 59:173 -KDQDHYKALVEIADDNVLQTIIEAMDIITHADRTVVDKDLMVALTDHILFAYKRIKQHQFIKNPFLIETKQL-YSESYQIAVSVIEHLNKLLDIEFPEDEIGFIALHIASSKDDLS---
292 UniRef50_B6FXG1 Putative uncharacterized pr... 70 2e-11 1 14.0% 21:120 294:394 --------------------LAMRIIEDMEKYTGIDYSNDfvNSVVMHFSVAMYRMQNNFKIENPLKEDIK-MRLGIIYQITEDVMKKYESEIGVEFPDDEVSYMAMHFGAAFERKTQEI
293 UniRef50_C7IC29 Transcriptional antitermina... 70 2e-11 1 15.3% 2:119 196:312 -QNSNKYNEIVKIYPKINIDEIGNIIHNAEKKFAFFMPEEHYNSMFTHLVISIGRLLKGIKVDD-ESELIEGQCNDIETQVARYIVSRLEEEFKISIPQAEFAYICMHLMGLNIYSGTD-
294 UniRef50_C2DZ21 BglG family transcriptional... 70 2e-11 1 12.2% 22:111 71:160 ---------------------TNKMVELSQIKIGIKFDNYAYTSLADHVDFMLTRNKENMILDNQMMQWEVVKLYPKEVAVARELVAMVEKEAKVTLPESEVVFLTYHLVN---------
295 UniRef50_B9Y550 Putative uncharacterized pr... 70 2e-11 1 9.4% 9:114 57:161 --------RLIQTVNPQILQIADQLYNEAVDQIPAELNPNLPFTLADHLEFCIERLNKNIELKMPLTYEL-ESSYPLEMKLAENALERIEEQLGICLPASEKAGIALNIINSEL------
296 UniRef50_C9KMP0 Transcriptional regulatory ... 70 2e-11 1 16.5% 1:115 463:572 MTTRERLLK---IVDASLVDFAEHVALYVQKRMNSSYHDRFLYAFSLHLSAFLKRVKSKDV--PHKELEGAVPQDSLCLEVAQEIGSLIEKHYHIEVPRVEIEYIALLLESSQED-----
297 UniRef50_A0AFK2 Complete genome n=18 Tax=Li... 70 2e-11 1 13.8% 1:116 282:399 IASKRILNVEDKEISedDYAYIEGMLNRIESHYSYHLQDDlkKDLIAHIHSMLYRVKYHMTVKNPMTEHIKRY-YPLAYEITLDAVESLKKDYPYDINQNELAYLALHIGASLERN----
298 UniRef50_C7UBV6 PRD domain/PTS system IIA d... 70 2e-11 1 11.3% 14:119 303:409 -------------IQKEYDAVVRKMIQKMSDSIQVDldEKLYMNILYHLVSMIYRSKLNVPVSNPLLEEIKR-EYSVLYSTTWLILAGIEKELDIRLTDDEVAFMMIHFQGAIDRLSAN-
299 UniRef50_C0CV60 Putative uncharacterized pr... 70 3e-11 1 15.6% 11:119 185:292 ----------AQWFEEDGLNKIKAIVTDVEEAFATYLDDIAYEALVIHIALSIKRFRLDEEYGEPKAADRIE-RDSLQYQMALEIVRRVNECFRIRLPDAEISYVAVHMGAKSSAITKQ-
300 UniRef50_A8GJ09 PRD domain protein n=3 Tax=... 70 3e-11 1 44.9% 1:118 1:118 METRLQILHDAQVIDTEVYIGMLEVVKRLEQHWQLNIRHTQGEMMITHMANALTRARRGEIIAAIDPELLDEIEASNVFANIREINSDLLSLFAFAIPDSELGYLLANVFGLYLAQTD--
301 UniRef50_C5WHN0 Transcriptional antitermina... 70 3e-11 1 17.3% 9:118 178:292 --------NMSNFVGKDILDilTIIVLDECRNQELKLSDYAIQNLVIHLALAIQRFQKGFRIAPV---ELCECKYQKELLVARNIADRLANRLGQeiPEEETAYIALHLISKSVAEQD--
302 UniRef50_A6LQ92 Transcriptional antitermina... 70 3e-11 1 13.1% 13:119 282:388 ------------EITEEVSNLVNHILERIKYDMGLNItdDILKDFVYHMAFLVNRLKYGVHIHNPIVDEIRK-KYKVAYKMAELARDVIEKSLDVKMTQDEVGFIAAYFGVFISEQQIE-
303 UniRef50_A6LPX9 Sigma-54 factor, interactio... 70 3e-11 1 10.1% 1:109 475:581 ITKLLNINELKTIVRPEVINITEGILELVREKYKF-INNSFFIALAIHINFTIERVMNGKVITK-SNIHMEKATMVQEMKIAEKIRIMIEKSTKLKIPKEETTYIAIYI-----------
304 UniRef50_C6VMH3 Transcription antiterminato... 70 3e-11 1 7.3% 6:115 54:162 -----QYYQLLKEIPTEIFDLSAAIVERAQALIPRILNPNMIFSLADHINFAITRLTHYKSAQLPFSYDVEQL-YPQETDVGYYAVRLINRRLNIQLPVSEVTAIAMHFVNSQTN-----
305 UniRef50_C9RTV4 PTS modulated transcription... 69 3e-11 1 14.7% 18:119 201:301 -----------------ELRNILDVLNECEKNLNIQFADDVLYHLALRFWLFGKRIVQGKKID-FDPVEKEVIQQTKEFEAAQTARSKLESIFQTSIPDDEVYYLATHLLSSKVQYSGN-
306 UniRef50_Q184K6 Putative transcriptional an... 69 3e-11 1 19.3% 11:119 197:302 ----------NGIFSEDDLSIIIDILRNFSRERKFEFSDYEFQSLVIHLAIAVERIRKGEYIEESLYIGNIENNQ---MSNTNYLAKQLEEKFSILLPKSEIGYINLHLVASDQHRDNN-
307 UniRef50_Q9KF98 BH0587 protein n=1 Tax=Baci... 69 4e-11 1 17.2% 1:116 4:115 LKARLDVLRDTNTITERASLIAERTVEQFVTDENA----DSYTMLITHLAMAVTRIDRLEPLSPPPESIMKEIYESRDLEEAKRRVAWIEETMGDTLPQEEKEFLIMHFVSALSMN----
308 UniRef50_C3RKG1 Transcriptional antitermina... 69 4e-11 1 10.6% 2:114 55:165 -QEKRLPHEIIRNVDPVFIEIASDIIRFAQEQFD-HVDTKILLPLADHIDFAIKRIQENVNMSNPFTKDI-ELLFPEEYKVALKGKQLINSITGFEITEDEVGYITLHVHSAIS------
309 UniRef50_C3WF22 Predicted protein n=1 Tax=F... 69 4e-11 1 22.1% 1:113 3:115 LQTRLEILCSTGTISNETREVMLNVIKMFQEKHQITLTEENGAMMTTHLSMAITRVKNNEPVKVINEEVYQEILESEFLEKAQEIYKDLESVLDVKLPEDEKKYMLVNICTIL-------
310 UniRef50_B0NY60 Putative uncharacterized pr... 69 4e-11 1 10.7% 8:119 188:300 -------LSQVKKYDNKLVDFVDRMLKVIRDILDVDldEKVKESLIIHLRPTIFRLRYGTPQKNALIDFIKK-EYKNVFRASWAISILFEEYYGLQITEDEIGYIVLYIQAAIERKKHQ-
311 UniRef50_B9Y4E8 Putative uncharacterized pr... 69 4e-11 1 14.2% 15:120 210:316 --------------NQDEIRFVRGLLEEIMEKYGIHMSDQSLQNFVIHIIIAIRRWKFYNYVK-IEDENLGELRSsrEWPAAQDLVRRLQDKLEILLPQEEILYFALHFKSKHITELDEI
312 UniRef50_Q724A6 PRD/PTS system IIA 2 domain... 69 4e-11 1 14.5% 8:117 268:379 -------LTTTSTIDAQVfsVVTRLLEAVDQNFHIDFseKIATYLVAHISALYKRANHKQYLTNPLTEELKN-KFPFIYNVSVYASAFIQKELAITFPDDEIAYIALHFLSASETIN---
313 UniRef50_B0MET8 Putative uncharacterized pr... 69 5e-11 1 16.2% 6:116 304:415 -----RFLIENLDGDYEYKEEIEDILNTIRSGTGIDLSDdlINGLAMHLSAALQRLRFDMNIRNEFLDSIKNL-YPLAFELAVVAGEVIEKKHKLKAKESEIGFLAMHFGAALERK----
314 UniRef50_B0P1K3 Putative uncharacterized pr... 69 5e-11 1 15.1% 1:119 294:417 LAAKIWKNKSENKIDEESfqLVMRIIAEMEILLEMEFFEnlIDGLCNHMKPAINRMKQGVFTENQYIDFLEE-KYSKVYVATIKACEFLKEELHIklPEGEMGFIALYFCVAVEQQKDK-
315 UniRef50_A8R9W1 Putative uncharacterized pr... 69 5e-11 1 14.3% 16:120 307:412 ---------------EEARELSDLLIAEWEKHLNYSFHEdlKSALYAHLCPAITRFRHGISIENPLMYEIKTL-YKNTFSIAKASAHILTERYQAPISDEEIGYFALHLAMALERAKKPL
316 UniRef50_A1JKN9 Putative uncharacterized pr... 69 5e-11 1 50.8% 1:120 5:124 IDARLNILCQSGVIDQDIGQGLDQVINRLEHFWQLPVHGEQGVMAITHMANALMRTRRGEEIAALNPAILAEIVQSKEIHYIREINQDLLAYFSLKPAENEIGYLLANLYGLYLSSDTPL
317 UniRef50_B9Y2V8 Putative uncharacterized pr... 69 5e-11 1 7.5% 14:119 286:392 -------------VSEEINAFIMDSLEKIHVEYGVDFTrdLKIALALHFVPLLSRMQNNRQLKNVLLTEIKQT-FPFAFDIANYFSLLIDDHYHVRISEDEAAYFTLYFNYGLENITMN-
318 UniRef50_C3RJ23 Predicted protein n=2 Tax=B... 69 5e-11 1 10.3% 4:119 258:374 ---KNSKQLSNNYINQEILDIVKEMLMIIEKVANIPFQADlqLALSLHLIPLVKRIQYGTFMHNPLKDEIKS-KLIMAYELAVKACVVINQRFNCTLSEDEIAYFALHINLSLEQKKYN-
319 UniRef50_C6CCS2 PTS modulated transcription... 69 6e-11 1 10.8% 15:116 295:397 --------------PDDGESLVDYILSYINTHYNFNLQNdlRADLLTHIKTMITRVRYQITIPNPLLTNIKQ-HYPMAYDVTLAAVSSWSKYTPYVISENEVGFLVLHIGVGLERH----
320 UniRef50_Q6GH48 Protein glcT n=59 Tax=Staph... 69 6e-11 1 10.9% 2:111 58:166 -QQKAHYKSLVEIADDNVLQVIIDSLNFISNTAMNVDSKQLVVSLTDHIIFAYKRLKQNQVISNPFVMETMQL-YSDAYHIAKQVIDQLNAALDVHFPEDEIGFIALHIAS---------
321 UniRef50_C2C005 Transcription antiterminato... 69 6e-11 1 8.5% 5:110 78:182 ----MQIAALLKDTDIADIQLAEAIILIGEKLLQQKIQRTSMLSLLDHIIFALERSKEKIAMKSPIEWEVKHF-YPQEMKIGEQAVELINRIKGVKLPESEQIFIALHFV----------
322 UniRef50_A0RA54 Transcription antiterminato... 69 6e-11 1 15.9% 6:118 187:298 -----RFEQNDTYVSLPHIPLIRSVILKYIEGGTIYLSDIEIDNLVIHIAIALKRCEDQHYMKGL-NAEQSELIIKKEYTIAKQIVGELEKELHLSFPKEEVLYVTMHLLSTAVTSKD--
323 UniRef50_A8AYJ7 Transcription antiterminato... 68 7e-11 1 15.4% 16:119 191:292 ---------------PISLEELTIIVLDECREGQLKLSDFVIQNLVIHIALSLKRIGEGFQIKQLDSWSMDE--YREEGKIAEKILKRVYHSTGLKFPKEEVDYITLHLVSKGNLQTNK-
324 UniRef50_B0KCW5 Transcriptional antitermina... 68 7e-11 1 14.3% 20:117 310:408 -------------------DLSKEVVEEVSRLLNIKIneQLIVGLSQHFEPALYRLTMGLQTTNPLVEEIKNY-YGDLFKAVNKACKLIFSKYNLMIPEEEIGYITMHIGAAIERQQ---
325 UniRef50_C2JT03 Putative uncharacterized pr... 68 7e-11 1 9.3% 1:118 246:364 LGNGLRFFMQDGTIPIPFERKIHALIETVSEKINLNLTKDVQldLSLHLYQMVLRLQADTTVINPLLSDIKK-NYPSLFGIVWYALVDFATENHLTISDDEISFVTIHFQAAIERSKK--
326 UniRef50_C1I3F9 Predicted protein n=1 Tax=C... 68 8e-11 1 21.2% 1:113 18:129 LTLRLDILRDAGQLSKENYNKIIQVINYFEEKRGVKLLEDNASMFITHLCSALGRIEENNLVNKLDDVVAQSLKENENYDEALKVAKDLEAVLG-EIPDSELDFIVMHVCTLI-------
327 UniRef50_A3CN37 Transcriptional antitermina... 68 8e-11 1 12.0% 2:118 51:163 -ENRRQLLME---LPAEVMEMSDKIVSFAREKLQKKLKDSAFLAMADHIHGVLLRLEDDIYLKNFLMWDIKRF-FPIEFEVGQYAKQLLSAYVSKELPDDEAAFMALTLVNAELENGD--
328 UniRef50_A6CU78 GlcT (Fragment) n=1 Tax=Bac... 68 9e-11 1 16.2% 44:117 1:73 -------------------------------------------ALTDHILFAINRLMKGMAIRNPFLMETKAL-YLFEYEVARDVVALLNEETNVELPEGEIGFIALHIHSAMMNKD---
329 UniRef50_C2E1U8 Transcriptional antitermina... 68 9e-11 1 9.6% 6:119 59:170 -----DLTSLLATIPLDFLTVSYSLIDEAQEKYDYSVEPYIYASLTTHLYESAKRLADGRLVETYLPDLEKD--YPLPYEIAGYVLDGFATRLNIKFPKQEQKSVALHFLNARTDIHTQ-
330 UniRef50_B9Y8N0 Putative uncharacterized pr... 68 9e-11 1 10.4% 2:116 54:167 -QDRNKVEALLADIPLDYFEIAKEIKVAAEECLACKLDDGVIVRLADHIHYSVIKSQKNISTPNLMLNEIRQF-YPKEYDIGRQAIQLVNQRFQSNLDENEAGFVTFHIVSSESQE----
331 UniRef50_C3WDH7 Predicted protein n=1 Tax=F... 68 9e-11 1 11.0% 17:116 290:390 ----------------EIEIMVKSFIEQVNKELEVDidETLILGLINHIKPTIYRIKNGIELENSIYGEVVE-SYPNLFSIIKKAVEKLENFIGITFTNDEIAFLTIHFKAAIDRN----
332 UniRef50_C4VSP6 Putative transcriptional an... 68 1e-10 1 9.5% 15:119 265:369 --------------DDKIQELFQEIVGFVRRTYNLNLNERLFkrFLPHLIRLIERCKNNATIHNPLMNNIKQ-SSPTIYECACLIAYAIHKSYGIEISEEEIAFIALHVGNSVAEQIQN-
333 UniRef50_A4AFC1 Transcription antiterminato... 68 1e-10 1 6.8% 16:118 286:388 ---------------EQLISRVRRTVQHVGEEYLVDLDDDDFImlSLHVRNLILRAQDLSYSRNPMTRSIKTT-YPMIYELAVFIAAEVQRDEGITIHDDEISYIALHVGSHLERQAK--
334 UniRef50_C6DIT7 Transcriptional antitermina... 67 1e-10 1 7.5% 6:112 192:297 -----SYKALINYFGEEDVSFVESLLQDMERQLSYPLGEPYYINIFTHTLIMMHRIAQGKAL-MMAEESVHQQVDNRIFSIAQNMVSQIEQRVESTLPSDEVWFIYQYIISS--------
335 UniRef50_C9A090 Predicted protein n=2 Tax=E... 67 1e-10 1 13.5% 9:119 282:393 --------NEKNVVSEEVSDLVRQVLKKIKNRRQIDFSQDLDlmLMLHFVPLIDRIELGIELKNPLLDDVKVHCN-VGYDLAIIAGQVIVAHFNKRISDHELSYLAMHFDVALNKKSSQ-
336 UniRef50_A8GHY9 Transcriptional antitermina... 67 1e-10 1 14.6% 15:117 226:329 --------------DLRLMAAIENMVERFQQISGMTFseDLISQLFAHLAPAVERCRFEIGIDNTLLEEVER-KYPRLMRTAQEALAPLEQEYGIHFSSEEAGLVAISFGAWLMQGN---
337 UniRef50_C0CWF4 Putative uncharacterized pr... 67 1e-10 1 9.3% 13:119 284:390 ------------VISHEFICNVTSILSLVSERYCTpfENDFILQFALHVYYAYQRCTYRIGYPNPIGPQLKK-DYAPVYDMAVFFAHKFSKIYQVTFNEDEIAFIAFHFGAFLENNKQN-
338 UniRef50_B9Y980 Putative uncharacterized pr... 67 1e-10 1 12.7% 6:115 56:164 -----NTIEQMGEMPENILKLSEQIVAYAKKHLTKKFSKNFVFTLADHIEFTIERVGQNMIFDFKGYTDFKYL-YPREVEISNYAMKKIEEELHIKLPPSELGGFVMNIVNSEVK-----
339 UniRef50_C0X124 PRD/PTS system IIA 2 domain... 67 1e-10 1 9.9% 9:119 277:387 --------QLQQIVNPKIIEVLEEVLQKVEQIYFIQLKNKEFFnlAIHLQGLYDRSNVEAFTRNSRLWDLKT-GYPLIYDISVYISSFIQERLNIWFTEDEISFIALHLGSFLESQRTE-
340 UniRef50_Q18CC4 Putative transcription anti... 67 1e-10 1 12.1% 13:119 489:593 ------------IVGKYIVELTYEVIKIASQYLS-SLEPNLHLCLAVHLKAAFERLKEGKVISNAHLKEI-IGNYPVEYSVAEKVAQYLKERYNINLPKEEIGIIAIYFKMSSRRDMSE-
341 UniRef50_Q185K2 Putative sigma-54 interacti... 67 2e-10 1 12.8% 1:109 480:586 LSDRRSRIDWGGQLKESTLEIMDKVIVFIKEQFK-HVNQGLYLALAIHIEHAIGRIKDGKTIINPSLDKIKA-SMPMEYELSRYIMGIVEDLTQVTFPEDELGYLAYYI-----------
342 UniRef50_C6P8P3 PRD domain protein n=1 Tax=... 67 2e-10 1 17.4% 1:115 5:120 ITMRLDILLKGNAIDRETLSMTLKIDDLLKSYDTIYRNNEQYEMFITHIAMMIQRVKNNNYveVLDDDIYDEIKKCLSYKEAVDILEKIEGISNTILPESERRFIILHLCNLLER-----
343 UniRef50_B9Y3X0 Putative uncharacterized pr... 67 2e-10 1 14.0% 13:119 298:404 ------------ILGADIQRLLDNIVQSVENTYCIDLneSFLIKFAFHLKNLLLRLENDIQITNLQFESIKT-DYPLIYAISVHISNVIYQFTGHVLPEDEIAYITLHIGVLMEETRAK-
344 UniRef50_B7GN87 Transcriptional antitermina... 67 2e-10 1 15.0% 9:115 60:166 --------QLLGDIPPEIIRLISETMDGIGLSSEAAQSSTLVIALADHVCGALRRAKNGipVPYPLNSEIRSL-YEREYQQGCALLAALNRRLDDALDPSESVAFALHFVNAGVR-----
345 UniRef50_C9XLJ8 Putative transcription anti... 67 2e-10 1 18.1% 14:118 323:427 -------------ISKNIDELMENIFNQIYVDMGIFIndELRVGLGYHLSFTLNRLLFNIKLKNVLLEEIKQ-NYILPFKLAQIAGKVIEKKYNLEVSEDEIGYIAIHFSGYLERNSS--
346 UniRef50_C9A4F5 Transcriptional antitermina... 67 2e-10 1 16.5% 12:120 430:536 -----------ELIPEDIWKLTNVLYDLAGQRLSRTYSEKARFAFALHLQSTLERVKEGHMIVHPDLNTVRKNLKS-EFQVAMDLSTIIEEERHVEIPFDEIGFISM-FLAIQVKQPSQL
347 UniRef50_C9AU45 BglG family transcriptional... 67 2e-10 1 15.7% 18:119 283:384 -----------------IIDLVERIVERFELLSGIRFKdsVIKQLYSHFRPTYFRMLFRLPIINPMQEKIFE-KYNDLYQIVKETLRPISDSFDSKLPDEEVAFLTMHF-ALLIRNSEE-
348 UniRef50_Q2BFF6 Putative regulator of sorbi... 67 2e-10 1 16.8% 14:120 283:389 -------------ITDDVRRLLEQILEQvfKKEIIEQNESFFQDLLYHLTFMLNRLIFGLRLKNALLANVKE-KYPVAYKMAEISGQVIESRYGLEVPEDELGYLAFYFGVFIGQSDIKV
349 UniRef50_Q721P5 PRD/PTS system IIA 2 domain... 67 2e-10 1 15.3% 9:119 276:386 --------ELDQFVDKKIIEALKSVLANVEETYLIDlnEQLFIKLAIHVQSLYYRSRYKAYTRNLSLLDIKT-SYPVTFDIAVYISSLLQEKLAIDFNEDEISFIALHIGSFLESENRD-
350 UniRef50_C5J5A2 PRD activator n=16 Tax=Ente... 67 2e-10 1 8.4% 6:112 191:295 -----SYKALVHYFGEEEVLFVQSLLLDMENELSWSLGEPYYVNIFTHILIMMYRNTHGNALSREEDQTRQ--YDENIFNVASQMIHKIEQRIAHTLPDDEVWFIYQYIISS--------
351 UniRef50_D2NQD9 Transcriptional antitermina... 67 2e-10 1 13.9% 6:113 58:164 -----RLSMTLSEIPAEILSIATLLESKVRAEGALELSNSFILPLADHLHYAVVRARDGVRVQYPLAPEV-TVLYPREVEYGRTVLEMVRERLQVELDPNEAIPLALHLVNAQ-------
352 UniRef50_B6G219 Putative uncharacterized pr... 67 3e-10 1 15.4% 3:119 208:324 --EKSTFDDLANVFGIESIRFIEARVKELEVDLNCEICEPYYINLITHILICIRRIKEGNKIKVHDDVESNIIKEDFRYIAVIKLIKKIEKEYSILLDNQEVSYIYKYIVSSRIENDID-
353 UniRef50_C0ETM8 Putative uncharacterized pr... 67 3e-10 1 15.3% 10:120 307:419 ---------LTDIKNLDVHQITLSIIKKVNEILHINfdSRLLTELSGHIQPTIARLRAGIPVENPLLKEFQE-SYPSVYKACEEGLSLLCPILGikVPASEIGFITLYFTMAMERIEKEI
354 UniRef50_B6FYB2 Putative uncharacterized pr... 66 3e-10 1 11.7% 16:118 285:388 ---------------EDVKRLIDRLIEQIAEYFGVDFSKdlKVGLETHIRSLIERQRNKVDVTNLYLKEIKR-KYPLVFEMAIHSAKVIEKFTGYVIDEPEIEFLALHLGAAYERIDS--
355 UniRef50_A8RD41 Putative uncharacterized pr... 66 3e-10 1 9.2% 9:117 286:394 --------EISTFVGAELIDFVRGMIQNTKQMFGIDlsEEFISRFCVHLHNLLIRNTNNLLNSNPLKNSIK-LQCPFIYEMAVYMANQIQEHYHIHLNDDEITYITFHIGGILEMQK---
356 UniRef50_A8U731 Transcriptional regulator n... 66 3e-10 1 21.2% 20:118 304:403 -------------------ELIERVIVEINEMYQLDFRQDVIlgLLLHLESALHRIRLNMPINNELIEEIKN-NYPFPMQLAKILASSLETNFNIKIDINEVGFLTLHFCGALERANS--
357 UniRef50_B1CAI2 Putative uncharacterized pr... 66 3e-10 1 14.0% 9:115 367:474 --------LLSRIVDERIIEAVIDAIDSVKTIYNNQENNKRIvaLSLHINNLIERIKSGKYSVNNNLIKSVEQLYPIDYYAAQKIIEVLSKELNIEISSNEIMFVTMLLHTMNDM-----
358 UniRef50_UPI0001692E24 transcriptional regulator n... 66 3e-10 1 14.4% 9:119 186:295 --------KLLDLIARDKLEMIDSALGEIDKELMAPFADTSYLYFMVYLALMLKRLELGQEL-SLDATSKEAAKRAPEYNVAEKIFRHIAETFGVELPEDEACGFTPYIKSGKLRKPSE-
359 UniRef50_A9QSQ9 Transcription antiterminato... 66 3e-10 1 7.9% 5:118 57:169 ----KKYEHLTNNTDPIAAQIAEKIISYAEEKYQLQLNEMIHLTLTDHIDGVISRFSKGIVLRNELNLEISRI-YTQEYKVGLYAIDQLREVIKSSDLGDEAAFIAMHILNNRLDLDT--
360 UniRef50_C8P1J6 Putative uncharacterized pr... 66 3e-10 1 18.5% 1:119 280:402 LSSQKKLHTDVDNINSenLQILNEALDDIYRIYGSDfdEILKQGLMTHLESALKRIELGLSIRNELLDEIEK-NYPFEIQIAKVLAFHFLKTNAIAFNLDEVGFLALHFCGARERARQD-
361 UniRef50_D1AMM5 Transcriptional antitermina... 66 3e-10 1 13.1% 6:112 193:299 -----NLYELFGQFGREEVEAVAKILKDTEQKLNYTMGEIYYINMITHILILIKRLRNGNILYENKMRRDIRKTDKRIYTISQEMSGKITETFKIEVPEEETYFIYQYLISS--------
362 UniRef50_C0DA35 Putative uncharacterized pr... 66 4e-10 1 14.3% 6:110 125:228 -----DKEQLSKMVNPRIMELVTEFLDQAARDFNRVYPVSVFYGLCLHLNAALC---EGEKRRELSSDRIMEmkYKEEYALAVKFAGRLEKEFSTRLPIDEVVFLTMFIC----------
363 UniRef50_C2KEC2 Transcriptional antitermina... 66 4e-10 1 9.5% 15:119 249:353 --------------DDKIEDLFRKIVGFVRRTYNLNLDEKLFkrFLPHLIRLIERYKSSSSIHNPLMNNIKQ-SSPTIYECACLIAYAINEAYGIEINEEEIAFIALHVGNSVAEQIQK-
364 UniRef50_Q5KYD3 Hypothetical conserved prot... 66 4e-10 1 15.2% 22:120 191:288 ---------------------IFDWICQFESTFSIRYTGEVIQTLPIYLALFQRRWARGKFVQ-MDEQEKEVLRSMREYQIADHLVRRIENVSQISIPDDEVCYLTTHLLSFRVADDKQM
365 UniRef50_Q5WC76 Putative uncharacterized pr... 65 4e-10 1 15.3% 22:119 303:401 ---------------------VMDFVHSITKQTGLPfdQEYFSSIYAHIQTMARRLKNELPIENPIADVIVK-QYPDLFAACRMAGNELERTLQLTIPIDEIAYLTMHTCVASERLKRQ-
366 UniRef50_B2TRB2 Putative phosphoenolpyruvat... 65 4e-10 1 11.0% 17:116 277:377 ----------------KVNNITQEILDELCKTLNIDCSNDLEFtiAMHLKVAIHRIKNNLVIENPMLEEIK-YKMSFIYQITETILSSKEDIIGVKFPEEEIAYMAMYFDAIFERN----
367 UniRef50_Q65NB6 Putative uncharacterized pr... 65 5e-10 1 13.3% 18:115 292:390 -----------------LYQLCEKLVFEFESRACITFPreVAESLYRHLKPAYFRMKYRIPIHNPLLSKIKK-EHKELFTIVQKLMRHLEALLNKPVPEEEIGFITIHFGALLEQ-----
368 UniRef50_B9Y9G6 Putative uncharacterized pr... 65 5e-10 1 15.7% 6:120 173:289 -----QVEQEINFFNNDIISSTSEIIMDVLAHNDYEISDLILQNLVVHVLIALNRMYANHYIEPEGIQDVFQNKnaHEILIAESIYRKLCRKYNIQINENEIYFLAINLKGKKNYHSANV
369 UniRef50_C2BXP0 Transcription antiterminato... 65 5e-10 1 11.3% 6:120 276:391 -----KNKQLKEVVDEKIITALHDVLKQVKKTYLIELGDdfFNKLAIHVQSLYHRSKYDTFARNSSLLDLKTA-YPLIYDISVYISSLIQEKLAIWFNEDEISFIALHIGSFLGTQKNSI
370 UniRef50_Q184X1 Transcription antiterminato... 65 5e-10 1 15.4% 7:110 191:295 ------FSALINLFDIDSIIFVETIITELEYNLGYTINQPYYINLITHILICLKRIEEGNQIESQEEREIsdNLDELVYKNVTTLIDKIENRYRVKITKDELMYIYIFLV----------
371 UniRef50_A8RTN9 Putative uncharacterized pr... 65 6e-10 1 15.7% 2:116 168:280 -ENFLNLNTLAHLYRSFNLIEVKDIFVDVLEEYDYSIHESMFPMLILHAGTSIERMNCANYIN--MEEGMQGLEDTIEYQIAQTFFDRISKRLHITVHDGEVGMFALVIMGRRASN----
372 UniRef50_B4TAC2 AAA superfamily ATPase with... 65 6e-10 1 12.4% 17:105 779:867 ----------------KTIGHIETIIAEWQSTLGFSFNNNLIISLYVHLSCMIERLVMRNEITHYKNMTEFNERHGEFIAMVNHSFQRLKILYNVALPVAEIGYI---------------
373 UniRef50_B0A6G9 Putative uncharacterized pr... 65 6e-10 1 11.7% 6:116 307:417 -----KFMSNKPQLRENISDLMEKIFKEIYIRMGIIISDQTldNLGYHLEFTLNRLLFNIKLKNLLLEDMKE-NYVLPYNLAKISADVIENVYNLVMPEDEIGYIAIHFGSYLEKN----
374 UniRef50_C2BXN0 Transcriptional antitermina... 65 7e-10 1 16.0% 11:116 194:293 ----------TNIIDVNLLHSITNVLNIFIESTSLQVTEYEYQSLSIHLAIAIERIKKNFYIDKKIAPANAPSKY------ATLLIELLEEKFQIQLPDYEREYIDIHILAIEKSS----
375 UniRef50_A8S9A5 Putative uncharacterized pr... 65 7e-10 1 14.1% 25:116 351:444 ------------------------LIREMEKALHTDLSGylRDDLYCHLRPMLLRVEQNIRTENPQLDTIRTA-YPGLWKATRAACDAVQQQFVLpiSDDEAAYLAMHFGAVLEQN----
376 UniRef50_B3W7W3 Transcriptional activator n... 65 7e-10 1 10.0% 9:118 284:393 --------KLTTTVGDNIVRAMSSLFAEVQHIFGIDlnDYFVFPFSLHLNKLFSRAMQGSSLNSPLTESLKQ-DFPVVFELAVFVSFRLSQLLHIPITEGERAYIALHIGAELDRQKQ--
377 UniRef50_C9ADA7 Transcription antiterminato... 65 7e-10 1 18.9% 28:117 199:286 ---------------------------DTCRKYFLKLSDFMIYTIVLHIGLAIKRLQAGFEIQLHPQE--ANLAQEVEYQSALEIVEKIRQQMGIVLPPEEAFYIAIHLKNKLVSET---
378 UniRef50_Q045X5 Beta-glucoside operon antit... 65 7e-10 1 11.9% 3:120 73:188 --TKRTIFSLLKNTPIDIAVTTMHVVNHAYKKYHYELFDYFYLSLSEHILGVYHRILDNTYQTSQIPDIKDE--YPLENKIAQESVKIIERDLKIKLPVSERKNIMLHLINARIPEKKQV
379 UniRef50_C6AQX2 S-ribosylhomocysteinase n=4... 65 8e-10 1 31.9% 1:116 3:118 IQQRLWAFQMRELIDEHIVDTVLNVRQHLQRHWQVDVETEQVKMMLVHIASALGRIKRGHRASPLYADFLAEIQSAVIFPQVLIIHQYVLELMPLSIPEEEQTYFLANVYGLVLDQ----
380 UniRef50_P23914 Putative phosphotransferase... 65 8e-10 1 13.5% 9:119 464:573 --------NLLTFVEDDVIQMTKQLKEIAEHELDCTFDRKFIYFLSMHIDAFLKR---GKQIDVLNTQETDEIRDtkEYRVAMIFKDKIQEYFKVAIPEIEVIYLTMLIHSIKSLKENK-
381 UniRef50_C4U196 PRD domain protein n=2 Tax=... 65 8e-10 1 43.7% 1:119 32:150 METRLKILYDAQVIDSAVYFGMLNVLTRLEHHWQLSIRHPQGEMLITHMANALMRASQGQVIPAIDDEILKEIEATAIFANIREINNDLLSLFVFEVPNHELGYLLANLYGLHLAQQTE-
382 UniRef50_C3RHS5 BglG family transcriptional... 65 9e-10 1 8.8% 4:117 60:172 ---KIQFKALLNEIPFKCIELTQEIIDMAKTDLNRNFNQGLLVSLSDHINFVSKNYLKGYGSYSLVSEEIKRF-YHEEYEVGLKALDLINRYYQINLNKKEASAIAFHLINAEFNNN---
383 UniRef50_C2HDT5 Sigma-54 dependent DNA-bind... 65 9e-10 1 13.9% 6:106 808:909 -----KVLDSVTILdeKVMEEIDHFMRELEVQLNRRISNPKKLALYVHVSCLIERLIRQMPIETYQGLEKWEQCQKEEIFAIKSAFSVIEEHYSVMIPRSEIAYIC--------------
384 UniRef50_B9Y6Q3 Putative uncharacterized pr... 65 9e-10 1 13.2% 15:120 308:414 --------------DNKLQEFVRKIISVVSNVLNVDldEALVHGLLIHMRPTLFRLRYERGHTNGLTNYIKT-EYKKTFRVAWLISVLFEEYFDLKVSEDELGYIVLYIQSALERNENPV
385 UniRef50_Q5WJ14 BglG family transcriptional... 65 9e-10 1 13.0% 20:119 291:391 -------------------QLAERIIEEFERVTLLPLeeTLKKSLYDHLVPAFFRISFKIPLVNPLINRIKE-EYPELFEFVKIALAPLSMWTGQVISEEEIGYFTLHFGGYLEKDKRN-
386 UniRef50_C0CTD3 Putative uncharacterized pr... 64 1e-09 1 12.8% 17:110 318:412 ----------------EMRRFVDDFLDEISRLTGINYdeKVMNVLSLHLKALMQRARAGNYSPNPIIAQIKN-RYPLEMNYAILMAQRFEERFGVSINEDEIGYLTVYLG----------
387 UniRef50_Q5WKW9 BglG family transcriptional... 64 1e-09 1 16.0% 26:119 295:389 -------------------------LSLLEKQYGVDldQKLLRHLTLHLQNMLSVLQDQYEIEAPSLSMIKA-QYIHAFQMAVVFAEELGEKLSISVPEAEVSYLALHLQAAIDRMERK-
388 UniRef50_B8DAY8 Transcriptional antitermina... 64 1e-09 1 11.2% 21:118 302:400 --------------------IVEKIIAEFERLACVNFEdnLKKDLLLHLQPAYYRLKFQIEWINPLRTDIKQ-SYSDVYEITKKSLEPLEDLLGETIPEDEIAYVTILFGGYLSRKNN--
389 UniRef50_B9Y2S2 Putative uncharacterized pr... 64 1e-09 1 11.9% 5:113 173:278 ----IDFLPQETMYKSSQLSLIQHVIAESLMNANISITADSCSALSLHILIAINRVETNNLI---NQEVSEAMRQSLEYKTAIDINRSIEEIFHVSLPEAELCYFAFHINGKK-------
390 UniRef50_C0D9V6 Putative uncharacterized pr... 64 1e-09 1 16.5% 2:116 171:283 -ENFLNLNTLAHLYRSFDLIEVKDIFVEVLEEYDYAIHEALFPMLILHAGTSIERMNCSNYINMEDNS--QGLSDTIEYQISKTFFDRIGKRLHIQVHDGEIGMFALVIMGRRASN----
391 UniRef50_A6VLW1 Transcriptional antitermina... 64 1e-09 1 13.3% 7:119 269:385 ------FLNRLDEINENAIniVHQLIAEVEHLTNIPfdEQLYKQLLLHVPSMISRLQDVNYMENPYTQEIKS-ELSRSYNILLIAVQKIETQFHIKFNEDEVIFLSLYFQVAQERLRKN-
392 UniRef50_C3RJI5 Transcriptional antitermina... 64 1e-09 1 10.3% 13:119 283:389 ------------LVSDEIIQITKNIIKNVDEHFFINLDSDNFItfMLHLKNLKNRLIKNNLLKNPMLDSIK-ISCPTIYDISTFIAYQLTLSFHENVNEDEIAFIALHVGTEIERQKKE-
393 UniRef50_C9XQF7 Transcription antiterminato... 64 1e-09 1 8.8% 5:117 303:415 ----MDTKSLPNYIDEHFVKLTKKIIKNVYDLYFIDLSDDEFVvfTLHVKNLISRAKNNQVLRNQIPQKLKD-SYPLIYDISVYICNQIQILENIEIDEDEISYISLHVGSFFDRQK---
394 UniRef50_C7TG26 PTS system, IIAB component ... 64 1e-09 1 17.9% 34:117 313:395 ---------------------------------QISPDKRLLEDLSVHLSGALVRVAHGMSIPNPYTEEIKR-NFPMAFDAAAQLSMTVAKHYHVQLNDDESGFLALHFESFFERQQ---
395 UniRef50_UPI000196A9D7 hypothetical protein CATMIT... 64 1e-09 1 12.4% 20:116 282:379 -------------------QLVEEVLLDIKDCFDIDfdEELYNSLVIHMQSLLDRIKVDKPNTTAYLKEIKR-QYPLVFEMAIHASDVISKATGKPLVEDEISYLALHFGTAYERH----
396 UniRef50_B0NXI9 Putative uncharacterized pr... 64 1e-09 1 8.1% 17:115 300:399 ----------------DYEETVRDVIKRMSEIQKLDLTRdlYESLLYHLPPMILRLQNNIQIVNPMLDNIKQ-EYPELFTTMWYALTQIELRYQVTLTEDEVSLILLHFQVALDQ-----
397 UniRef50_C2BGB6 BglG family transcriptional... 64 1e-09 1 15.3% 2:119 217:333 -NSFINELEDLNLFHKATISQLLIILLDEIREYGISVNDYAIQNLVIHFALVIERVKINCLIDNYDKD-IAKGEGDEFLDFAKSVIRRISKSFAIDLPIEEKKYIYLQLLSKTKLSSEN-
398 UniRef50_B0A8M3 Putative uncharacterized pr... 64 1e-09 1 12.1% 13:119 282:388 ------------EITEEVIDLVLDIIKLIKLEMDITITpnLLDEFTYHISFMLNRLKYGIKIKNPVLDEIKE-KYMVPYKLAELTKMLIEDRTKKKVSKDELGFLAVYFSVFISENSYE-
399 UniRef50_UPI0001C425D1 mannitol operon transcripti... 64 2e-09 1 11.0% 20:119 302:402 -------------------DVVRKMVIDFQRYACIEFEHfvEENLLIHIRPAFYRLKYGISAKNPLTKSIKE-KYGDVFELTKKVLPHLERFVGAAINDDEAAYITMHFGGWMRKEGSQ-
400 UniRef50_B6GAR0 Putative uncharacterized pr... 64 2e-09 1 14.1% 45:115 4:73 --------------------------------------------LADHLQYALERTGDGIAIENPLSHEVAFV-YPREVELGRRGIELVSERMGVNLPESEITSIALHLVNAEVD-----
401 UniRef50_B9Y4W4 Putative uncharacterized pr... 64 2e-09 1 16.5% 3:111 187:294 --NEENRMVLAGIYGIQSLRQVEQCVGEIEEAIGVVLGDIYYINIVTHILIAMERMRSRRYI-NPGGVMDPKLINPLIYKKIAACVQTFSQAVQITFPPNELLYIYTHFMG---------
402 UniRef50_A2Q6K4 FruR protein n=5 Tax=Actino... 64 2e-09 1 15.4% 9:112 60:163 --------QLLGDIPPEIIRLISETMDEIGLSSEAAQSSTLVMALADHVCGALRRAKNGipVPYPLNSEIRSL-YKREYQQGCALLAALNRRLDDALDPSESVAFALHFVNA--------
403 UniRef50_C0CTE0 Putative uncharacterized pr... 64 2e-09 1 10.0% 1:110 782:889 LQNVIEYLTILNA--DKVLEFVDDTLEQLQIALGRRFSAKTIIGLNIHICCLVERLVTKTPFTSHMNEEEFKSCRKDFIDAATICFSNITSHYGVELPISEIAYIYDYIY----------
404 UniRef50_Q180U6 Putative transcription anti... 64 2e-09 1 10.0% 1:110 267:377 LKTKDKKATIKNIDKNKLQDIMFEFFREIDKKYNSNfdKEFFNLFYLHIACLIERIKKNHKIINPFSVKISQ-QYPTVFNLSIQFSKIIENEYHIKISQDEIGFIATHIA----------
405 UniRef50_C8ZWZ0 RNA polymerase sigma-54 sub... 64 2e-09 1 13.9% 5:105 800:901 ----IRVLDSLTILdqKIMSIIEELIVTLEERLALKLTNPRKIGLYVHISCMVERLIRQVEITEFADLEQFVFIHQREIRVIKDAVSVLETIYSVQIPLPEICYI---------------
406 UniRef50_A8AYR4 Transcription antiterminato... 64 2e-09 1 12.6% 16:118 283:386 ---------------KEIREIVVAVLTKINDNFDINFSDdlVSGLGNHISSLIERQKTNTSMSNVYLREIKR-KYPLVFEMAVHAGEVLSERLGKKVSENELSFIALHLGAAYDRVNS--
407 UniRef50_A6LQT2 Transcriptional antitermina... 64 2e-09 1 15.4% 3:119 279:399 --AKLQHINENEDieSDIRYVVYDMIQEYDStyQIKQDTEFIRGLIAHIRPTIIRLQHGIEIQNPFQNEIKRL-YPQIYEKAERAVKVIESKYNLKVPAQELGLLAIHFGGAEIRLQNN-
408 UniRef50_D0R2Y6 Antiterminator protein n=7 ... 64 2e-09 1 10.4% 5:119 59:171 ----NDLTTLLANVPLDFVTTSYDLIDQVQAKYKFAVEPYIYVTLTTHLFGAYQRLIKNEEDVNYLPDLSDT--YPIPYQIADDVITGFRNSLDISFPESEHKSIALHFINAHTSESIN-
409 UniRef50_B2ISN0 PTS system, IIB component n... 64 2e-09 1 13.9% 12:119 189:294 -----------NFFDQTvlEEFARIVLDECQEANLKLSDFVLQNLVVHIALSVIRLKSGFEIKNIDCQMTDD---AIERKVAQRILSKVREVTNQEFPVQEIDYITLHLLAKSQQCQKN-
410 UniRef50_Q1JEW2 Transcription antiterminato... 63 2e-09 1 17.2% 18:110 320:413 -----------------IYDIMEEIINSVAVNTGLSITdeLRQNLYSHLLPAYYRLYYDIDLTNPLKEQIKQ-DYESLFYLVKRSLSPLEKQLGKLVNEDEVAYFTIHFG----------
411 UniRef50_A6QKC9 Transcriptional antitermina... 63 2e-09 1 10.9% 18:118 279:380 -----------------IQSYIDRLIELMQQRIHVPFNEDSiqNLYNHFSKAYLRITQNIYLNNPLVIEIKKL-YPFVFNTLFEAIDKLAIDTDIEMSEDEIAFLTIHFQAAIERRTK--
412 UniRef50_C6JIT2 Predicted protein n=2 Tax=F... 63 2e-09 1 11.7% 17:119 291:394 ----------------EIEMIVKNFINRINEKLDVDIseTLMTGLVNHIKPTIYRLKNGIELENTIYEEVVE-SYPNLFSMIKGSVGELEDFIDNKFTNDEIAFITIHFKAAIDRNIKK-
413 UniRef50_B0M974 Putative uncharacterized pr... 63 2e-09 1 18.2% 21:119 305:404 --------------------VVNELLNDIKNKFHLDLTDdlKAGLVTHIRYTLKRIRMEPESTNPVLMLLKT-EYPFVFDMSLFLYERFYDVFGVRLNENELGYVATYLGSAVERMERK-
414 UniRef50_C0ES87 Putative uncharacterized pr... 63 2e-09 1 15.9% 13:119 281:387 ------------ELDEKIRPLLQKIVEQIRQELNISIDTHEfeKFMYHIMFMINRLRYNVHIDNPMFEDI-HYKYPLAFKMAEIAARVIKEDAEVVVTQAEMGYLAAYFGVFLEVNTLN-
415 UniRef50_C4FUJ1 Putative uncharacterized pr... 63 2e-09 1 13.3% 4:116 56:167 ---QEQLLGLIKELEPWVFELAQDITIIAEACLKKSLMDTFIFTIAKHLQYALDR-EPNEEGDYDPFQYQLHYLYPDEYQAAAEAIAQVNAKYQLRLAQEEVSFLTLHLVNGQIDQ----
416 UniRef50_Q899A8 Transcriptional regulatory ... 63 3e-09 1 15.7% 17:118 256:358 ----------------KLVNSIEKMVSQFEKEVDIALedEIINGLFVHLMPAINRAKYSIKIKNSYKEDIKN-SYNEFYTITANLVRIINNEFNVELGSDEISYVCLHFVAAIEKMNK--
417 UniRef50_B9Y6L8 Putative uncharacterized pr... 63 3e-09 1 27.2% 2:115 4:117 -TERLNLYLEGGMIQPDDVADVQAIITMFDQKYHIVLQEENADTFIAHLCAAFGRSATGEEVEPLPPEVKAELEGLDSYPQSLQMLKDVMAATRNRLNPTEQDYALLHINNLIAR-----
418 UniRef50_C5WEK4 Putative uncharacterized pr... 63 3e-09 1 14.2% 15:120 294:400 --------------NQQFVQLTKQLIKRVGQLSGLDLSHdlVKMISNYLRPMIYRLKNGINIANQTTEEIKK-RYSILFHVVWLASKVLSDQYQLELLDAEIAFLTIYFEIAVEKLEPPL
419 UniRef50_D2EIS8 Predicted protein n=1 Tax=P... 63 3e-09 1 15.4% 38:115 315:391 -------------------------------------DEVLLRDLAIHLATAVDRLKKGIVIDNPYTDEIK-MNLPIAFDVAIQLGEAIETQYPVQLHDAELGYLALHFEAFFER-----
420 UniRef50_UPI000196AFF3 hypothetical protein CATMIT... 63 3e-09 1 10.8% 1:111 791:898 LSNVMNNLTILN--PDKLLEHVAKAIDHLQNILHKRFKNRTCFGLYVHICCLVERLVTRQAISNFTDQDFKE-KHQEFIDQVNISMKEVKTYYNVEIPDEEIEYIYNYIIN---------
421 UniRef50_B1C6X3 Putative uncharacterized pr... 63 3e-09 1 14.0% 21:120 48:148 --------------------IVKSFLYRLTCEYDINFLNDYKLqlTAHIISLYNRQKNNEKIINPYKEDLLK-NYKKDYEIISENIYILEEDLGIKLDDNEMTYILMHIVAALERMKQNV
422 UniRef50_A8RJT7 Putative uncharacterized pr... 63 3e-09 1 6.2% 4:116 295:408 ---QNDFYYVREQPDSQAESLLEKILIEINVEYGFDfdKNFCHEMTEQLHGALERRRHRQHVINPVLSTIKS-KYPLEYDIAIFFADRFKNLSGISLSEDEISLFAIHFIRAMETN----
423 UniRef50_UPI0001694F32 transcriptional antitermina... 63 3e-09 1 15.0% 16:115 208:306 ---------------ENVFQAVHSLIKMLEEKLNLLLTDQEMIGLLFRFSIAIRRIRDNERIQ-IEAISVKAIKQSASYKIVLEGLTDLGLQMGIKFPEEEAVYVSMQLIVGREE-----
424 UniRef50_Q18D25 Putative transcription anti... 63 4e-09 1 11.0% 11:119 485:592 ----------NNIVNDSIATTVKYILQKHDKWSKREGLDKLIKAIALHIQNLIERIKIGNIVKHPNKDEIMK-ERAYEYNIAKEILSNMSLMYGVEFPEDEAIFLATFLYLSYVGLNEE-
425 UniRef50_B0MAW7 Putative uncharacterized pr... 63 4e-09 1 14.1% 13:111 183:279 ------------YIDERQLAKIKNILTDIFVNYKYHIMDTDFNNAILFLNIMICRMGEGFYIQPGELDISEQLGN--EYEIAKAVFGKISRRFFIKVPDEEIRYFSLYLKG---------
426 UniRef50_B0MEI2 Putative uncharacterized pr... 63 4e-09 1 13.7% 15:109 281:376 --------------DGRVMQATEQLIRKFCSDLKieIDPEIQRQIMMHLKVAVFRLKNKIKIKNPLMEDIK-YSHSFMYELTERLLKGQEEMLGVVFPDAEIAYTTMYF-----------
427 UniRef50_B3W710 LevR protein n=6 Tax=Lactob... 62 4e-09 1 12.8% 1:109 734:837 IRGRLQILN-----PDIVIQESQRIVSHYEDFYNVKFGSRLKLNLFMHLSLMIERMMTSKRSTTSIDRATLTPPEQEFFSLSSGIFQPVEQKFNIKVQDYEIALLYQLL-----------
428 UniRef50_B9Y3A0 Putative uncharacterized pr... 62 4e-09 1 10.3% 9:115 300:407 --------EELTSYDKKLKQFVHKIISVISDIMNVDldNELYYGLLNHIRPAIFRMKFEKHSTKELTNFIQQ-EYKQTYRVSWALSALFEEYYDIKITSTELSYITLYIQTSLER-----
429 UniRef50_C3RIK3 Predicted protein n=3 Tax=B... 62 4e-09 1 14.9% 5:118 112:226 ----LEINSGFDLLDDQVFKILRETMYTIYQDYHKDfdDKLFVAIGLHLEPALERLANGQLVENPLKEKIIE-RHQEEFNYSKILNDVVRHDLNLSFDDDELAFIALHFVVANNRIDE--
430 UniRef50_C3RJ67 Transcription antiterminato... 62 4e-09 1 13.9% 4:118 279:392 ---RKDIIKEKLAVDVEHL--VEAVIVEVKEYFDIDFSKdlKVGLAMHLQSLLERQKNNVQVTNVYLQEIKR-KYPLVFEMAVRAGEVLAETCEDNINENELAFLALHLGAAYDRVNS--
431 UniRef50_C1QBY4 PTS system IIA component; t... 62 4e-09 1 14.3% 15:119 168:272 --------------DEKYINkiEKFVIDFIKDNDIKLSEINLENFILYILVSIERIKMGKVIDCYDKDILKDIKE-EELKLANQLAEILEKESNIKFNEAEKIFIAIHIASKSLLISSE-
432 UniRef50_B9CM75 Putative uncharacterized pr... 62 4e-09 1 27.8% 3:117 6:120 --ERIEILKQAGFVDENDAESLKNVVALIEHECGPAESDEHIGIIITHIAAALKRNVEEEEIAPINQQALEEVYASPVFPKANRIANDISDMFAERLSKDEFGFVLVHIAGLLVAHQ---
433 UniRef50_C9B288 Predicted protein n=2 Tax=E... 62 4e-09 1 18.3% 14:117 178:287 -------------INAFDINFITSILEFIERKLANSIAYPYNMNIFSHLYILILRMREGefIEGLDEEEQHLIEQHQeyQIAQQVIEKINAYLVTELPESEVFYLYQYLVSSRVENK---
434 UniRef50_B1CBL8 Putative uncharacterized pr... 62 4e-09 1 12.1% 21:119 312:411 --------------------IVKSLLYQLSKVYNINldYKLHEYLTGHILSVFHRIKDGNYLVNPFKNELIEEYY-EDFTILKNNIYILENGLACKFSDDEISYILMHILTALIKNSKK-
435 UniRef50_A5Z559 Putative uncharacterized pr... 62 5e-09 1 13.5% 16:119 10:114 ---------------ESNYELSKALVAEFEKVACVKFEddLEKALYYHLNTSMYRFQYGIQVGNPMLEDVVR-EYSELFDLTKIVCHYLEQQIGLPVPEGEVAYLTLHFGAHLKKEEEQ-
436 UniRef50_C4FXZ4 Putative uncharacterized pr... 62 5e-09 1 10.8% 15:116 282:384 --------------DPTVVQIMDEIIKQVKANTGLEFPMGIHfnLFAHLYPSYYRLLFNISLHNPLTHQIKR-EYRSLYELIRRSLKPLEEMTGKPLSSDEIAYFTIHFGGYLQAK----
437 UniRef50_D1AHU1 Transcriptional antitermina... 62 5e-09 1 11.1% 21:119 295:396 --------------------FIKEIIKNVGGKLQINLEDdlLEGLMNHIKPAIYRIRNNINLKSMeyYEEAREIYPRLFTVIKEELKALEKLINIEFPENELLLFLIHFQAALERNKNN-
438 UniRef50_B2TQY1 Transcriptional regulatory ... 62 5e-09 1 11.5% 5:117 507:618 ----LDKEVLSKIVTPEIVQIIKESFIEDSGECIKNIDTKLIYSLALHIETLLERLRIGNIVIYPKSEDNYK-DYKQEYGLATLIKSKIEEKFFVKIPNDELVFITMFLHSVNTKKE---
439 UniRef50_C7TGH5 Transcription antiterminato... 62 5e-09 1 18.3% 15:118 289:392 --------------DRNIFSVTNQFVQRFSDVSGIVFADNHKVtmFTHFRSMYYRLQFGYPITNPLTEQVIE-NYGEVFTLVAQAIQTFEDILG-KVPDDEIAFLTIHLISFIYTSDN--
440 UniRef50_C1IA41 Transcriptional antitermina... 62 5e-09 1 8.9% 16:116 281:382 ---------------EDLRKDIERFVQEIDCEYDTNfdEEFKKNLLYHISLLINRLQKETSFSNPLVKEI-SIKYPTIFDIAIKFSNEIEGKYKISISQDEIGFIATHFAAHLEKE----
441 UniRef50_A8S5N7 Putative uncharacterized pr... 62 5e-09 1 9.6% 5:118 307:420 ----LNFEQIHTILPAQVCGILFKIITAVHSIYGIDlaDNFMVRFAFHLKNLMDRAANSLVVPENYFITIKD-DYPFLYVIAEYIASIIGQEIHAALPENEISYIALHLGVLMEEKNN--
442 UniRef50_A6LRF6 Transcriptional antitermina... 62 6e-09 1 16.4% 2:117 56:169 -TERGLTKEIINNIEPQILEIANNIIMEAEKKFH-EVDENILCPLADHIAFAVKRIRDNEQISNPLTQDIKAL-FPEEYEVACKGKDIIKEIEGIEINEDEIGYIALHIHSSLGNEK---
443 UniRef50_Q5WAK4 Transcriptional activator o... 62 6e-09 1 15.7% 5:106 825:924 ----LNHLTILN--PNQLMEHLSDALELLQNLIGRRFSNATRISMYVHLSCLIERLVTQRPIDSYPNLETFNQQQEEFIQVVRQAFESIEKTYSITIPLTEIGYIY--------------
444 UniRef50_A8RW19 Putative uncharacterized pr... 62 6e-09 1 13.5% 14:117 320:417 -------------VTDKVISITGNILGQ-----GLDRDDYLFDSLLLYMKSKTLKLRCGILEENPLKEVVKS-KYPNIYAAAWSASLIIESELEVRIGEDEVAYLALYIGGAIERLN---
445 UniRef50_C7CXK4 BglG family transcriptional... 62 6e-09 1 7.5% 11:116 71:172 ----------IDNFQPEILSVSARIIESGELILNQKFGTGLLFSLADHLTFSIYSIQEN---DNPIKWEVPHLYY-KEYQIGKKALEIVQNEMGVTLLPEEASFIALHFVNAQIDQ----
446 UniRef50_C4V215 N(Pi)-phosphohistidine--sug... 62 6e-09 1 12.6% 17:119 284:387 ----------------DVYAVVMEMLAAVQRTFCYDFSHdlIASLSTHLIPLRTRLLCGMQQENPVGREIRE-GGPLAYEMANVACGILRSAYGCEASADETGYIALYFHVALERMRAQ-
447 UniRef50_A5ZAB6 Putative uncharacterized pr... 62 6e-09 1 15.7% 12:119 282:389 -----------DILTSDFIEEIREILLNVFSSYMLEIndEYLYSFALHIHGLIKRA---NSIQSSGNDFLNNIKkpFIYDVSVSIAQKLNKKYNISIADSEIGYISIHIGYLIESSNSD-
448 UniRef50_Q8GGK1 Transcription antiterminato... 62 7e-09 1 15.5% 10:112 61:169 ---------LLAEVPLEYLDLSTELIASVSAELDSPVGSATVVALADHLQMAVKRNGLEPELTSKPNPLSAEvlYPEETRLATEILERTNNWLAEklPPAEVVAISLHLVNA--------
449 UniRef50_Q5E1U1 PTS system, mannitol (Crypt... 62 7e-09 1 9.8% 15:116 292:391 --------------PTEQLELTQYLLDYVNTHYNYDldEQLKRDLLCHITTMILRVKYQITIPNPLFDHIKRY-YPLAYDMTVAAISHWGKHL---IPDGEIGYLVMHIGVGLERN----
450 UniRef50_C6D7L7 PTS modulated transcription... 62 7e-09 1 12.5% 15:118 299:401 --------------DLVLTDTVRSLIEYAQHAMGADYNKdlRDGLFLHLKDALQRLNEGTNIRNPLLDQIKK-DYASLFNVVRKAANRV--FTDMVVPDEEVGFLVMHFGASLERLKQ--
451 UniRef50_A8F9J6 Bifunctional PTS family fru... 62 7e-09 1 12.6% 1:111 181:283 ITEREQLH-----FPDISLETIRSIVLTNLHQESLLIKDIALKNLVIHLAIAIQQTRKNQRI---PASTTRTQRSPVLVRIAQKIIHQVSDTFHVTLSEDETDYLVMHLLA---------
452 UniRef50_UPI0001C35378 PRD domain-containing prote... 62 7e-09 1 26.3% 1:114 7:119 LNQRLEILLNSGVISQRISDYCKTAVKLLIKQ-KPEADGDRAAMFITHLAMAGQRILEGKEEKPLDGQILESVKQEPAYSKALDFLTYMLNQTDLEFPDTEKDFLTVHLCNLFM------
453 UniRef50_B0N368 Putative uncharacterized pr... 62 8e-09 1 16.0% 15:120 183:283 --------------DHEFIDELRKVIFN----DGITMPQRVFQNFIIHIQVQLNRIQRKCYISFHDN-EIEKMKMEYEFLVAKDVSKVINKYFHIELSVEEQCYLAIHILGKKSNSTSAI
454 UniRef50_B3WBC3 LicR (Transcriptional regul... 62 8e-09 1 15.3% 22:119 62:157 ---------------------IERILVNVLMAHHYHISDTLFQNLIVHIEVSIRRIQEGFSLKTTKPDLLH--YFVSEIEVAKEIFAGLEKRFSFQATDGELLNLAIYLRGKSDYQNDD-
455 UniRef50_B9DU03 Transcriptional regulator (... 61 8e-09 1 13.5% 16:111 190:282 ---------------PISFEELTIIVLDECRSQSLKLSDFVIQNLIVHIALAISRVNDGFKISQLS---IDEKKFKTEILVATNILRRVEYVTGTDFPTEEINYIALHLIS---------
456 UniRef50_A5Z3Q0 Putative uncharacterized pr... 61 9e-09 1 14.5% 11:120 191:297 ----------INNFGQDNFEKSVEVIHYIEETYGIAYTDYSFKMLADYLCIQLFRVRMGNVITEDIIPEDENIKYS---DIVDKVVEKFCSLSKCNLNEYEKQYIEILLASASVQSNTDL
457 UniRef50_D0Z7Y6 Transcriptional antitermina... 61 9e-09 1 12.5% 14:117 72:173 -------------LPLDAIATCERIILSVYTGQG-KLQAGLASALAEYCYCAIERHRRGAVIHNALLREI-IGRYPREFALGLQVKSLITQYFSLALSHDEVGFIALHFVMARLNSH---
458 UniRef50_C9XML5 Transcriptional antitermina... 61 9e-09 1 16.4% 4:119 285:397 ---RKNTSEIEERISSVISSALQDIFLISGSDYTK--DDEFMVAISDHIKRFLNRARANVKSNNPLLHQIKE-KFPIAFNLAVFLSNKLETEFNLKLDEDELGYIAIHFAASNERMKKN-
459 UniRef50_D1AH38 PTS modulated transcription... 61 9e-09 1 10.1% 21:119 299:398 --------------------IIKNLINKVNTHTQINIseELLSSLLSHIKPTIYRLKNNLAVEDDIYIEAVEA-YPELFNIIKNALFELEELIGKKIPDSEIALFTLHFLASLERNKEN-
460 UniRef50_C5F792 Putative uncharacterized pr... 61 1e-08 1 15.2% 12:116 189:287 -----------NLIGSETLRTAQAVLSELQRVTKIEFTEYQYQSLLIHICISTVRIQNAEYLPTWSSASQA---LSPETSI---LTRLLEEAFNIQVPKSEQEYLNIHILAAKQSK----
461 UniRef50_Q04DX9 Transcriptional antitermina... 61 1e-08 1 10.6% 16:119 286:389 ---------------QEILPIAKKIIFRFNRIAGVNLrdSLQVNLSTHLLATYYRIKYGISYKHPDLDLIKQ-KYEQLFSFTRFSVRPFEEFVKKDIPDDELALIALYFGGEIKAIEAE-
462 UniRef50_D1ALX8 PRD domain protein n=1 Tax=... 61 1e-08 1 25.2% 2:108 3:109 -TERLDILVEAELIDQETYEKVKRIMNEVSEEFTLDLSTESGQMFITHVSMAIMRIKNNEATTDVENAIFEEIKESENFENALRFAEIIENIIEHEIPKNEKEYLVIN------------
463 UniRef50_A6LQU8 Sigma-54 factor, interactio... 61 1e-08 1 11.9% 10:118 482:588 ---------LRSFVSEDLLDFIETFMEELIKEnsLEINKNVFKYLAIHVEESIKRIRLKQKIINVDKIISDT---TYEYEVAKRFAMGVEKIKDIEIPNDEIIFIGLYIKAALKSENK--
464 UniRef50_C5RM48 Transcriptional antitermina... 60 1e-08 1 10.6% 15:118 306:410 --------------DIDYGDVVRELVTEVSKKInlSIDDQLIKDLTQHFKQTFYTLNLGVKVINPLINEIEE-HYSQLFEIINEKCKLIFSRYNLKIPREEVGYITMHIEVAIQRQQS--
465 UniRef50_C0DC14 Putative uncharacterized pr... 60 2e-08 1 10.4% 15:110 307:402 --------------PAKLLDEVEHSVTRLSRITGQKLEGRIIIGLYVHLCCLVERLVTKTSIENYQDLEGFQKKHGDFIGWVQECFQDISNHYKVDLPVSEIAYIYDYIH----------
466 UniRef50_Q0I1W6 Putative uncharacterized pr... 60 2e-08 1 26.7% 1:116 25:140 IQQRLIFLVQRHLIDEDIMTITLNIRNRLGKKWRVNLKTKQVDMLLIHLAMALGRIKRGYVAKALNPDFFSEIERAVCFTKILKLHQELLTFIPFPIPKEEQSHFIANIYSLSLAQ----
467 UniRef50_B9Y9G7 Putative uncharacterized pr... 60 2e-08 1 7.1% 21:119 5:104 --------------------FVTRILLEIQRQFQLDlnANLRIALALHLIPLLTRLKYNMQLTNDMKDEIKA-SFPFAYELSVITSDMIQNTYHYALSDDEISYIAIHFSNHIEQLYQQ-
468 UniRef50_C8ZWZ8 Putative uncharacterized pr... 60 2e-08 1 12.3% 15:120 287:393 --------------NQQLKQAIEKTLELVDLRYHTQfdQELGNALLMHVAPLLQRLYTGHQLDNPIIDDI-YTQYANVFNVAMVFISELNKDLDADISKDEIGYVAIYFAASLEKQANQL
469 UniRef50_C8NFM1 PRD domain/PTS system IIA d... 60 2e-08 1 19.2% 20:118 282:381 -------------------QLVHQIVLDMCSVLKLTINNdiKAMLENHMFSMLYRLRNHQKIENPFVDQIKE-EYGVVFQTIWIVLQKYESLLSVQFNDEEIAYLTIYFQTFIEENRT--
470 UniRef50_A7AZV3 Putative uncharacterized pr... 60 2e-08 1 15.7% 14:115 296:398 -------------IPEEYLLITNQFLDRVDRRFHTNynSELISRLSVHIMKMIKRIQQGYFETNPVLEDILN-SYERDVEAADELNKILEEQYHIKANIHELCYIAIYLRAYYER-----
471 UniRef50_UPI0001C369FF probable licABCH operon reg... 60 2e-08 1 13.7% 20:114 200:293 -------------------DTLVRIVWEACRANKIRLSPFLAVDLASHMYVSVLRMKAGCGIGELPGHTM-TVEYVRERYAAGEVADQLEKLYSVSISEKEREYFALHILSKKM------
472 UniRef50_C5ERF8 Predicted protein n=1 Tax=C... 60 2e-08 1 20.2% 1:109 277:386 MLQFRSLEEETGPEDDRFDGVIRRMFQRIEEKFGLRFseQLAHYLKLHLPRMAQRCRNRILIENPVLNDTF-CNYPLAVDVANVAVQVLEQELDIKVNSNEFGYLAVYF-----------
473 UniRef50_B2TIY2 Putative transcription anti... 60 2e-08 1 14.6% 13:115 299:402 ------------TIGENITLLRKQIFDKVFEFTGLSldEQLIQGLEYHLYYALNRIVLNIKYKNPMLKEIKE-KYKLPYEVAKIAASVIEDKYQVQVEDDEVGYLALHFGTYVER-----
474 UniRef50_C3WAH3 PRD domain-containing prote... 60 2e-08 1 7.9% 17:117 305:406 ----------------EIDILVKKFIDNFNKKIDVDISKdlLEGLLNHIKPTIYRLQNKIKLENSIFVEVLN-SYPNIFYNTKNSLKDIEKYLGIEFSNDEVAFLAIYFKSAIDRNK---
475 UniRef50_B7CCL3 Putative uncharacterized pr... 60 2e-08 1 11.1% 3:119 246:369 --TRIEISLKLNNIdqEYKYFLMEIFDEIKQIYSINLKDdlMDELSLHLKYAERRCKANTQLKNPLIDEFRK-KYVLVYDIAAFISSRFYEKTTLRLDISEVGYIAMHILGALQKLSGE-
476 UniRef50_C5EV18 Transcription antiterminato... 60 2e-08 1 11.1% 20:118 298:397 -------------------KLVAEALDGIYSLFGLDFREdlIAGLKMHIHGLIDRVKAKAHMQDVFVEEIKR-KYPLVFDMGIYVVELLEEKLEASISEVESCYIALHLGAASERINS--
477 UniRef50_C8Q416 Transcriptional antitermina... 60 3e-08 1 11.8% 3:112 180:287 --DRFSRVQLIAEFGQENVANCMNLIALIEEELQGSISEPYYTNLFSHLLVTLRR--NLHPGRNMAEQTFFIRYDNREWRIAENAILWLENEYQTRFPAIEVNYIYQYIISS--------
478 UniRef50_B1C796 Putative uncharacterized pr... 60 3e-08 1 14.3% 2:120 292:411 -ENKKDKEINNGSDKNHFMAIVDSLLNDIKDNFGLDLseELRVGLCSHIKYMIKQKSELQSSSNPILGLLKT-EYSFVFEMSLYLYECFYDMFDVKLNEDELGYITAYLGAAIERMESNM
479 UniRef50_B4U065 Transcriptional regulator, ... 60 3e-08 1 16.7% 12:119 286:395 -----------GTVSDDFFelTAAIVDQMQGVALLSFsdQLKEDLKRHLIPAYYRLRYGLPSDNDYTLRVKD-SYSELFDLVKQSLEPLAKELDSPIPDSEIAYFVLHFGGYLKQQGKD-
480 UniRef50_C0XEY9 Sigma-54 factor, interactio... 60 3e-08 1 13.5% 1:111 742:846 IKDRLNFLNPSMVIDE-----VETIVKKYEDYYNVQFSGKIKLNLYMHLSLMIERVLLNSDKQNMTN-LFRDEKAKEFQSVSKTIFKPVEMKYNIVINDFEISLIYELIEN---------
481 UniRef50_C0ZED9 Putative uncharacterized pr... 60 3e-08 1 15.5% 2:111 192:300 -EARTGPLLEKWLISRAELGEIIHSIKAWMNAAAETLADRALISLLIRLCIVFHRVQRGQLVTA-DDAELGEARHWSGYELFSHEVRALCQRLHVDIPEHEIAYACLPLLG---------
482 UniRef50_C7T9M3 Conserved protein n=2 Tax=L... 60 3e-08 1 16.1% 4:115 8:115 ---KLQILYDVGKLSDEDLAF----IRLADQYLVRTVGERDSEMFLIHLSIALERSHKQEPVDALPDNLWAEVTADPEYLNALNIWKHIAESRPVNFSDFETRYIIMHLVNILRR-----
483 UniRef50_D1AQE8 Transcriptional antitermina... 60 3e-08 1 12.6% 9:119 295:404 --------NLENWIHEEVF--IKKMVNEFNkeLDITSDEILIDCLIYHMKPVIYRIRNNIRVTNPVFKELIISKDP-ILEIVRIITRDIEKMFGIEFPEEELALLAFHFKASIDRNTHQ-
484 UniRef50_B1C8U8 Putative uncharacterized pr... 59 3e-08 1 12.5% 1:120 269:403 IPNKNDIHYLAGFISNKDitTVATFLYKISEQLDISLYDelFEFLIKHLNAMAMRIKNEELLINPIYEQLKE-KYDYVFKAVKENIRLIEDFYKLKIDKNELSYIVMHICAEIERETTKM
485 UniRef50_C9AYJ5 Transcriptional antitermina... 59 4e-08 1 13.5% 16:119 282:385 ---------------EFLLECASKIIHEMERLAAIEFVDylLMNTFYHLVPAYFRIRYGFPLENVLIEEIK-LQYNELFELTRRALGSLEDLVG-TIPDEEIGYFTILFGGEISKQKAK-
486 UniRef50_B1CBZ7 Putative uncharacterized pr... 59 4e-08 1 15.8% 1:114 187:298 LKERANTILLDDLFKDLDREFLIGQIQHLEKELGEIFSDETFSSLLIHLSIIVYRVSRNCSLKEITGET--TLNNSIEYTLTSQIIENINTRFTITIPSEEIYYFTVHLLGAKV------
487 UniRef50_C0QXV4 Transcriptional antitermina... 59 4e-08 1 9.5% 25:119 179:271 ------------------------IIINFLNKYEIKFSEINLENFIQYINVSISRIKNNNFICSYEKDIIKDI--SEEIRLSEELIKQIQNEIDIEFNDTEIIFIAIHIASKNLFSINE-
488 UniRef50_B0P5V1 Putative uncharacterized pr... 59 4e-08 1 10.3% 15:111 311:414 --------------NDKLAERLSSIVDKMLEVLHSyyRDKLKMNLMNHLKLTVKKYQLQIPSPNPLLAQMK-VNYPEIFAVAHQMSQVFEMGTGIPLDEDEIGFIAIHIAA---------
489 UniRef50_C3RJL5 Predicted protein n=2 Tax=B... 59 4e-08 1 8.5% 6:111 427:531 -----DKEQLSKIVSMKLISLVERFITRVSSELAINYQENILYGLCLHINASLIKVSSKQRLANEEIKRMIDL-YPKHYHLAKEFVHEIEEEFRVKMNIDEIIFTMLFILN---------
490 UniRef50_UPI0001C3629C transcriptional antitermina... 59 4e-08 1 10.2% 21:108 308:396 --------------------ILNEFCQEVLNKYSFDlsDELFNNMALHLEYLIRRIDTGYRIDNPILQDIKT-QYPYAYEIAILLVPIMFKYKSIPIRDEEIAYMALY------------
491 UniRef50_A6LS16 Sigma-54 factor, interactio... 59 6e-08 1 17.4% 15:106 820:911 --------------SNKIIERIEDGINEFENNQKRKIPNDKKIALYVHLSCMVERLVRQAEIEEYTDLNLLIEEHQSEIKLIKNSFSVIEKSYSVQIPIAEIGYIY--------------
492 UniRef50_D0DS13 BglG family transcriptional... 59 6e-08 1 8.4% 38:120 322:404 -------------------------------------SQKLFQNLSKHIYPLINRLENNIKVKNNLLKQIK-LEYPQLFRIVKDSTRQLSERYDlqIDDAEVGFITLYFAEAAESTRPPI
493 UniRef50_B6W9F2 Putative uncharacterized pr... 59 6e-08 1 14.6% 14:109 280:375 -------------IGDEIYDLIEEIFMAIKKRMDLEVdgKVKKEFTYHIYFLLNRIKLDYKIQNSLNDEIKK-EYRVAYKMAEIASKVIEDKLDKKINESEKSYLASYF-----------
494 UniRef50_C5F6Y5 Predicted protein n=2 Tax=L... 59 7e-08 1 15.9% 10:116 291:401 ---------DVGVADADLVKAIQTMVAKFEQQTFIKITddFVKRLLAHLRPAIFRVRYGLHLHDIgqVMAADSRHRFLVDTINAIIEPLEKLTGKTIPEDERNLIAFYFDGELEKS----
495 UniRef50_C2DBR7 Sigma-54 dependent DNA-bind... 59 7e-08 1 18.3% 16:119 822:925 ---------------EKIIRQVEVFLIQLEERWQQTIQNDRKLAVYVHVSCLIERLIRNEPIENYNGAEQLKQCQRTVLQELKEAFSVIEKVYSVNIPESELFYVYDVLFGKTEFNNAE-
496 UniRef50_C2HE82 BglG family transcriptional... 58 7e-08 1 10.1% 9:117 291:400 --------KEIKKFPEEVEKITTYYLEKVGKRINMKvnESIFIDLANHIKPMINRLKNRIHVKNGLLDQI-QLTYEKIYNSVSEVSKEVSQHFKLpiNADEIGFITLYFARMLETQQ---
497 UniRef50_D1YA29 PRD domain protein n=3 Tax=... 58 7e-08 1 11.7% 18:111 90:182 -----------------EVRVAQAIVELAREELGTPHARRMMLPILDHLVAAVHRAKQGAVIDFPLEWEVRQL-YPDEAELGRRAVEIVDGALGIHLQPEEWVAFSLHFIN---------
498 UniRef50_Q03HM3 Transcriptional regulator c... 58 7e-08 1 13.6% 18:105 818:905 -----------------VMDNIDRAIKSYSDLSEQIIGNVTRMSLYVHISCLIERLIRNEPITTYDLSVIGDTNAKQTFKWIKEAFSVIEKIYSVEIPESEYGYI---------------
499 UniRef50_C9KLV3 Putative multidomain protei... 58 7e-08 1 11.0% 21:120 300:401 --------------------FADHLASRFASLSGLDITQelVDRLTVHLISAYHRLQNGIRYHNPMLSKIKQ-DYQSLFYLTKTAVKSQEYLWHADFSDDEIALIATYFGGAVVQQTEEL
500 UniRef50_C4FVQ8 Putative uncharacterized pr... 58 8e-08 1 10.9% 15:115 295:396 --------------PLDLTRLVQDLGQHLQDLVGLDfdADFKDRFHLHLQGLIERLHYQVELPNLFLQDMKR-QYPLVFDLAVTVSTWLGARLGVVLSEAEIGLIAVHIGSSYSR-----
501 UniRef50_A8FDW3 PTS family L-ascorbate (L-a... 58 9e-08 1 12.1% 18:116 288:387 -----------------IRTIARQMIFDFQRYACISFEEylEQNLTMHLIPAYYRLIYHIDINNELTESIKKTQ-PEVFDITQKVVCHLEKATCSKISEHEMAYVAMHFGGWMRRE----
502 UniRef50_Q184U4 Putative transcription anti... 58 9e-08 1 16.5% 18:120 315:418 -----------------EYNLSEAIAVHWGSILNLNLKDDLIlsLANHLKSVLHRINYGFTITNPILNDIKRT-FPYTYKAAKESNTVIKQLMNYEVNDDEIGYLALYLISAIDRSKSPL
503 UniRef50_A4TMW0 RNA-binding protein n=24 Ta... 58 9e-08 1 10.7% 15:117 258:361 --------------DARLIAAIKQLIHRFKRLSGMHFsdSLVSQLFAHLAPAIERCYFNIGIDHSLPKDISKM-YPRLLRTTQQALIKFEQEYQIRFSIEEVILIAISFGAWLIQGN---
504 UniRef50_C0XP64 BglG family transcriptional... 58 9e-08 1 14.6% 21:116 184:283 --------------------VIQQMLEIVAAGLSITLdsISVARFITHVRYLLVRLSHGRQLDHDQSPLTRQLlyPREVACARQVATVVELRFDCALTEDKIAYLGLHIVRLRETQ----
505 UniRef50_C9A0D6 BglG family transcriptional... 58 1e-07 1 13.5% 18:113 293:389 -----------------IHELVERIIKRFELLSGIRFKDkvINQLYSHFRPAYYRLFFQLPIINPLHKKIIE-EYEDLYQIVQETLRPIGNLFERGIPEDEVSFLTIHFASLI-------
506 UniRef50_A8S2X8 Putative uncharacterized pr... 58 1e-07 1 11.7% 7:117 198:313 ------LMTILDIFTEEDLNFVEGLIKHIETSAGYRFDEREYMEFSVNLLVMIYRVRNGFLMEPVLKSNYRKQERDPLDAIAFELASRLSGSYRYTLSVSETSHiaTHLGNFLMQKE---
507 UniRef50_B9DPY6 Putative transcriptional re... 58 1e-07 1 9.1% 22:120 285:384 ---------------------INLLIEKMENRISVQFTKdlKENLYSHFSRTYLRIMKDVYLNNPLTKEIKTL-YPFVFNVLYEIVQRMSDDSGVELTEDEIAFLTIHFQSSIDRNEQDV
508 UniRef50_C7XUI8 Multidomain protein n=1 Tax... 58 1e-07 1 8.9% 7:118 286:398 ------ISADNAMIPP-LREISAKIIKRFNEIACVSldNTLNKNLTIHLVSTYYRVKYKINYQNPLVNKIK-IVYKETFEIVKLAIQPLNDFVHQKLSDDEIALITVYFSGALRNSQE--
509 UniRef50_B0P4U6 Putative uncharacterized pr... 58 1e-07 1 14.5% 7:116 279:389 ------ISLEDTIEDRKIMMATQSLIQEFCrkIDMKIGQDISTQIMMHLKVAIYRLKNHIEIENP---LMEDIKYsfVYEITKKILREYEAMFDVVFPETEIAYTTMYFETLFQEN----
510 UniRef50_C7T7M7 Transcription antiterminato... 57 1e-07 1 15.9% 10:116 277:387 ---------EVGVADTDLVAAIRTMVSKFEQQTFIKIDddFVNRLLAHLRPAIFRVRYGLHLHDIgqVMAADPRHQFLVDTINAIVAPLEKLTGKPIPEDERNLIAFYFDGELEKS----
511 UniRef50_C5EGL6 Transcriptional antitermina... 57 1e-07 1 11.9% 1:118 763:873 IVSRLRFLN-----PTVVINEVELVLMKYEQYYHLEMTGHVRLNLYMHIAFMIERLMTTDPVQEQTRGL--SPQENRFYGISREVFKEMEQKYRIRMNSYELSLLYELFRRIIIEEKD--
512 UniRef50_B9YDX2 Putative uncharacterized pr... 57 1e-07 1 13.0% 2:116 272:386 -QEDISLDNIAKFVPQPIIDRTLLALLKLENYYHlqFSEAFKVKIILHAMLMIDRIQSANPQSNAMLATIKT-KYPFVYEMSVHFVKELFKEDYIKVPDSEIAFLAIHIGAYINDN----
513 UniRef50_Q03XN7 Transcriptional antitermina... 57 2e-07 1 13.3% 7:111 182:284 ------YMKNKSFFKAISFDQITIIVLDECREAGIHLTDFTIQNIVLYIALSVQRLKCGFELQAAPVDINPEIRNVS--DVARKIFSRIESGLALKFPESEVDYLTIQLMA---------
514 UniRef50_D1YDT2 PRD domain protein n=4 Tax=... 57 2e-07 1 12.0% 15:106 277:368 --------------DEEVPGLVDAIFERIAEVMQIHLddELADEFAHHLTFMLNRIRFRVTIDEESVRSIR-YQYPVAHRMAEISRDVIEERTGMRISDSETGLLT--------------
515 UniRef50_Q4EEJ1 Sigma-54 interaction domain... 57 2e-07 1 13.7% 16:117 207:308 ---------------EQLVYFLRKVISELQLQLNVILESGVDIGMILHLAFLIERVKLGAVDREFPDLNEFAKNHMVEMQITQQMMENVEIEYDIVIPQSEIAYLTQMMLSNQVEEN---
516 UniRef50_B0MAW6 Putative uncharacterized pr... 57 2e-07 1 12.1% 21:119 310:409 --------------------MIAETIYQISSCFGIDfdFTLYDLLVAHMRSAVHRLKNSEVLVNPLKDTLMQ-DYPEIFESVKQHLGSLEDYVGQKFSEDEMSFMVLYFASVMEKEKAE-
517 UniRef50_A8RAH0 Putative uncharacterized pr... 57 2e-07 1 11.7% 13:115 293:395 ------------LLDTDFIQNIHNILKSAFRHydIDFSDNIY-SFSMHVDGLIKRSKAMQPAYNYAVRSLKS-DHPFIYEVAVYIANNIKKAYNIQINDSEIGFICIYIGSLVEN-----
518 UniRef50_B6EP62 HTH-type transcriptional re... 57 2e-07 1 9.0% 17:116 310:407 ----------------EQLELTHFLLDYVNEHYNYDldELLKRDLLCHITTMILRVKYQITIPNPLVDHIKRY-YPLAYDMTVAAISHWGKHL---IPDGEVGYLVMHIGVGLERN----
519 UniRef50_UPI0001C367E1 transcriptional regulator n... 57 2e-07 1 13.6% 9:111 430:531 --------ELKNSLPEDVVDFTIEILEKASMDLGKAISAKLAYALAFHINYLILRSKMGHQ-ESEQTKRVAQEQGTKENQAARMIASRISERFTIAVQEKEVAFLTELLKN---------
520 UniRef50_Q5WJN3 Putative uncharacterized pr... 57 2e-07 1 8.7% 16:119 287:387 ---------------QKEKDFCTSLLEQISTILQVDldKKLMNDLLYHMKAAFLRIEQGLVIDNPYTEEIK-VRYRAIYEM----VHQITADMGYTLVAAEVAFITMHVSAGFDRSKSK-
521 UniRef50_B9Y3S8 Putative uncharacterized pr... 57 2e-07 1 13.9% 20:120 292:393 -------------------ELVDDMLNNILNLCKVDFRSdlRKALMTHLYASFSRYYLKATLPNPLMTLIKS-QYVEAYNYSLIGCEMLKEKHHLAINDDDIGYIALHFAAALEKDRAAM
522 UniRef50_B9Y892 Putative uncharacterized pr... 57 2e-07 1 14.3% 5:109 165:266 ----LDLDTLKQSFSPAEIEKISQILNDFFKQGTYNLNNFSYTNLLLHFAILIERVKTGNSLSEIREIM---TKNPEELALVRQLSDRIEQDFSITLNAYEKNEIYIFF-----------
523 UniRef50_C0D9E2 Putative uncharacterized pr... 57 2e-07 1 12.9% 17:109 63:159 ----------------QVTETVQELIKMIQIHFNMSLDETsyQRLITHIRYFVRRLFVNEPAGGGDDLLFEQVkyPRSYTCVCKIRDYFRMKFHCEITEEEMTYLMLHI-----------
524 UniRef50_B9YAP5 Putative uncharacterized pr... 57 2e-07 1 15.5% 2:111 297:401 -EENEQILQ-----NERFRGQIRKLLDKTFRHFQLELDYsvFDNFVLHVHFLLLRCRHQNFFHNDFATSLRT-SHPFIYDVAVYLAYQLEKEFQAAIPGDEIGLIAIYLGS---------
525 UniRef50_C2DH70 Sigma-54 factor, interactio... 57 2e-07 1 17.0% 1:106 732:833 LSEKLEFLN-----PDVIIKQVENVTKNIEKRFDLTLSGKMKFNLMMHNALMVERTMLgeDYEVPANLEELTINQKPFFQNAKNIFYTLEQFYRIEISNWELYVIY--------------
526 UniRef50_P54901 Stationary phase-inducible ... 57 2e-07 1 18.3% 6:120 222:336 -----DPLRDAHQRDRQLRQSIKRLVNHFRELGNVRFYDelCDQLYTHLAQALNRSLFAIGIDNTLPEEFARL-YPRLVRTTRAALAGFESEYGVHLSDEESGLVAV-IFGAWLMQENDL
527 UniRef50_D2ELR0 BglG family transcriptional... 57 2e-07 1 10.6% 17:120 302:406 ----------------KFINLTRLLLKNISEILKITIqdGIEEDLSLHVEPMFKRIINGIEIKNPILEDIK-LEYPNIFQSTEIAMKKirEYYSSNVSDDEIGFVAIYIAKFIEQHGHNM
528 UniRef50_D0BLL7 PRD domain-containing prote... 57 2e-07 1 11.9% 20:120 298:399 -------------------EQVKTLIQKVSNLLSLNldEHLQMMLSAHISKMIIRLRNQNFISNPALEEIKK-QYSSLFNVIWLSIRTLSQYYELSIPNEELAFIVIHFQVAIEKIMKPL
529 UniRef50_A6LWY3 Transcriptional antitermina... 57 2e-07 1 7.6% 14:118 279:384 -------------FTDNLTDDIEVFLKKTDETYDTHfdQDLKRLLLSHISLLVDRLHNKISYKNALANEL-SITYPMIFNIAIQFCDILHEKYNVEFTFDEIGFVAMHFAAHMVKEKQ--
530 UniRef50_A6D1D8 Putative uncharacterized pr... 57 2e-07 1 30.4% 1:115 1:117 MKQRMSLLLEHNVISQIAFDATMRAVGILMIEWNVKEDSEQFQMAMTHFARAIDRVLQSNPieGLDSEILKEMQDDDVFSDIVSMNNQLCSASGveMPETEISFLLSNLYAIKLS-----
531 UniRef50_D1APG7 Transcriptional antitermina... 57 2e-07 1 10.0% 21:120 314:414 --------------------LIREIIKNVDEKLDISIVNDNLlgLINHIRPTIYRIKNNIRLKKLDLNEITE-KYAALLDIVKESVKPLEDYLGKSMEIEELAYLTIYFKLAIDRKRKKL
532 UniRef50_C0XDC6 DNA-directed RNA polymerase... 57 2e-07 1 11.0% 2:110 414:522 -NNQESLQELSKIVPKDIIDLTAGYLTEATKVLKRRFDSSIFYGLCLHINSIINLGTNNKHEISDQKVKQLKNTYSQEYTLTTAFVDRIEKRLHYSFDEEQKINLLMFLV----------
533 UniRef50_B4U0A9 Transcriptional antitermina... 57 3e-07 1 12.2% 22:119 321:419 ---------------------IGDFIDQLELRYQLHFThdLLRQLTRHCKALVYRKAYGIFSINPLTDHIKE-KYEELFAMAQSCAVILEQAWQIRLTDDDVAYLTIHLGGELRHSHAD-
534 UniRef50_A4VY33 Transcriptional antitermina... 57 3e-07 1 14.7% 10:118 303:415 ---------DVHVFSQDFIDlvERFIHHFEIHSPFElpDELAKHLLAHCKALLFRKTYGILSKNPMVQQIQD-KYSTLFAMTRVSGKILEEEWQIELSDGDIAYLTIHLGGAIRRSGT--
535 UniRef50_C5EFX5 Transcriptional antitermina... 57 3e-07 1 15.9% 13:119 288:395 ------------VIHEQTDRLALEMIRLVDHDFHMDfnFEMRMTLNQHLVPFDVRMRYDIPLKNPMLQEIKE-KYSLAYQMSGVSCSVLKEYYHREIPEDEVGYFALIFELALEKGDLE-
536 UniRef50_C8PAD3 Putative uncharacterized pr... 56 3e-07 1 15.1% 1:106 754:852 ISEKLSFLN-----PDVILKEVEDVNSKYEDFYHLKLDGKIKLNLYLHIALMIERLIVHNTKDISIQAISNEEK--DFFKITKSIFQPLEMKYNIHIPNYELSLLY--------------
537 UniRef50_A0AFI1 Complete genome n=2 Tax=Lis... 56 3e-07 1 19.5% 6:118 177:284 -----NYLRKFTSITKETIQQIYEKIERVEKKLELKFTDEKIFILPYVFASMLRRIEMGKGISSYFQINYNELSDTNEYQAVEILLEGVAD-----LAEEERLYMALQLLTSNVSYQS--
538 UniRef50_P44003 Uncharacterized protein HI0... 56 3e-07 1 24.3% 4:118 6:120 ---QLERWKIRRQINQSIIDVIFRLRDRLAHYWQADVNTPQVDFMLLHIACSLGRIERGGCVSSLYSEMLEEMQSAVIFPQVLAIHQDLLKLMPFSIPEAEQTYFLANIHSLVLEQKQ--
539 UniRef50_C2FPY5 PTS family L-ascorbate (L-a... 56 3e-07 1 9.3% 44:118 315:388 -------------------------------------------SLTVHLLSTYYRAQYNMPFEYPDLKSIQQ-HYHHTFEITRKVVVPFEQYIHHTLSDDEIALIAIYFGGAIREQKT--
540 UniRef50_Q3CZS6 MW0309, putative n=3 Tax=St... 56 3e-07 1 13.5% 20:115 293:389 -------------------KFVTALLEDVSKAMSINfdQYLFDQLSQHIPAMLYRLKYHTHIQNPFTDKIK-LEFAITYNVLWLVLQDLGQELDVVFNEDEVAYLTIYFQLSIEK-----
541 UniRef50_D0GNT1 PRD domain-containing prote... 56 3e-07 1 23.3% 1:116 4:120 LKFRLDILKNSEVIDEEIYNKVISLIEHLDKKWEITLTEENGAMFITHLSMALKRIKQNENVNNIDKTVFEEVMVSDKLDKIEEIYEDIEKNIFIelPEEEKKYILVNLLLLEEDK----
542 UniRef50_B3W837 PRD-and EIIAMtl/Fru-contain... 56 3e-07 1 13.8% 5:113 169:281 ----MNFEAMTQGLAEHDTTFALKQVDVVAQFLKADLPYPYDVNLFSHIYVLISRIRkkLPIEDQDITRLKehNYPDLFSVSEMVKRNLENYLGESISENEVYYLFQYLISAR-------
543 UniRef50_B9Y618 Putative uncharacterized pr... 56 3e-07 1 15.4% 15:118 330:434 --------------DMDIYLSVYEMIEAFETVSCIRFneQLVDYIFQHWKAAYYRILYDFHIENEMLEAIKN-RYTYLFDLTRRSIYPLEKTLNKPIPEEEIGFITILYGGWLRREKQ--
544 UniRef50_A9QSG5 Transcriptional antitermina... 56 3e-07 1 9.2% 2:120 303:414 -NNKENMLLAKQIVSDVTFDLFQ------LTKSRWTLDEGLKLSLIDHFNRLLN-IHQIKSTRNNPILDVVKNDFPYPFELAISQVQKIEKRYDVSLTEDEVSYIALYFASAIENSNDNV
545 UniRef50_Q8NYI2 MW0220 protein n=49 Tax=Sta... 56 4e-07 1 17.9% 8:119 285:396 -------LQESDNISNLTM-AIAQMIHHFEQITFINIEDKEKLslLLHLTPAFYRIKYNLTDRDELINPL-QGNYQSLFHMVKQSCQSLTEYFGKSLPDNEIAYLTMLFGGSLRRQDEN-
546 UniRef50_C9XL63 Putative transcriptional an... 56 4e-07 1 11.0% 2:119 236:354 -RSKRSSILENEQNKEIIINSIKTFCKNLKLATSIDISNDKVFelYKHISSLCKKIKLGINQSPIMAQDIK-IKYPFAFELANIAKKTIEKDLKIEINEDEVANIALHIGGAVERASYN-
547 UniRef50_Q3XZH6 Transcriptional antitermina... 56 4e-07 1 10.1% 1:119 276:395 IANLFTNSQAATRFQKESSALADHLIEQVEQFLGYSLKEdlKQNLRSHLSSTYFRLHYGLQISNPLTKNVFST-YTQLFLVLQLILEDYFEKENFYVPQEETAYLTIHFQAAIERHKHQ-
548 UniRef50_B9DT71 Transcriptional regulator (... 56 4e-07 1 13.0% 13:120 275:383 ------------IISSQIDQLTFEMLDRVYKLLNLDFRneLRMALSQHLVPMDIRLRYNIMLENPLSEQIQK-EYPFPYTIASTAVTVLNEFYQKDISQGEMAYIALIFALATEKRNRDI
549 UniRef50_C6DH96 PTS system transcriptional ... 56 4e-07 1 18.4% 4:106 760:856 ---RLNFLN-----PVIIIDEVEAVIKQYEFFYKIHFESYLRINLFMHIALMIERVMVNTGMCHRDDSALTAEQQAFV-DVHDTFFQVLNRKYHIVVPLTEVLMIY--------------
550 UniRef50_C0CN20 Putative uncharacterized pr... 56 4e-07 1 13.4% 2:120 174:289 -NARGNAFYQYQYLDEELVDLIMLESQFYLRKYGIVLEDINMIVLNLAIAIACCRMNDGHFLESRKEPL---PLDPACVHAADDLLESLEKKLGCIFPDSERQEIYLHLSCARLLDSSAL
551 UniRef50_C7T9J5 Transcription antiterminato... 55 5e-07 1 17.1% 13:117 295:400 ------------NFSDEVTKVADFYLSKVGQRLNLAVNSsiFHELANHVKPMLNRLRNGIRVKNVLLEQIK-LSYQGVFKIVTEVSKIVSKKFNLpiSDDENGFITLYFARMNEAHQ---
552 UniRef50_D1AIK5 Transcriptional antitermina... 55 5e-07 1 12.6% 17:119 309:412 ----------------EIDLLAKKLINNMNQKIEADISNdlFRCLIHHLKPTIYRIKKGVRIVNPIFENMK-IKKDDFYYYVKDAAKELEKMLGQEIPEDELFLLIIHFKASIERNRPK-
553 UniRef50_C6SRZ6 Transcriptional antitermina... 55 5e-07 1 19.2% 21:119 297:397 --------------------LTIQLIDFVEQETEIPFnnILQQGLYQHMVSMVARVKNNIQLTNPLTERIKQ-SYGSIYQAVAKFSFHLEKLLKRKIIDDEIAFLTIYFSTTLSEINQE-
554 UniRef50_B0N6K6 Putative uncharacterized pr... 55 5e-07 1 10.8% 10:111 186:283 ---------EYTLFEGIDLDLLKQIISNKLKNAHIKTNDFNFKNLIIHFALMISRIQFDCYINTNNTIKIDDNYTDFIDDIANE----IEYTFNITISEGEKKYIYSHLVA---------
555 UniRef50_B9YBE9 Putative uncharacterized pr... 55 5e-07 1 18.7% 5:111 822:930 ----LQSLMENLTipARLLDCVYEAVSALQRQMNRRFQSRTLVGIYIHVSFLIERLVTRTAIESLADLTPFVQAHRDFIEQVNASFAPLLKNYNVSVPIDEISYLYDYIEN---------
556 UniRef50_C7N9S2 PTS modulated transcription... 55 5e-07 1 10.4% 5:119 288:401 ----LKNNSFEDWINEELI--IKKMISKVSKIVKTDldEILYNGLLYHIKPAMYRIKNNIQITNSVFQEL-ILEKDPILDVVNKAIEEIEGLFEVKFPEDEIALMGFHIKASIERNTSE-
557 UniRef50_C4VFI2 HTH domain protein n=23 Tax... 55 6e-07 1 16.3% 16:119 307:411 ---------------QDMVQLTKQVIESVSKELNYPfdRQLFTNLFAHLSL---RFTKKHLFINEYNPFSEEIkhPALFLAIQSACKQLIQRSVLLVNDSFCAYIALHFLAAQERQQQE-
558 UniRef50_C9XST4 Putative transcription anti... 55 6e-07 1 17.3% 15:118 293:401 --------------DTEDKDVISKIVNKMMTKFGyiSQEKIFKQLYSHFRPAYYRLLFKLPIYNPICEKVKE-EYKLVYRIVSNAMKEFCGLFGEEIQEEELAYLTMHFATLFSNKKE--
559 UniRef50_B1R0C0 AAA superfamily ATPase with... 55 7e-07 1 16.2% 1:105 779:890 IKDLIKLLSLQNIipERVINDVERIINILETELEVKLNSDLRLTLFIHTAIMIERVVLNRDTKFDDDDEIHISCDTRDLELVQNILDNELKEYSIKIPAYETAVI---------------
560 UniRef50_C9XKF8 Putative transcription anti... 55 7e-07 1 9.0% 9:119 466:575 --------EIFKVINPKIYYAVEHSLKEAEKISRNKYTKQTYIALSMHISALIENINQDTY-NPKYNLYNDKIFLDKDLNISKIVLSIIENDLQTSLPKDEVKFISMFLNSMYLEPNNQ-
561 UniRef50_Q65MQ9 Putative uncharacterized pr... 55 7e-07 1 23.1% 1:117 6:121 LEEKLSILLTSRVITKNAFNTTLNTFVFLSEKLKKEVIKDS-EMFWTHMAMALTRIKEGESEEVPANAIINEMYETPYKSAIEEVIDFIHSLAGLELPEGELVYFYLHLHKVIESNK---
562 UniRef50_C2C4I7 Protein-N(Pi)-phosphohistid... 55 7e-07 1 10.2% 22:119 291:389 ---------------------INDAMTAIDQQYGTAfdEELQNALLLHIYPLMLRLHYNLQLDNPIIEDL-YTRYANVFNISISFVQYLQDNEDFIITKDEIGYVAMYFAASLEKERNQ-
563 UniRef50_B5F2K0 Sigma-54 factor, interactio... 55 7e-07 1 16.5% 5:119 439:550 ----KKLEHVDHGLPNATLVFCQSLKNELELQLNKEFSHGFLLSLGYHLNNIIqrSRTNTWIRHYRVDNLE------EYESALTIKKRLYKEFDIDINDDEVVYLTILLASLVVRERDK-
564 UniRef50_D0ZD91 Transcriptional antitermina... 55 7e-07 1 12.9% 15:115 233:334 --------------DSALMHEIERCVDCVERDSDVRLseRLCARLFAHLGAAIERALFDIRIGTPLAAELAS-HHPALLALTRRAIAGLEQRYRIRFSPEELSLIAVSIGAWLMQ-----
565 UniRef50_B7GN85 Transcriptional antitermina... 55 8e-07 1 11.1% 21:119 4:106 --------------------VIQQLLAVIESTYNIELDEHSVnrFITHLRYLFVRIHQHEQLSKEPEAIISSisYAKASKCARLIASLIELRLDTMLTEDEVAYLTLHVARVTDQTNQN-
566 UniRef50_A6LS08 Sigma-54 factor, interactio... 55 8e-07 1 17.6% 16:106 821:911 ---------------DKLLRNIEECLDNLEIAMKKKLNNEKKIALLVHISCLVERLIRHEEIDAYPNLENFIECQKDMIKTIENSFSVIEKIYNVKINLPEIGFIY--------------
567 UniRef50_C9BKW7 Transcriptional antitermina... 55 8e-07 1 15.7% 21:109 301:391 --------------------LTIQLIQFVENETHVPFheALFENLYKHMAALIVRIKNHIQVMNPLKENIRT-NYFPIYRAVTHFVPTIEEVIGGKILEDEIAFLVIHF-----------
568 UniRef50_A5KJK5 Putative uncharacterized pr... 54 1e-06 1 12.4% 20:116 290:387 -------------------DMTERAFQRIKNDYKVDldDILVNGLVLHLASNFSRYLLGMETENLFYNDVLE-SYPTAYYYAMEVAEEISVWTKLSLSKYEISFLGMHFASYLERS----
569 UniRef50_Q5WCM9 Transcriptional antitermina... 54 1e-06 1 16.3% 8:111 180:277 -------LEIGTDIGKHEISEVHACIEKVEQKLGIQFTDEKLMAMPYILTLVLKRISIGHVL-PPFPIEYDELSDTKEYQATEEIFRHLKD-----VPKQERLFVTLYLLT---------
570 UniRef50_B0MDG5 Putative uncharacterized pr... 54 1e-06 1 16.0% 22:115 316:408 ---------------------IHTFIEYVEDRMGLQldKELKESLYVHIERALTRIRSGMCISNPLIEDVKK-DYEELFGIIREGADRIFQ--DDFFPDDEIGYLVLYFAVSLDK-----
571 UniRef50_B1CAC3 Putative uncharacterized pr... 54 1e-06 1 9.8% 13:104 287:379 ------------QMPSQIIEIVESLISNIKDDYDLDLsdELFMGLIFHVRALINRVKYQQLVESPILDMIKK-QYTFIFELSLHIYEIFKKVLGIKLTESELSY----------------
572 UniRef50_B0P2P0 Putative uncharacterized pr... 54 1e-06 1 10.1% 21:119 300:398 --------------------VTRKFIEHISKDLGVNLNRDfyENLTDHLESIIMRSFNVTQRDDFLKQYVE--KNPKVLEVVQKYKDMLSNFMDREISEIEIDYIVIHICAALERRKKK-
573 UniRef50_D1ARV2 PTS modulated transcription... 54 1e-06 1 8.9% 16:116 314:415 ---------------KQVKQILENLISKVSSDINLDMTNDllNDLIYHMKLAAYRIKNNIKLKNSIYKEVED-EVPFLFGIVEKRIAGYEQYLDEKLNKDEIAFITIHFKMSIDRN----
574 UniRef50_UPI000196BD9B hypothetical protein CATMIT... 54 1e-06 1 8.5% 15:120 188:289 --------------NDVEVNYIVSLLINVFNKHKIQTDDYKLKNLTTYFALMISRILNDDYISVMNNTEIPNNIK----EIMNEICESLSDYYDITITRGEKQYISLHFISNIKYNNNSI
575 UniRef50_Q67PY3 NifA family transcriptional... 54 1e-06 1 20.8% 11:116 456:555 ----------AGVVSNRLLEIVTGFVREVGDELNENFGSEVVTGLALHLA-----ARSDHDLD-VDQALALVAQCPAEYAAVNRLAPRLEAELGVRLLPGEKSFLALFLAAHRPRN----
576 UniRef50_C8NIY4 Putative uncharacterized pr... 54 2e-06 1 13.5% 12:115 288:390 -----------EIVDLE--EVVRQIGEQLYSIMGVSfqEDFTMRFQLHLQGFLERVQLNLSLPNVYVQTFKR-QYPLVFDTAVSISQYLMSVFQCEMTEEEIGFIALHIGAAYMQ-----
577 UniRef50_C9B6L4 Transcriptional antitermina... 54 2e-06 1 14.4% 1:111 752:857 LSEKLEFLN-----PDVIIRQVEDVVEKCEKRFSLQLNAKMKFNLMMHLALMVERTILgkDYPVPEDINQLKINNKLFYQNTQTIFYTLEQFYKIKISTWEL-YILYEILA---------
578 UniRef50_C6VPE0 Transcription regulator lev... 54 2e-06 1 17.9% 6:111 396:500 -----NTQNLAQIVAPLIIKIVKDWQPDCERLLARPLTESVFNGLCLHINGMYRQMPTTKPASATMITQLQS-QHVAEYEAAVKLAQVLATKLDLTISPAEVALLATFLVA---------
579 UniRef50_Q82Z58 Transcriptional regulator, ... 54 2e-06 1 17.0% 1:106 319:420 LSEKLEFLN-----PDVIIKQVENVTKNIEKRFDLTLSGKMKFNLMMHNALMVERTMLgeDYEIPANLEELTINQKPFFQNAKNIFYTLEQFYRIEISNWELYVIY--------------
580 UniRef50_D1AWK7 PTS modulated transcription... 54 2e-06 1 13.3% 17:106 287:378 ----------------EVNDIIQELIYYVKLTFKIDldEELYKNLYTHILALCIRIRFGIKIKNPLLEDIKK-NMPLEYNVATYVCNLISKRFNksLSEAEIGFIA--------------
581 UniRef50_A8RA27 Putative uncharacterized pr... 54 2e-06 1 7.7% 6:109 282:386 -----SNFRNTDYISEDLNEFILYALEKIKESYPTDfdVNLRMSLALHLVPLISRAKNNVQIKNEMLDYIKQ-SFPYAFDIATYFSYLLSERYNCLIKESETAFLAIYF-----------
582 UniRef50_A6M234 Sigma-54 factor, interactio... 54 2e-06 1 8.9% 5:105 807:908 ----KKIIEKLTILdnKVLNFVQDAVDKMEEKLGVKMSNNKRFLLYLHASCMVERILRKEDVDMQEDIKEFVQREKRKIDIIRYAFSEIEKEYTIKISDLEIRLI---------------
583 UniRef50_C4LKZ8 Beta-glucoside operon antit... 54 2e-06 1 17.6% 24:108 189:277 -----------------------QLFDIVDSSLGITMDRKSVNafITHMRYFFVRVRNGNQLNEGMSVLRDSlsHPDAVLCADRLASVLELRLDTELTDDERAYLALH------------
584 UniRef50_C4Z8V3 Probable transcription anti... 54 2e-06 1 17.0% 22:109 7:95 ---------------------VRKCATFIEEKihIDVTTMAYNRLMNHIRHMVSRAATGEKLKVDLNQFIEK-NYPESFALAGDICKELGKDLNHEFLDNETGYLAIHI-----------
585 UniRef50_A8RA76 Putative uncharacterized pr... 54 2e-06 1 15.2% 1:105 697:800 IQNKLLSESLIFLNPEKACQALFNILLNIINDLSIPYSDDLLIKFLFHTTFALERCIRKEPYTYPKARYLIK-EHSKLFNVIDKNFKVINEIFAVQIPTSEIGFI---------------
586 UniRef50_A0AKP3 Complete genome n=21 Tax=Li... 54 2e-06 1 11.3% 6:120 172:286 -----DLKTEYSDLNKADVQFIVRQMEIIERKLMISIPYPYDINIFSHLYILINRFRQGEVEDFDEIDESYPVTNEKLHNIAIEAMEAIEHYLKMDLPKRETFNFLQYLISSRFNHDIEL
587 UniRef50_C5R2K8 BglG family transcriptional... 53 2e-06 1 15.5% 1:116 53:171 MFNQLDLEQITQnlDGELAHFCLGLLITLERELGVNIPYPYNINIFSHLYIFISRNRRSTSIHVVA-PSKPTIVDEKIYSVCQKIIQEIEQYFKMKVDAVEIDYLYQYVVSSRLQK----
588 UniRef50_D1AHL2 Transcriptional antitermina... 53 3e-06 1 11.1% 21:119 299:398 --------------------LVNKLIVDINSKIDTNidNILFEGLLNHLKPAIYRIKQGIKLENAIYEEVLD-NYPELFLMIKDSMTKLIHYLEVEINDDEIAFVTIHFKEAIDRRAEK-
589 UniRef50_C9BQD5 RNA polymerase sigma-54 sub... 53 3e-06 1 13.0% 15:106 752:842 --------------SKKVFNEIEKVLYLYEKYYDVKIPSFLRINLFLHLSGMIERIMIGDGITNEHLKEGAQLFDTFL-NVSKDFFSEIKDIYCIEIPKGEYELIY--------------
590 UniRef50_D1AV48 Transcriptional antitermina... 53 3e-06 1 9.2% 21:118 267:365 --------------------LIKKMIKSVGDEIGIDLTEdlYDFLLTHIKVSIYRLKKGIKLKNSIYQQL-VLENNPIIPIIKASIVEMEEIFEIKFTEIEISLIAYHFKASIERMKT--
591 UniRef50_C3RLU7 Predicted protein n=2 Tax=B... 53 3e-06 1 14.4% 17:113 187:282 ----------------QLILKIEDIVDRILTRYQISMSEVSVQNFIIDIYISLKRIKKGIFLKSTDKMVI-DIARWTDSIVAVELAKLINDELTIEMKDQEIVSLSIHLAAKR-------
592 UniRef50_C7H646 HTH domain protein n=1 Tax=... 53 3e-06 1 13.0% 17:116 253:352 ----------------EERQDIRHTFLKILRESPVSLRDSATQRVAVYLIIARNRVQNGHEIR-LPDPWLESISGTMFYPLAQSIYHTLEEQygYAMPQDEVAFLGILLFSMLDVN----
593 UniRef50_C6VJG9 Transcription regulator, ma... 53 3e-06 1 16.4% 1:116 299:414 LTFRIDQDASLSNYDLQLTYRVKKFIDAVATNFNWSfdDRLLNNLTAHMQIALQR--NGVNGPVPPTAELQEvqYPKLYSAVVRGFATIFK--DQDFTTDELTYLLIHFASTYEQQ----
594 UniRef50_C2BFG8 Transcriptional antitermina... 53 3e-06 1 11.9% 2:110 255:364 -ENSIFNKYMYDDLDYKINKIVDEALSKICKTSsySFDDEFIKAINFHLKILIHRMELNDKIKNPLVNEIKR-KFILEMNDAMIIKDMIYEHFNIQIDEDEVSYLAIYLM----------
595 UniRef50_B0MFP8 Putative uncharacterized pr... 53 3e-06 1 18.0% 17:116 292:392 ----------------EIMEAARQVIDNFEKIinIKERDILLEALFQHVKPAFYRVKYHYHIEQSIVDMVL-PRYSSLHAMVKRSMKPLEELAGSEFPDEELVYITALFGAWLQRE----
596 UniRef50_C3RP75 Predicted protein n=2 Tax=B... 53 3e-06 1 15.3% 16:113 196:292 ---------------DKYWKIIIKVMNDFESHSEKKLTYLSYKDICIHLAVSLTRIELGYDII-LHQDYLIEISKTEGYHDAQFICSQIMQALNIKMSQSEVAIITILLNSAR-------
597 UniRef50_B0MBD2 Putative uncharacterized pr... 53 4e-06 1 15.3% 22:119 317:413 ---------------------IEEFVELVEGRMGITLSQdlMDGLLTHIDKALVRTRSGMSISNPIIRDIEK-DYSQLFSIIKDTVRKVFP--DDYFPDDEIGYLVLYFAVSLDNITKK-
598 UniRef50_C7TGF2 Transcription antiterminato... 52 4e-06 1 14.7% 5:113 169:281 ----MNFQAMTQGLAEHDTTFALKQVDVVSQVLKADLPYPYDVNLFSHIYVLINRIRkkLPIEDEDITRLKahNYPDLYSVSEIVKHNLENYLGEPVAENEVYYLFQYLISAR-------
599 UniRef50_A8U9C7 Putative uncharacterized pr... 52 4e-06 1 16.4% 1:116 2:116 IQEKLTILRENNVINDSVYDYAQEVLKFMKAQ-NIINNEDEADTFITHLAMATARQYTEETINSVDQMINEQIKADQKYDEALKYWNEIAALAPIPFRENEAEYLHLHLVTLLNNY----
600 UniRef50_C7HSJ2 Putative uncharacterized pr... 52 4e-06 1 11.5% 7:119 173:281 ------FLDSINLFNIKEIDEIKRLTLKILNKYDLSLTGVAFNSFVIHILISIIRNQNEI---NYDKDLLKTMDKSVEKDIVRELMKTIKEKLNYDLSSD-YYYLTKHLITSQKFSKDD-
601 UniRef50_D1AJW2 Transcriptional antitermina... 52 4e-06 1 9.8% 6:117 294:404 -----DISLVNNWINVEFL--VQSLIANFNKYLEIDISGdlFNCLLYHIKPTLYRINKKIKLENTAFRELIINQDPTL-EIVKNAVNDMEKALNIEFTEEELALLAYHFKASIERNT---
602 UniRef50_Q928S7 Lin2455 protein n=4 Tax=Lis... 52 4e-06 1 16.4% 1:110 264:374 MNNFENQVTTKMVLEGELYQEILLILEEIKHVYLIDFTTDLEVtmTKHIFIALERAKRGIVIKNQVTHIITQ-QYSYLLDIAIFIGEKLLERLGVILNQEEIILLVMYLY----------
603 UniRef50_C2BY17 Cryptic beta-glucoside bgl ... 52 4e-06 1 6.3% 6:116 60:169 -----QIEEVIAAVPEFYLKIAEKIAALGEAATRQQFNFGIILSLADHIQFAVECAQQEYRIKSPLQWEMKTL-FPLEVRAGYEAIDYINTQIDADLPSEDAYAIALHFVNANKGN----
604 UniRef50_Q5WJQ9 BglG family transcriptional... 52 4e-06 1 11.4% 15:119 291:396 --------------NPEVIGKIEEILRQVEQVYQVPtqTRFRNNISNHIYRIINPASHNLLIYNPFVKETKA-EYFFSFSIASNIALQIEKEFAVEIQDSEIAYLAYHIQVILDSQDKK-
605 UniRef50_C6J1G7 PTS system IIA 2 domain-con... 52 5e-06 1 15.0% 19:118 190:283 ------------------VAALRRKIEAVESKLNLKFTDEKLESMPYILLLLLRRVKQGRVVEGFHIH-YDELSDTKEYRAVEELLSELE-----PIPMEERMFITLHLLTTNISSTD--
606 UniRef50_C3WF15 Predicted protein n=1 Tax=F... 52 5e-06 1 9.7% 18:120 296:399 -----------------IEKFIDNLIYRMSKKIEKNLIEdlREGLINHIVPTIYRLKNNLELQESISSEIKE-EYPQYYYYIKEFVKELENYIGKDFSENELAFLVVHFILAIKRLDEKI
607 UniRef50_B4ACX6 BglG family transcriptional... 52 6e-06 1 9.3% 11:117 292:399 ----------VTNFSFKVMQITQFYLEEMSAQLKitDNDQLLLELASHIKPMINRLENGIHVKNSLLDQIK-MTYETIFRKIVQVSKQVSKNYQLpiNEDENGFITLYFARMIETNQ---
608 UniRef50_C2DAD7 BglG family transcriptional... 52 6e-06 1 11.7% 15:117 208:305 --------------SQKYLDSVKNDVLKIEKFLGVKYTDEDFYPLLYFISSIFVRIERGQMIDSSRIQEREEIEHTKEYQSLSYITTDF-----PDLPEDEKVFISLQLLSSNVRNK---
609 UniRef50_C8NIB7 Putative uncharacterized pr... 52 6e-06 1 18.6% 1:118 2:120 LEEKLDVLVVADVIDEDTKKYILKASDFFRNEMKIN-DDTKVEVFLIHLAMAESRRRKNEVLDAKMEEIIreVNNHHNFAECKEFWSRLSNYIGEEvsENELEFIYLHLLNLLEGDKD--
610 UniRef50_B3W851 Phosphoenolpyruvate-depende... 52 6e-06 1 13.3% 22:119 293:391 ---------------------LEASLKRAEEYYGIPlnERYRAQIMNHIMRLLDPLEESIPIFNPYSKQTKR-EYLFAYSIACFLYDDLESDFRLQIPESEIAYLAIHIQLVLTEETKN-
611 UniRef50_C4ZB72 PRD/PTS system IIA 2 domain... 52 6e-06 1 13.3% 4:116 184:318 ---RRAAEVIANNFRSVNLSMAVDMIHHVERRFDIIFTDYTFQMLAEYIAIALFRVDVEKELKTDELDLSNRICDaeHENMAKEAAGFLERHHGISLSQPEIMYLAMLFSCAEGQN----
612 UniRef50_B6FXT7 Putative uncharacterized pr... 52 7e-06 1 10.1% 21:119 294:392 --------------------ITRQFVEGVSHDLKINLNDdfYLNLSNHLE-SIFRSKNYNFPQNEFIDEVVS-KNPDIVAATNKNIDVIEKYAQRKISDIEIAYITIHICAAIERKKKQ-
613 UniRef50_B8DAX2 PTS system IIA 2 domain pro... 52 7e-06 1 13.3% 6:118 176:283 -----EYLQDFMQVDEARIKELREKLEQVEHHLNLHFIDNKMQILPYILEAVFRRMKKGQTITTSFLIDYNELSDTREYGAAEIF---IEEEPN--MPEAERMYITLQLLTSNVLPKQ--
614 UniRef50_C9ATS7 Transcriptional regulator n... 52 7e-06 1 15.5% 6:102 418:513 -----NITQLAKIVDAKVIQIVDFWLKTCKKELNREFKSSVFYGLCLHINSLLT-LASNRQTLSQEEVTQFIQQYPEEYALSVQLSMELKKQLNLNLPKDEI------------------
615 UniRef50_D0GPK3 Transcriptional regulatory ... 52 7e-06 1 11.4% 6:119 472:583 -----NYRELQQIVGEKILTSVMTAYEKAKMSF-TDLNSKIIFPLSIHMKTSADRIKEGKQLPTSVSAGFK-MSNKKETEVAKQMLAIINEKCYLNFPDSEAGFIAMYLKEFRKNEKYN-
616 UniRef50_B0P5U9 Putative uncharacterized pr... 51 1e-05 1 14.7% 3:118 5:122 --DRVKNVEEKMELTPELSASVEklLEDLERE-GVAFDENSGIGFISHAINLVKRLESGEKVNDLGEDVLSQLE-KDALNASRKVLEPIEKAYGITLDHSELALVTIHVQAAMMKMKK--
617 UniRef50_C5R8Q6 BglG family transcriptional... 51 1e-05 1 17.0% 14:113 171:269 -------------ISKTDQTFISSQMTLIEKELDVEILDPYTVNIFSHLYILLDRVRT-HNVELATPTEINHHYDELLLRVARQVINNISEYAHVEINSQEIENLMLYLVGLR-------
618 UniRef50_A8UBU9 Transcription regulator, ma... 51 1e-05 1 18.3% 11:114 200:304 ----------LKQLSKEDLYHVYAVVKQFGQHYFDEVTDSQLQRLVILLCISIMRLREGHQIHSfaTTLLADSDQTKSIETATAVYDFMQKLYGIAITKEEIQFLGLQIQGLNV------
619 UniRef50_C9A355 Putative uncharacterized pr... 51 1e-05 1 20.7% 1:116 2:117 IRDKLTVLLDSGIVDQETYDYVFNVLSYLLEK-EIVEEEQQADVFLTHLAMADMRRKNNETVNSLESFIQAEIEGDPHYLHSRELWQDLQKMTSEqfADAELDYFYLHIINMLREE----
620 UniRef50_Q034E8 Transcriptional antitermina... 50 1e-05 1 16.2% 14:118 178:287 -------------ITDYDQQFITRQVQVIEQATGGKLAYPYNVNILSHLYILIQRVRRQGKVERLKIVNSVEvqNMHLYRLAEIIIGNTENYLAKQLPPEETDYLFQYLISSRIDNET--
621 UniRef50_UPI0001C35023 transcriptional antitermina... 50 2e-05 1 14.6% 24:119 320:417 -----------------------DFIDAFSVIMEVNLREelYQNIMAHIALMLRRVKANTTARNPLTAQIME-EYMGTINVCQVICWILSRKFRldISMDEICYLTLYIQGEILEKEEK-
622 UniRef50_B3W767 PRD-and EIIAMtl/Fru-contain... 50 2e-05 1 21.7% 28:110 257:338 ---------------------------DTRHKTDFATHPEFLSLMYFHVLALIGRLQKHQSLAGLSLEPLAR-DYPIAFNWAVQFAQWLTREYQIAVPKTEIGYLTTHLL----------
623 UniRef50_C3WG94 Predicted protein n=1 Tax=F... 50 2e-05 1 9.4% 21:116 298:394 --------------------LAKKIIENFSINMEIDldKDLLYGIINHLKPTIHRLKNSISLENSILTDFLK-NYKPIFEATKKSLSPLEDFIGMEITPDEIAFLGTHFKSAIDKN----
624 UniRef50_Q18CM3 Putative transcription anti... 50 2e-05 1 7.5% 13:119 292:397 ------------YLNEELASYTKKIINLVSEESGINFNNdlYEQLICHLNVTMHQMKSNVYLENPLLDNIKT-KFCFLFTVISSSIEI--ELKGKQITEGEIGYLTLHFQTSLERKYSK-
625 UniRef50_C9BZ81 Transcriptional antitermina... 50 2e-05 1 12.8% 1:117 171:287 MESKTFFQVLNMLFDSKVISVIHDLLFNDYSELTEKVSDYYVRSLISTLVIQCNRLLKGHHLTVEEEFLFNSIRYMETYIVANGLIEELKAKLNLPFYDADKEYLCRQLFAHRVTNN---
626 UniRef50_D1AIW4 PTS modulated transcription... 50 2e-05 1 12.6% 10:112 191:292 ---------LNNYIKQIDQNFLKNYLKDIESKLVENTSNEVFELLIIYFSIAILRINQNNIITQSDFYNTYIIR-TKEYKILTENIDILEKKYDVHFNEEEILKLAEYFLGS--------
627 UniRef50_C4VHV1 Sigma-54 interaction domain... 50 3e-05 1 12.6% 16:118 145:246 ---------------KKIIDLLWSFAKNIQTQLAMPEEYTFYINLIMHTSGMLERILRNDTLTVSEKELGRLVQEP-IYSVIVASIETMEEALNMDVPAEEVYFIAQLVKNAQCIEDK--
628 UniRef50_C3RHR0 Predicted protein n=2 Tax=B... 49 3e-05 1 13.7% 3:119 279:395 --NEENYETQILYNDYSFVYKIKEILDDLVEHFSLQLnqMSLNHFALHIHRLFFRNHSSLYFQNDFHNNLKNT-HPFIYELAVYFAYKFQESFNITVNINEIGLLAIHLGLMIQSNEEN-
629 UniRef50_C3RJP5 Predicted protein n=2 Tax=B... 49 4e-05 1 8.9% 26:115 197:285 -------------------------IIEIINQHQIIMSDISLIDFLICFSIAIARNTINHTIDSPI-ANFEQFKDRFEYATAKELGKYVQERFKIDFNEYEIQNITILLICKRSS-----
630 UniRef50_B0MH65 Putative uncharacterized pr... 49 4e-05 1 13.3% 21:118 302:399 --------------------ITRTFIEHVSIDIDLNldYIFYENLINHLESMFSSAIRDNTVSSVVTEVLE--RYPKIQKAVQNNVFVLEDYIGRKLNEVEISYIVVHICAAIERNRN--
631 UniRef50_C0CTK5 Putative uncharacterized pr... 49 4e-05 1 12.2% 9:106 191:291 --------YEQAFADRDDKDQVRRSTLEILRASDNEVFDIYVNRLVDYLLLLRNRMKDGHSLenQWTVWKKEIQRCREYKLARTLASELEHFPDFTVNDDEVTAIA--------------
632 UniRef50_Q04H56 Transcriptional antitermina... 49 4e-05 1 12.6% 13:115 293:399 ------------IFNGQTPKIVEKIVSYSLDYFSIDKRTklAEDLTNHIKPMMNRLNSGIVVANRLLSDI-QITYPNVFDKVRILFQKISRKFKidVPNDEIGFITLYFAKYKEQ-----
633 UniRef50_B7C884 Putative uncharacterized pr... 49 5e-05 1 9.3% 15:111 822:917 --------------PAKLLEQVANAIDVLQKYVGVRFSNRTCFGLYVHICCLIERlrNAEY--DPSLDFLNEHKDFVDY--VKKAFKQVEDFYGVDIPTEEMIHIYNYVKN---------
634 UniRef50_C8P116 Putative uncharacterized pr... 49 5e-05 1 16.0% 15:114 293:394 --------------DAQDEALIYDIFTEIDNNFAINfnHELFRYLLLHIPQMIKRIQNGLTIRNP---LIHRNLREFLfkVTISAVSVIEANydISINLDEFGYLLLYFQGALM------
635 UniRef50_UPI0001B419EF anthrax toxin expression tr... 49 6e-05 1 15.6% 24:119 35:129 -----------------------DLITKLEKNLKVKLYQNAKHTLCILFAITISRLLIGNTIENI-NEFIKMNKNDEHYKTITGILNELQPHFGVRLSENERSFLAVAFLLSFQNYTTE-
636 UniRef50_C9ASX5 Transcriptional antitermina... 49 7e-05 1 12.2% 1:115 88:203 LNHFDELEIVREIVDRKLLAIVERSFRESIADKQIELPESYFSSIIVSILLMIQRLREGKKIskGKNQYGKYFLEFNKYPLVCELLHQLEEQRIYQFSQEEVQYLTYVIVGSGLR-----
637 UniRef50_D1WYJ0 Transcriptional antitermina... 48 8e-05 1 20.6% 4:110 8:116 ---RIQLFREGGQVKPEVADFVAAELAALEAEGHL-VTEATAAMLTSHLMMAVGRLLNGEPIEQFLTDDQVAAehPEAVVRARAVAARAERELGAALPESEINFLGMHLA----------
638 UniRef50_B9YDF9 Putative uncharacterized pr... 48 9e-05 1 8.3% 15:110 195:289 --------------DDEERYEIRHIFLKTLRDSDCHILDINTQRLSRYLLLMVSRYQAGCPISLTQNQ-RKYIRRFREYSVAKDVIEKCQRFSGFDVSEDEILAFALLLI----------
639 UniRef50_B3W835 SipR n=2 Tax=Lactobacillus ... 48 9e-05 1 15.8% 6:106 807:906 -----RLLSAVTILDakVISSVSDMMTELEENTGIRLTNNQRVTLYVHVSAMIERLIRNEP--PLVYKVVSSEERKQGCTKIKRALRNIESSYGIKVDQNELNYLY--------------
640 UniRef50_UPI0001693F30 hypothetical protein Plarl_... 48 1e-04 1 21.9% 14:86 56:127 -------------FPNEDIYFVIDVVRCLETNLHIEFSGGSHSALILHILMAMERLKRQFAIQ-MDRDSLLELRKTKEYNIVKTVA----------------------------------
641 UniRef50_B0MBK6 Putative uncharacterized pr... 48 1e-04 1 11.1% 20:118 190:282 -------------------SVIQKILGEQEQRYKKYLDDSSFREIILYLRIMVNRNQMGEFLEPQPDT------NSENYMFALDTLKYISQYCDVVTTEDDIKYFSRFLDGVRYMNNS--
642 UniRef50_Q8EMT4 Hypothetical conserved prot... 48 1e-04 1 17.5% 5:118 175:281 ----KEKLHEALQLEGSLLEQFHRRLERVENKLHIEFTDEKLMTMPTIFSLILRRIRKGFQIQ-PLSIRYDELSNTKEYQATEEIL------YDKSLPVPEKLFITLNLLTGSVHRNQ--
643 UniRef50_Q44651 Beta-glucanase (bglA) (Frag... 48 1e-04 1 20.6% 42:109 9:78 -----------------------------------------YYRFVTHLKFFDQRLFNGTHMESQDDFLLETVkyHQAYKCTKNIHTYIEKEYGHKLTSDELLYLTIHI-----------
644 UniRef50_C9XMT3 Putative transcriptional an... 47 1e-04 1 10.6% 9:112 184:284 --------REIELFNNVDLIELQRVVLSEINKFNINFLDFNLKNFIIHLAITISRILDGYCLDNVLDVVLTDFQSNT---TVENIFNYIESKYTIIISKADRVYLYNHFITK--------
645 UniRef50_B9Y3A7 Putative uncharacterized pr... 47 2e-04 1 8.6% 14:106 194:286 -------------VDEEERNEIRHIFLRVLRESGIAISDTYTNRIAWYLVLARNRIKAGFGVTR-NEAKMTYVRTFGEARIAADIVAALQDVygFELPEEEVLAIA--------------
646 UniRef50_Q6M215 Transcriptional antitermina... 47 3e-04 1 15.8% 43:118 1:82 ------------------------------------------MALADHLQMAVKRNELEPELTSNPNPLSAEvlYPEETRLATEILERTNNWLAEklPPAEVVAISLHLVNAGFRTED--
647 UniRef50_UPI00016945E4 hypothetical protein Plarl_... 45 7e-04 1 22.7% 73:116 2:45 ------------------------------------------------------------------------LKSTAEYAAAVNISKELEQVFLIPFPEDEVCYIAMNLLGSKVNH----
648 UniRef50_C9AS60 Predicted protein (Fragment... 45 8e-04 1 16.0% 11:91 193:267 ----------NNFLNKDILKKVAELLNRYMNKTQLKFTDYEFQTLAIHLAIAIERIETSNFLSRSNNSEEEISENTLI------LIKMIEK-----------------------------
649 UniRef50_C7IBL1 Transcriptional antitermina... 45 9e-04 1 19.1% 4:97 171:260 ---KDGIVLEENLISKEILNQIHIVLEQVLKEYKLEIDDYGLVYLIISVAIAYLRILDGHRLKNVDNICEELIIQ----EASAEIWEKLNKQWQLDI-----------------------
650 UniRef50_C4VQU1 Cryptic beta-glucoside bgl ... 44 0.001 1 13.0% 65:118 1:56 ----------------------------------------------------------------MKNNLLWDIkyPKEYKIGLAALDIIEHLTSFRLNDDEAGFITMHIVDAQMEQGS--
651 UniRef50_C0DZ78 Putative uncharacterized pr... 44 0.001 1 14.1% 45:108 108:173 --------------------------------------------FLTHVRLFLTRVLGGQQLDTGLSAVRASlnHPEAMRVGRNIARLVADDLGVDITEDEETFLALH------------
652 UniRef50_C3RPA7 Predicted protein n=3 Tax=B... 44 0.002 1 8.7% 26:117 205:294 -------------------------IISLLKKYNVSLSDTSLIDFLVYILVMISRAKSKHLLTEIDIPE--EFNLSIEMQVAKEIALKIKDTINCQITYDEIKQIAIELFAKEDKGS---
653 UniRef50_D1P1R2 Transcription antiterminato... 57 2e-07 1 12.1% 1:116 280:397 IAQRINNQDSTTQKSGSHNALSEHILNYINDRYNYDldEKLKKDLNTHLSSLITRLQYHISTPNPLLSDIKQY-YPFAYDVTLSALTSASKhlPYPVNEDELGYLAVHIGVSLERN----
654 UniRef50_C2HB07 BglG family transcriptional... 57 2e-07 1 11.8% 18:119 279:381 -----------------LLECSSEVIHRMEFLMAIEFDseLLMNVFYHLVPAYFRISYSFYLPNVMIDQIKH-QYATIYEMTRKALRPLEKRIGKSIPEEEVGFFTILFGGEIRKVDEE-
655 UniRef50_D0BM95 Putative uncharacterized pr... 57 2e-07 1 11.5% 16:119 284:388 ---------------PEIIKIMDEIILQVKVNTGLEFPeqFRKNLYAHLYPAFYRQIFDVSLKNPLTSQIIK-EYDYLFALIKRSLKPLEEATFKKISNDEIAYFTIHFGGYLENIQKE-
656 UniRef50_A4VZ09 Transcriptional antitermina... 55 7e-07 1 14.4% 15:118 290:394 --------------DDLFYHLTVEIVEEMERLSLITFesEMIEGLQRHLIPAYYRLTSRLVNVNSYTETIKE-EHADLFYLVKKALRPLEEHLGFTIPDSEVSYFVIHFGGYIEAGQQ--
657 UniRef50_A0KQ06 Transcription antiterminato... 55 7e-07 1 9.3% 20:116 295:392 -------------------QLVEHLLAYIHQHYPYDLRGDLQLrlQTHISAMLLRVKYQIGSHNPLADHIKQY-YPLAYDITLAAISEWIRQTPYRLTHHEIGYLVIHIGVGLERH----
658 UniRef50_B6G892 Putative uncharacterized pr... 55 7e-07 1 15.5% 13:115 147:250 ------------LITDGVWNVVAGMLDAVYQAYRFDFRNDlrMNLARHVAPLLVRLSYGLSVDNPLTEDIR-MRFPLAWSMAVDASQALQQMSGATVDMAETGYIALAFALAIER-----
659 UniRef50_D1AI87 Transcriptional antitermina... 55 9e-07 1 9.8% 17:118 300:402 ----------------EIKLLVQEIISEVNNYTDLDidEELFNGLLNHIKPVIYRMKNSLGIEEEIYYEAIKA-YPELFDIVKNALKGLENLIGKKIDNSEIALFTIHFLASIERNRN--
660 UniRef50_C0X3T6 BglG family transcriptional... 54 2e-06 1 12.5% 16:119 274:378 ---------------EFLLDISGEIIRKMELLAVVQFEqeLLMNVYYHLVPAYFRINYGFYLPNVLIKDIRQ-SYRSLYHLCEQALAPLEKLTKRSIPSEEIGFFTILFGGEIFGQKNE-
661 UniRef50_A6LQ03 Transcriptional antitermina... 54 2e-06 1 10.7% 15:117 305:408 --------------DINYENIAKEVTEEISTKIYVDidEQLIRDLTQHFKQTFYMLNLGLKVINPLINEIKE-HYSELYKIIKNTCRLIFSRYNFKIPPEEVGYITMHIAVAVQKQQ---
662 UniRef50_B2DUK0 Transcriptional regulator, ... 54 2e-06 1 14.3% 7:118 278:390 ------FEGEVDVAPVYFNQLTEAIISRMEDilHFKQREGLRENLRRHLIPAYYRLKFGLPSSNEYVLHVKE-HYPDLFELVKDSLMPLMDAIDNPIPDSETAYFVIHFGGYLKKADT--
663 UniRef50_Q7X1P0 Putative transcriptional re... 52 4e-06 1 12.5% 16:111 211:307 ---------------EFLYDCSYEICRKVEHSTGIEFknNVVDHIYAHLVPAYFRILGKFTIQNVLIEQIQK-QYNHLFQITHYSLTPLEELLGERLPDSEIGYFTILFGG---------
664 UniRef50_Q03C88 Transcriptional antitermina... 52 4e-06 1 11.2% 3:118 286:398 --NRRGAIDLDDWVKAQIFSVA--LIDHMETEIGFPfnEKLFEELYNHMTALFKRLSQHVKVVNPLRKTIQQ-GYGPIYDAIDRFFKT--GRYQLTMSDDEKAFLAMYFSATQAEDRQ--
665 UniRef50_C2C385 BglG family transcriptional... 52 5e-06 1 13.7% 18:119 283:385 -----------------LLHCASQMIQELERRSAIQFEDylLLDVFNHLVPAYFRIYYDLEIEQPFLTTIER-DYPEISAITEAALSPLEKLVGKPISKGEKAYFTLLFGAAIKNQQEK-
666 UniRef50_B9DVZ2 Transcription antiterminato... 52 5e-06 1 13.0% 6:120 266:380 -----SLSYQEGGVSQKLLNLYQEMVQEVKDSLLINFdeKLFVEMHTHLKFLVNRLIFHIQANDLFHGEIKQ-KYPLAFEMATVAGKVLEKNFATRIELSECSYLALYFELIMREKEDQI
667 UniRef50_C2JT05 Transcriptional antitermina... 52 7e-06 1 11.9% 18:118 291:395 -----------------ILLAIEKMVDRFEQDTLVKIPNRKAFdlLAHLRPAYFRVKYGMHLTNidKVFKEDTWHKMLFETVKADLEPLEKLVGKSFPIEEIKLITFYFGGVLESRRQ--
668 UniRef50_B0MAU3 Putative uncharacterized pr... 52 8e-06 1 13.8% 5:120 303:416 ----KKFLIEKEI---DIEDAAQNMIQYISSIVGRDFREdlKTSTALFLNSSFIRVKFGFEIKNPFLDEIKRT-YSAIFSACFTASKEYESLVGAFPTEDEISYMAILFGGAMVQNKRDI
669 UniRef50_Q04I39 Transcriptional regulator, ... 51 1e-05 1 14.3% 7:118 278:390 ------FEGEVDVAPVYFNQLTEAIISRMEDilHFKQREGLRENLRRHLIPAYYRLKFGLPSSNEYVLHVKE-HYPDLFELVKDSLMPLMDAIDNPIPDSETAYFVIHFGGYLKKADT--
670 UniRef50_D1APJ4 Transcriptional antitermina... 51 1e-05 1 10.7% 17:119 293:396 ----------------EIEIFVKDLIALVNEDIDYNidEQLAEGLLNHMKPLIYRLKNNFSI-NSDIHIKAVEEHFNIFYLVKKSLSKFNSIICKEISDSEIALLTLHFLASIERNKNK-
671 UniRef50_A8RAP2 Putative uncharacterized pr... 51 1e-05 1 16.5% 15:117 282:385 --------------DIQLFELAQHLCDVFERLAYIQLVDklINSLYIHFKLTMYYYRLSIQVVNPLIEEVKE-NYSDLYQLVSEICKDLSSEFPFPVLDSEIVYITMHFGGHLRQGS---
672 UniRef50_A8RDS9 Putative uncharacterized pr... 50 2e-05 1 12.8% 16:109 808:901 ---------------EKVMEDVEDIVTDLEELLEKKLSPTTKVGLYVHISCLIERMILRQEITTVEGFDALLGEHGDIIMKMKHVFSGVEMRYSVEVPYPEMYYILNYF-----------
673 UniRef50_C7TGA7 Transcriptional antitermina... 50 2e-05 1 11.4% 22:109 293:381 ---------------------LESSLKRAESYYGIPlnESYRNQIINHIMRLLDPIEESIPVFNPYSQKTKR-EYLFAYSIACFLYDELQNDFDIQAPESEIAYLAIHI-----------
674 UniRef50_Q9KGB4 BH0193 protein n=3 Tax=Baci... 50 2e-05 1 13.3% 16:120 290:395 ---------------PNLLPALVDMLRLFEKRACIALQEklLTKLLLHVNPAYYRIKYQLTEMSKTSTKISE-EYKELHHLVKQSMKPLETLIGVEIPENESSYLTLLIGGWLTRQGDSI
675 UniRef50_Q5WJH1 BglG family transcriptional... 50 2e-05 1 15.3% 29:113 302:387 ----------------------------LEVSYGIQLneEVLEQVYAHFRPAYYRIIFQYPIVNPLKDKIKK-QYNALFKLLKDILEPLNLPNNITVSDDEIAYLTIHFATLI-------
676 UniRef50_D0BN54 PRD domain-containing prote... 50 3e-05 1 14.2% 15:120 284:390 --------------NAQIEKTVDEFIALVGELAGIHfdDYLRGMLINHIPAMIMRLRNKIHLKSDLMEEIK-YQYGVLYNFVWLSGKVFKNNFNVELTDNEAALLTIHLEISVEKIKKPM
677 UniRef50_D1AKT2 Transcriptional antitermina... 50 3e-05 1 8.7% 17:119 295:398 ----------------EIELLVKELIKNVSSRTNTDidDELLEGLLNHIKPAIYRMKNSIF-TEEDIYFDEVKEYKELLEIVGESLKPLAELIGSGFSNSEKALFTLHFLASIERNTKK-
678 UniRef50_D1AGS1 PTS modulated transcription... 49 3e-05 1 8.7% 17:120 307:411 ----------------KIETLVGRILEDAAKVFDINfdQILIKELINHMKPAIYRIKNKMSLKVSILEDVKS-EYADLYEKTRVSLGVINEFLDENIDEDEIAFITIMFKRAINRNQEKL
679 UniRef50_C9BJZ7 Transcriptional antitermina... 49 4e-05 1 12.6% 16:118 305:408 ---------------QDVMKLVENVIYKVSKAINHSfdPQLLTNLYAHLSMRLSRKKKFVNEYNPFKEDIKQ-KYPELFDAIKQAVRQEISEQNILINDSFVAYIALHFLVSYEREED--
680 UniRef50_B4U0E0 Sorbitol operon transcripti... 49 4e-05 1 12.8% 16:109 276:369 ---------------ESIVRLYSKMIEQIKASLLVTIddKLFVALHTHLKLLVNRLIFHVQANDIFHGEIR-YKYPLAFDMANVAAQVLAEEFDCAIELSECSYLALYF-----------
681 UniRef50_B9DJ28 Putative regulator of sorbi... 49 4e-05 1 10.9% 18:118 282:382 -----------------IMKIINNTIRDVKRYFDIQIDENLFndIKLHIKHLINRLIFNIKLENNVSAEM-DIQFPFAFELSKILGDSITKYTGLSISKPELGFLTIYFSVYLEQLEQ--
682 UniRef50_A8R9X4 Putative uncharacterized pr... 49 4e-05 1 12.4% 14:118 290:395 -------------FELELFEAASKVLYNFENLVCITFKdsLLDALIQHLRPAMYRIRYHYHIEGKILNMIL-PQHSYLFELTRHAMQPFEEMIKSPFPEEELAYITILFGGWMTKEGT--
683 UniRef50_D1ARA3 PTS modulated transcription... 49 4e-05 1 10.1% 21:119 322:421 --------------------LVRKIINEVDKYTEVEITKdlFEGLLNHIKPTIYRIKNNIFFPGLVLEEIINTE-KELLEIVGKSLADLENYIGCKISNIETALFTVHFKLAIERAKEK-
684 UniRef50_B0MFY1 Putative uncharacterized pr... 49 4e-05 1 12.4% 15:111 298:395 --------------DLYISNFTKALVVNFERIACISFddRLMTRLKGHIRPLYYRLKYGVQSTNPLVQDVMRM-YPEIYDFTGRAVREMKDDLAKMLTSDEIAYLTIYFIS---------
685 UniRef50_C0CS52 Putative uncharacterized pr... 49 6e-05 1 10.1% 18:116 304:403 -----------------IYRFTASLLKNFERIACIAFeeRLANRLRGHIRPLYYRLKYGMQSTNPLLKDVMRM-YPEIYEFTERSVRAMPDELAQTLTDDEIAYLAVYFISDEKKQ----
686 UniRef50_C3WAJ1 Predicted protein n=1 Tax=F... 49 6e-05 1 12.1% 21:119 303:400 --------------------FIEKFIRDVSSQLKYNLTKdlFNGLLNHLKPAVYRIKNKINLENSIYEEL-ILKEKKLFDIVKKSIENIPEL--KEISNDEIAYLVVYFKASIERIEQN-
687 UniRef50_B0MI12 Putative uncharacterized pr... 49 7e-05 1 14.3% 2:106 381:485 -SMRNIIGQLTILNPDKIIVDVEEAVEKIEDFSRSAFSVDLKKMLYIHISIMVERLILEKGRLPLEDESQFAKCHSEFIINAKNSFSVIESKYNVSVNQKELKLIY--------------
688 UniRef50_B9Y7S9 Putative uncharacterized pr... 48 7e-05 1 7.8% 29:118 4:93 ----------------------------VSQLYSIDlhESFIIPFGLHIKALITRASLGKYNRNPLSEKIKQDC-PIIYDIAIFIALRLSEIYQVAIAEDEVAFIFLHVGTEIDRQNS--
689 UniRef50_C2FLI0 BglG family transcriptional... 48 1e-04 1 10.1% 10:118 305:414 ---------ERDNVKTKVYKAAIEVVESFQQITGFSFYDrlTSELYVHLLSTYYRVKYHRQYRDGMVKAIEE-NYPDIYTYTELSIRPFEKLNNYPLNENELSLIAIYFGSQMYQDES--
690 UniRef50_D0BMI3 PRD domain/PTS system IIA d... 48 1e-04 1 11.4% 5:118 273:389 ----LLLNYKFEELPQEKVdfINDLVKQVSKAMNINfdDVLLKQLHQHIPAMLSRLKYQTVVKNPFSEQIK-LEYSITYNILWIILEEILPQNISKINEDENAFLTLYFQLSIEKLKK--
691 UniRef50_C6JP15 Predicted protein n=2 Tax=F... 48 1e-04 1 13.5% 17:120 301:404 ----------------QIETFIMQLIKEVSkySGLDKDETLLEGLINHIKPAIYRAKTGIQLSSEIYNDFKE-SYPLILNQVEEAWKK-CDFQGLNMSNEEIAYIAMHFQLAIKRVKKRV
692 UniRef50_B1BZF6 Putative uncharacterized pr... 48 1e-04 1 13.3% 21:118 302:399 --------------------IVTNFISGMSLEMGIPFQNdlIEGLFNHIVPLIQRIKLGVVVDENVISLLST-KNLEVYEIVSRVITKI-DILNKITNENEIAYLTIHFIASLKRINT--
693 UniRef50_Q721U2 PTS system IIA 2 domain pro... 47 1e-04 1 12.5% 15:118 277:383 --------------DEAVIefVTGICEKMGEIYQVDfdTDFFTQIKAHIKLMIRRVRAGVTIENPIFNEFMR-DNREIFMRVKESLDALKPLLPISVSSQEISFLAIYFASEVQRNKQ--
694 UniRef50_D1API4 Transcriptional antitermina... 47 1e-04 1 13.1% 21:119 310:408 --------------------LAKEMIKNIEEETGILVTNKKFEevIRYLRPAIYRIKNDIQNTAVDYKKVME-RYNFLYKATEKSLKSLEEFLGKKIDANEIAYLTVYLRMAVENYRKN-
695 UniRef50_C5ERS0 Putative uncharacterized pr... 47 1e-04 1 15.4% 15:118 319:424 --------------DEVFRLFCEDFIDAFTTITNINlnPSFCENVISHINLMLKRLLGRTPASNPLMELLIKDYQSTL-NVCRIICCILARKFGleLSVDEISFLMLYILGETVRQSE--
696 UniRef50_C6VLN1 Putative uncharacterized pr... 47 1e-04 1 8.2% 21:118 291:388 --------------------IVRQIIRRFNDVSGSQIseSLEVPLLTHLLSTYYRVKYQITFKQPSLSIIMK-QYNELIFFTRLSLKPFEDLIDQRLSDEEVTLVAIYFGGILRKENK--
697 UniRef50_D0DS07 Multidomain protein n=1 Tax... 47 1e-04 1 10.5% 21:115 295:391 --------------------IAKKIVRNFEGLARVNlnSKIVSDLAQHLVTTYYRVAYNINYKNPLLGQIRSM-YQQTFSFTKVSIQPFIKFTNHEISDDEVSLITTYFSGALYN-----
698 UniRef50_C8P2Y4 AAA superfamily ATPase with... 47 2e-04 1 11.7% 17:119 821:923 ----------------KLLNFVSDSTSHLERKMQKTFQSKTIVGIYIHVCFLIERLVTKTAIDDYKDVKRFEKDHQAFIRDVNDSFGPMLEHYNVMLPVSEIALLYDYIENDKNREHGE-
699 UniRef50_UPI0001BC4864 transcriptional antitermina... 47 2e-04 1 13.7% 18:119 299:401 -----------------IESIIDKLIKSIGEDLEVNfdSELFEGVLNHIKPMIYRIRKGIKLENTITREIIE-ESPKIFLSLKKNIGILENFIKCKVDDDELSYLCVFFKLALKKHYPN-
700 UniRef50_D1AJ16 Transcriptional antitermina... 47 2e-04 1 15.5% 13:115 299:403 ------------IVDKNELSMAKKiiELVEASLKVNldSTLAEGLVGHIDRALIRIRSGISVSNPINSEIKN-RYEELYRVIRQSIDEVFQ--DDLFPEDEIGYLVLYFVVSLDK-----
701 UniRef50_A8AVC7 Phosphotransferase system m... 47 2e-04 1 15.2% 18:116 289:385 -----------------VLDFINSVSKLTEESY-FCVDTDLFEGILTHLRPATKRLLNGEELLNPLYDEVIS-HFKELHEAVLESLPALERKLGVTFTLQESSFLTLFFESSLQRK----
702 UniRef50_D0AKJ9 RNA polymerase sigma-54 sub... 47 2e-04 1 9.9% 6:106 779:880 -----NLMEQLTILNpkLLERVSDAIYILQNDLGISFDNNTCFGLYVHISCLIERLVKQNTLEDEIYFNETSEEFQKFQTHFKQSFSVVEHYYSVDIPIHEVKYVY--------------
703 UniRef50_B5Y2A8 Sigma-54 dependent transcri... 47 2e-04 1 10.1% 17:105 820:904 ----------------KVINQVEQFLLRYEHLAGCDVPNDRKVALYVHISCLIERL-----IRNASPSHYSGRQCPqeLATLREAFSVIESGYSVKIPVVELCYI---------------
704 UniRef50_A6LZV7 Transcriptional antitermina... 47 3e-04 1 14.6% 16:111 295:391 ---------------KEIAELTEEFLSIVDKKYNCSynPELKKMLSIHIDKMLYRSEQGHFEHNASIRNAKEL-YKLQTEMADILYKLIFDKYGYKIQEEELGFIILYMGA---------
705 UniRef50_D0GPJ5 PRD domain protein n=1 Tax=... 47 3e-04 1 7.9% 20:120 315:416 -------------------SLIEQFLVKLSRELKINLATDVILrlLNHLKPAIYRMKNKFKLTESILKEVKA-QYTDLYDKTTMSLKIISDFINIPFDEDEAAFITVIVQRAVLRNNSSL
706 UniRef50_C9BPG8 Transcriptional antitermina... 47 3e-04 1 13.1% 35:118 295:378 ----------------------------------IDLDEslYQEMKQHLSLLINRVIFRYRLTDLFYGEIEK-KYPFSYQIASECIQALEAILQHKISKVEISYLTLYLELAFRYQKE--
707 UniRef50_D0GNQ2 PRD domain protein n=1 Tax=... 46 3e-04 1 11.0% 12:120 295:402 -----------NWIDIDVL--VKSLIENVNNKLDVDISEdlFQYLRQHLKPLFYRIKNDYSLNEKFVQDLKFSKNSLFY-LIKDSLEILSNILKKDIPDEEIFLLMLHFQASIERAENNV
708 UniRef50_C7XVA0 Transcriptional antitermina... 46 3e-04 1 10.3% 14:110 295:396 -------------IDDEVSSDASKLADYYINGFQLSIHDPKVKAliSHIRPMFNRLKNRIVIANKLLDDIKS-EYQKLFDCLKRLSRQANDdlSWKISDDEIGFLTLYFA----------
709 UniRef50_C9XIX8 Putative transcription anti... 46 3e-04 1 11.4% 6:119 282:393 -----SLNEDMDLISTEII--VQDLIYNMSEILEISFKEdlYKGLLNHIAPLIERIKQNIQIYEELLHVIPD-KYQYVLEATKVSIQK-NRVLSQIKNENEIILLAIHFLGSIHRNERN-
710 UniRef50_C3W9R0 Predicted protein n=1 Tax=F... 46 3e-04 1 5.1% 22:119 292:390 ---------------------IYKIILDFSNLKKINLTEdlHQELLNHLKPLLYRALKNINLGNSILREIKH-NYNNSFEICKNIFIGFEKNTSIKISEDEIAFVVLLFERAIQRIEKN-
711 UniRef50_C7CWS4 Transcriptional antitermina... 46 3e-04 1 13.6% 14:116 298:400 -------------FDTQLAYAVKQLIEAVSQETEVNFFEdlYKMLLTHLSGVFSrvLQEEDLTNPILERIMNQYQ----EIAAALRQALPQIfqKNLSEEEIAYMVLHFANSLERS----
712 UniRef50_C6JPW9 Predicted protein n=4 Tax=F... 46 3e-04 1 12.6% 18:120 300:403 -----------------IEKMADDLIKKVSEKINLNidSTLRDGLINHLIPTIYRLKNDIELENSIHREIIE-QYPVLYSEVKTALKKIEDFIGKEFSENETSFFVVHFVLSIKRMAEKL
713 UniRef50_C9A5U2 Transcriptional antitermina... 46 4e-04 1 6.2% 21:117 307:404 --------------------IVEELLTAIKQTSNYALETdlIDDLTSHIEGFINMNLMDARRSNPLLATIRK-SFPQAYDLCLTHLETVSLKHGFYFSPDEIGYIALHIAGAMERSS---
714 UniRef50_B0MF89 Putative uncharacterized pr... 45 5e-04 1 11.8% 2:111 773:882 -TMRNLIGQLTILNPDKILDDVEKALTRLEILEGENYPIDLKKMLYIHICVMVERLILEKGQLSESNPTQSLKCRESFVKNLKESFSVLEAQYNVSINDMEIHMIYSLIKN---------
715 UniRef50_C2H750 Transcriptional antitermina... 45 6e-04 1 15.4% 5:95 513:604 ----NKIVENLTILDakVLRLVQKAVKELEKLMGIEFSNNQLFLLYMHCCSMIERILRKESVDEQADIKEYIQKEGHNMELIHQAFQEVEKEYTI-------------------------
716 UniRef50_C9BLT0 Transcriptional antitermina... 45 6e-04 1 13.3% 1:98 789:881 IADRLNFLN-----PTIVMSEVETVISKYENYYHFTLNGRVKLNLYMHTALMMERLFLARTEKSEEPNYDLKPDEDEFYYVSRSIFQSMEMKYNFKVN----------------------
717 UniRef50_A2RJK7 Transcriptional antitermina... 45 7e-04 1 13.6% 15:117 251:353 --------------DNGLYRMAFNIMENVMKLSAIEFDdkTFMALLAHLTPAYYRIRNHFELKNVLLERIKN-EYHSLFLLMDNALRPLKDEVG-EISESEKAYFVILFGGEIYKNK---
718 UniRef50_D2EIK0 Transcription regulator n=1... 45 7e-04 1 10.0% 20:119 307:407 -------------------KVTKEIVDNFKKLSGMNSNNelLNDLYTHLVSTFYRVKYNHQYRDGLVTQIK-GKYFNVYTYTKMSLQPFEKLNVGHLNENEISLIAIYFGSQMVRQAKQ-
719 UniRef50_B0N881 Putative uncharacterized pr... 45 7e-04 1 11.0% 20:119 291:389 -------------------DIIIQLVTMMSDELGVFfdMILIKGLLNHVAPMLERIKNNIRVYELSQTVIPQ-SYEYVFEVLKSIVLSIQPL--QEISQEELIYITIHFIASIQRLRAN-
720 UniRef50_B2VI26 Stationary phase-inducible ... 45 8e-04 1 12.0% 18:117 231:331 -----------------LLQAVESSIARFQHIAGIEFrpDLSARLYTHLAQALERALFAIGIDDNLSENIC-LHYPRLLRTTRKAMKPFEQQYAVTFSHQEMELVAIIFGAWLVQEN---
721 UniRef50_C0CZN4 Putative uncharacterized pr... 45 8e-04 1 23.0% 47:120 29:101 ----------------------------------------------YHRSSAL-RCRYGIELENPFLEDVKKT-YPAVFSACFAAGSVIyrVTGEELSENEVSYLSLLIGGAIVRSEKKI
722 UniRef50_Q182P4 Putative bifunctional prote... 45 8e-04 1 12.7% 10:119 249:361 ---------LNSEVKEDVVEevDKLIDKFEVNTAIKLEseFKKNILRHLHSSYNRIRFKFPIRNPMLDETK-YKHESLYKIIKSIIEN-EEEFPVfiREEEIGFIAAYFGGYLRGSRDN-
723 UniRef50_C9BA26 Transcriptional regulator n... 45 9e-04 1 16.7% 17:106 826:914 ----------------KIQKSLMDFIEELECTFHKKFTYSILLKLLIHTACLIErlINGHELKIISEDDTRPSHEPIFH--VKKAFKNIETEFGITVSYDECFFIY--------------
724 UniRef50_C9ABI6 Predicted protein n=1 Tax=E... 45 0.001 1 16.5% 41:119 323:402 ----------------------------------------LRENLLQHILPMLSRLRNGIIIENSLLDE-EKAEYRDTFNKLMEIVEDINnmFETKINEEEVGYLTLYFEKYKLSKENQ-
725 UniRef50_Q8EVW2 Transcriptional antitermina... 44 0.001 1 10.3% 3:118 282:398 --NKLKYHKKILLGLKNLKDVLYKMLSEIEKNHYIFfkDKLVTDLINHLIPAYYRAKFNLNVNVEYLNIVKE-KYKKFFNITVKHIGVVENYLKIKFSQEEIALLSLYFVSNILYSSK--
726 UniRef50_B8DCH4 PTS system, IIA 2 domain pr... 44 0.001 1 12.8% 10:118 285:394 ---------LTEKLTEDLEKVVLTCLDLFEKKALVSLKNklIEKLLLHLKPAYYRIKYQMNLEDTLYEKFNQEFEALNF-IVKEAFDPLAKFIGREIPAGEIFFISLFIGSDMIPQND--
727 UniRef50_D1YCX5 Phosphoenolpyruvate-depende... 44 0.001 1 17.0% 17:110 285:378 ----------------DIYSTVSRCLDDTVEHFGLVIaeELYGSISKH----VGRLMAHAPSMPYFRNTLREsrSPFLYDAAVYLADKLSRLLGIFFTDDEIGLLAIYIG----------
728 UniRef50_B7C836 Putative uncharacterized pr... 44 0.001 1 12.0% 4:120 273:390 ---KIKSTDEVPKITDFTVLVFDEFCNEVFDKYSINLKESEALsmLLHIEFMNRRVIGGYELKNPIVDDVKT-KFPFAFEISMMIVPILFKYKRVYVTEDEISYLTVYVAQFLENENVKL
729 UniRef50_A8RV91 Putative uncharacterized pr... 44 0.001 1 12.5% 23:118 289:385 ----------------------MHMLERFESISCVRLDgeFLEILYQHMKPAVYRIWYGYHVEPDITDMIL-PKYQYLHEIVRKAVRPYEVYLTCTFPDPELVYITVLFASWLHKEGK--
730 UniRef50_D2BKR5 Transcriptional regulator, ... 44 0.001 1 13.6% 15:117 251:353 --------------DNGLYRMAFNIMENVMKLAAIEFDdkTFMALLAHLTPAYYRLKNHFELKNVLLERIKK-EYHSLFLLMDNVLQPLKEEVG-EISEYEKAYFVILFGGEIYKNK---
731 UniRef50_B4TA25 Sigma-54 dependent transcri... 44 0.002 1 16.5% 15:111 837:932 --------------PQRILKEMEGVFNHLTSSLSLKPSRQVTLRFLIHCCCMVERIVINRKPLQMALESQPNL-DARAFSVIKSAFLPIEDAYAIRLSDAEYFYIYELLYS---------
732 UniRef50_D0GJ33 Putative phosphotransferase... 44 0.002 1 9.1% 17:115 294:395 ----------------EVNLIIKNMIYKMEKEMKINFSEdlLEGLLNHIKPAIYRAKNKINLEETELYLNeeSFDKNLLEKVEEEVKKIENLLDINFKREEIILFIVHFQASMER-----
733 UniRef50_B0M9X8 Putative uncharacterized pr... 44 0.002 1 12.8% 9:86 275:353 --------NDFENVELEYRLFAVTIIQECENELKVPLseFLMKGLAVHLKIAMYRLRNQLVIDNPLMVDI-QYRIPFIYEMVKKLL----------------------------------
734 UniRef50_A0AG83 Complete genome n=13 Tax=Li... 43 0.003 1 16.7% 6:119 283:394 -----SLNEEMDLITTETL--VNSLINSMSEELNLPFLEdlYKGLLNHVAPLIERVRGNVQIYEDTFDVIPT-EFLYILQATSKVVKTIPLLESVE-NESEISLLAIHFLASIQRNQRE-
735 UniRef50_B6G1I6 Putative uncharacterized pr... 43 0.003 1 14.0% 14:113 177:269 -------------LDSDLIDAIKQI------ALEYELDSVAVEYFIKFFTVMIDRFLNGNPLSKLDKK-YEELKESIAYIFAREIANNISKVLMTDLPEEEILFISIPIAGMR-------
736 UniRef50_C2H0N6 Transcriptional antitermina... 43 0.003 1 12.5% 15:118 287:393 --------------DQELRKLISQMVENFQNQTLILIDddFERRILSHLRPACFRIRYNLSLGVYsdSLIKDSNHAILIDLMKELIIPIENWLNKAFPNDELDLLSYYFGYQLSNHNK--
737 UniRef50_A0AKK6 Complete genome n=19 Tax=Li... 43 0.003 1 16.1% 15:107 284:377 --------------SEEIAYAVDEFIALLEMYFATEikNEFKEKVILHVRPAIYRTILGFQINNPLKKQFIK-EYTSTFNIVEKASKPFEKLVGHKWSEEEIVYLSM-------------
738 UniRef50_B0MD50 Putative uncharacterized pr... 43 0.003 1 11.8% 11:112 294:394 ----------LGIIPSNTV--IHTFLVNVSHDLKLKLANdlYDQLSAHIKSFFSLLERSTSFDQSFYKELED-EYPAICKSVKNNLYILEQSFHRTYSENETAFLVMHIAAA--------
739 UniRef50_C7XZD0 Transcriptional antitermina... 42 0.005 1 11.6% 5:116 227:339 ----LKQKIQLNENDRKIVTFVHQMVESFKSQTLVDIPNQMQfrLVNHLRPACFRVKYDLSTIAIVNMNIDENT-KILADIIHQQIKPVEEWLGTPFPEAEIKLLAVYFGTNLIDN----
740 UniRef50_C9AHR5 Predicted protein n=5 Tax=E... 42 0.006 1 15.6% 17:106 44:132 ----------------KIQKSLMDFIQELECTFHKKFTHSILLKLLIHTACLIERTLINGHELKIISEDDTRPSHETIFHV-KKAFKNIETEFGITVSYDECFFIY--------------
741 UniRef50_C9MZ75 Putative PRD domain protein... 42 0.006 1 9.3% 12:119 295:401 -----------NWIDLDIL--VKNLIENINSRLNVDISKdlFEYLRQHLNPFFYRVKNEYTLNDKFIQDLEFTKNNLFY-LIKESLNILTNILKKDIPDKEIFLLTLHFQASIERVTNN-
742 UniRef50_C2BXH3 BglG family transcriptional... 42 0.007 1 17.5% 40:119 320:400 ---------------------------------------SLYEDLYQHVLPMLSRLRLGIGIENNMLDEVIS-EYRDTYLKVKAVSSEINKefEKKINNAETGYITLYFEKYKIKQKEQ-
743 UniRef50_C8UXN1 Transcriptional antitermina... 42 0.007 1 4.8% 15:118 326:429 --------------NDNFVAMTHRIILAVGALVDHDFSHdlQENLYLHLSQSLG--KENQLLQYSPFTQDIKHEYPQLFAAIEKTVHKELAAYRPILNDAFVAFIALHFMVSLNRDSQ--
744 UniRef50_C2JN59 Sigma-54 dependent DNA-bind... 41 0.009 1 12.8% 1:109 453:570 MQNKVEQLYDMDIFAQEPLAiiQEAIVFFEQLIQEKLTEDFQNILIVHLYSAVFYSAQMNETFYSDTKNIYSGKVTQ-YQAAKTMVDFLQTLFGISFADTEILFFDLFI-----------
745 UniRef50_Q8EUZ8 Putative regulatory protein... 41 0.009 1 13.7% 16:117 308:410 ---------------EKISSSIEKLIEKFEQETFVYLNNkvIEDLTKHIACAYHREKIKFTF-LLENIPNFIVKYNNYFLAIKKNIYIVEQLLDVKFQDIEIYYILLHLISNIVVEK---
746 UniRef50_Q8EVQ5 Putative transcription anti... 41 0.009 1 8.1% 20:118 304:401 -------------------EAVDTFLKNIKANNSIQYNQelKANIVDHILRSYLRIK---YFLMGSEYLRIKDEYKFIFNFVKENISVIEDFLGVKIFDDEIGLISLYFISDLFSDNS--
747 UniRef50_D0GLQ1 PRD domain protein n=1 Tax=... 41 0.011 1 10.2% 21:118 291:388 --------------------LVKNIIKTVENKISIQITKDKLLelIQHLKALIYRTQKGYKLK--DSIIVEERDEDKLYMTIKDSLKLISQQLGNEIENNEIHLLKIHFLASIERINK--
748 UniRef50_C0EX25 Putative uncharacterized pr... 41 0.011 1 7.6% 1:118 298:417 LSLRKQKIACQDQIMDKMRHPIKEILKGISERLSADFSEdlIEGLSSHIYTTILR---GNHLDVETDEYmmKRQYPFGFEMAAIAADYIADIYNLSMKENDLIYLAIHFQAAIERMKD--
749 UniRef50_C6PD99 PRD domain protein n=1 Tax=... 41 0.012 1 15.2% 15:106 319:407 --------------PDKIINLLIRFCNRLEIELNKQFSNTMKIKLIIHTGCALERTIINDSIKYKDSVL---NLNKDIIEKVRNCSKIFSDALNINLIDDEIYLIA--------------
750 UniRef50_A8RYZ8 Putative uncharacterized pr... 41 0.013 1 15.3% 20:117 297:394 -------------------EVTFSLISAMSKRMNMPFDKdlVEGLLNHMIPLIQRINNHVDIHDNVSSLMRPEEQQFL-SIVKQCCKETDTLEKLE-NEDELVYLTICFMASIRRMK---
751 UniRef50_B9Y7U3 Putative uncharacterized pr... 41 0.014 1 9.3% 22:118 261:359 ---------------------VTRLITCFESRMAVVIEDREMisIAQHLLASYYRIQFQFPIRNFCLDEIKS-RYFELFTMIRLILED-EQIFpkGIREEEIAFLTAYFGGVLRSQES--
752 UniRef50_Q5WI61 Putative uncharacterized pr... 41 0.014 1 20.0% 1:115 1:108 MEGKVQELYRKSE-NYELCVEVMQFTENLLRQEHIQTTDAQKLSLLSHLSAMVYRSTHKERIEPIDKHLFQEVS-KQSIEMAEKVCNRL-----TDLHEDEKYLLSIHFETAKMK-----
753 UniRef50_Q44636 Anthrax toxin expression tr... 40 0.015 1 13.2% 14:104 170:259 -------------FPYINKQNITDLINKMEKILNVQMYTYSKHKLCVLFAITISRLLSGNTIDNVS-GLILVNKNDDHYKTVASITSELQNSFGVTLHETEISF----------------
754 UniRef50_Q5WI63 BglG family transcriptional... 40 0.017 1 11.1% 17:115 302:401 ----------------DVVDITEKMIQYVSEQERIDydPKLYSNLLSHLSL---RLQNGSFYLNEMNPMEDEVkhASLFQSVKESCRKYVKQHTLIAQDSFISFIVLHFLVSYEN-----
755 UniRef50_Q88S25 Sorbitol operon transcripti... 40 0.017 1 10.5% 33:108 292:367 --------------------------------HQIPFdeHLYEQIKYHLFFLINRTILHVP-TAQLLPENQLTKYPLAYDLAHTILGFLETHLDFKITTAEFGYLVLY------------
756 UniRef50_C9YJN8 Sigma-54 factor, interactio... 40 0.018 1 6.9% 17:117 430:526 ----------------KFKSMCESIRQIIKEDEEIDISESIFKSMAIYIKSVL----DKSSSTNNIDLNQIRRNNRSEFKTALKIVGIIENEFDLFLSIETVAYITLFIVQAKQDEQ---
757 UniRef50_UPI0001C3689A transcription antiterminato... 40 0.020 1 14.0% 12:104 281:378 -----------NQIDEHNlgLVMKGMKKIRNNYGVDLseALVNGLILHVASSYGKYLVHMETENPFYEELQKI-YPTAYYYAIELAECITEYTKQNLSVGELGF----------------
758 UniRef50_Q1WQZ9 Sorbitol operon transcripti... 40 0.025 1 12.4% 20:108 280:368 -------------------ELFAEIFSQVKENISLDIdnRVFEQIKYHSIFMINRSATYMRNDDLFSREIVE-KYPVAVDLAIMTVNLLESKLNIKISDKELGYLALY------------
759 UniRef50_UPI0001B44A10 transcriptional regulatory ... 40 0.027 1 16.3% 15:106 39:127 --------------PKKTIEILSSFASVLEKKLGYKLDNTFKINLLIHVGCALERMVLN---DGLIYREPKNMLETNIFKALEQTNREVIYKMNLKLTNDELCYLY--------------
760 UniRef50_Q6LNG7 Putative uncharacterized pr... 39 0.036 1 28.7% 13:113 1:103 ------------MISQVAHDGTVKAVDLLVSEWQLDTSTEQLQMAMTHLARATDRILSDQPITqlDEDILAEIISDDDFPVIQATNRQILGGFGIEqpDAENTFFLSNLFSLY-------
761 UniRef50_C0X3N3 Regulator of sorbitol opero... 39 0.038 1 15.9% 4:116 267:375 ---RNSLLTDEGLLADYFQKMMKKIHHSVVVEFDEDF---LFSEMKDHLRNVMNRLVFHVECHDLFYGEIER-QYPLAYELAKIGLQELGRLLNRCVPTVEFGYLALYFELALRGN----
762 UniRef50_D2BLS2 Transcriptional regulator, ... 39 0.040 1 10.9% 8:117 273:380 -------LLFMEKFDTDFSYKIRQLIDKVSTILEIEfdDRLYGLLYAHLkpVLFPKKENDFIKKINKD------NPEIYKTVKE---SLREVFDKNFSEMEIAFISLHFVATLERSD---
763 UniRef50_C3RP00 Predicted protein n=2 Tax=B... 39 0.041 1 13.0% 35:111 4:80 ----------------------------------FTFLAKTIIGLNIHLCCLIERLIKKEEIVSHINIVDFEKNNQEFINGVRISFKAIANQYNITIPISEIAYIYDYVLN---------
764 UniRef50_D2MP77 PRD domain protein n=1 Tax=... 39 0.042 1 15.0% 6:105 185:281 -----QYLSDRTQVS--IIQKIRNFILKTAKETHTKITESDLQRAVLFVQIAIFRMQA-HQFTSLNAGTAQKIKNSEVRHYLEEHLKTLTRHFHVELSDEEMIYL---------------
765 UniRef50_D1YII1 PRD domain protein n=1 Tax=... 39 0.042 1 9.7% 9:111 189:291 --------YVTESFKDKILDVAQDIVNRYAYISGIKisPKFVIALINHLYASYFRSKFNFDFNSEALSDV-VHKFPEIVKFVQLSCSPLAKLVSKPISINEIALIILYFIS---------
766 UniRef50_A3I7T2 Capsule synthesis trans-act... 39 0.044 1 17.4% 14:105 176:265 -------------FTNSDFDVIHQLITTIENEKNIVYFINSKRKLSFLVAIVLERIKKENYVKMNDGHYLWE--KGIFYGPVKKLAKTLEERFSMELPNNELFFL---------------
767 UniRef50_Q034D2 Sorbitol operon transcripti... 39 0.044 1 12.2% 39:120 9:89 --------------------------------------DQFYSTIKYHLIFLINR---GIFHISPSDYLTDRMLQRFQldLSILMIDKLEEKLGIHIADVEINYLTVYFEMALQKTDANV
768 UniRef50_C6VNI0 Sorbitol operon transcripti... 39 0.046 1 10.8% 17:109 278:370 ----------------EVEDLMQSVFPILKQKLDVNLdkRLLMELRYHLLFLINRAIFDVKSEGFISVDMLS-KYPVSTELAQLTLSTIATKLNIRIRSQEVGYLTVYF-----------
769 UniRef50_C7XKI7 Transcription antiterminato... 39 0.047 1 9.6% 6:119 240:406 -----NFNRNIPYIREEYFDKVSKFFEEVFRSYELEYSEAEFHYFIYHLAlfLDRIKDDYVFNLMQDKELIRNlfPLAYEMTVTASPLIEHQLNMKLSPDELAFITLHVGASMERLYNN-
770 UniRef50_B6G7P8 Putative uncharacterized pr... 39 0.061 1 12.2% 20:101 189:261 -------------------QFLFDEIEMVERTLNCPFTDNARHELAIYLQVMMLRIRKGKTIPPRAGAV------PTAFAT---LLDHAEEHYGIALGPGE-------------------
771 UniRef50_C4VQU0 Transcription antiterminato... 39 0.064 1 12.3% 2:58 53:109 -QNAEQLINMLNDISLDEMEAANEILNLASNKLSMHLNDTEIISLSDHIHNAIARGKE--------------------------------------------------------------
772 UniRef50_C0D0X3 Putative uncharacterized pr... 39 0.064 1 15.3% 21:118 303:400 --------------------VTFSLISAMSKRLNMPFDKdlVEGLLNHMIPLIQRINNHVSIRDNMISLLR-PQDRQMYNLMAQVCAeiLKEIS---NEDEIVYLTVCFMASLKRMKS--
773 UniRef50_C7TMX2 Transcriptional regulator, ... 39 0.068 1 15.8% 15:115 23:117 --------------DPQAVQVIVSDVIQLAEQAEIHFTAVQLQVLTNHLIEMINRSKSGEKLPAVDPQMFAEVSKKSL-DLADQVVRHIG-----HLADAEKYVLSIHFEAAQNK-----
774 UniRef50_A5TT08 Possible transcriptional re... 39 0.071 1 13.2% 28:118 302:391 ---------------------------EIENKIDLKNIDVFLDEIFYYIKPLIFRTKRKIKLKNSILKDVKKL-YPSIFNFLKKNFYFLEEVIDEKVSDEEIAYLVPFFHKALQNNNK--
775 UniRef50_A7MM39 Putative uncharacterized pr... 38 0.078 1 13.0% 16:115 10:106 ---------------DETATLAGRMLDEvlERHQITPNAVQRQMLSSHVRAMAHRSVTGEPLPEVEESLFEEISESS-MALAREIVAQFGN-----LPDEEAWLLSVHFEVAKEN-----
776 UniRef50_Q9RMX9 Capsule synthesis positive ... 38 0.086 1 9.3% 2:119 272:395 -KEKEESVQYFKEGNLSIYELVKDFINSLEEKLKVDldEEFIFALVDYFKRTIYHLQYLCMFERPQKQTIQYMqhSETFSAVKEVYTEFVKKNEIavSVEEIAKVTMYIEASRLRYTSN-
777 UniRef50_B5CR43 Putative uncharacterized pr... 38 0.087 1 11.5% 17:120 191:292 ----------------DSWQKIREILYEAVYLDQSRLREDSFEKIVLYLGIMIHRNQQGSYI------EIQKRQPNSKYRMAQNILIQIAKEYFISHKEDEVQFLSELLisGYVSEKNEM
778 UniRef50_B0NYR0 Putative uncharacterized pr... 38 0.097 1 9.0% 20:108 57:153 -------------------SFVQEVMAIIQEFYEIVLDTeaYQRFATHLqlSKKRPIEEDEEDDVEFYERNQKKYPEAYVCSQKIVEHIEQHYNCKLSADEKMYLIIY------------
consensus/100% ........................................................................................................................
consensus/90% ......................thh..h.......ht...h..h..Hh...h.R...t...................h.hh...h..htt.ht..hs.tEh..hh..h..........
consensus/80% ..................hh.phlt.htp.hththpp.hh.tlh.Hl..hh.Rht.t..h.t.....h.t......aths..hht.lpp.hththsppEhshlshah..........
consensus/70% ............thhphhpphlp.hppththphspphh.sLh.Hlt.hlpRhppsh.lps.h..phpp..h...aphstthhp.lpp.hshplscsEhsalshahhs........
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown